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ABSTRACT 
 
DNA damage responses in the context of the cell division cycle 
Simona Giunta 
 
During my PhD, I have investigated aspects of the DNA damage response (DDR) in the 
context of three different cellular scenarios: DNA damage signalling in response to double-
strand breaks during mitosis, coordination of DNA replication with DNA damage 
responses by regulation of the GINS complex, and checkpoint activation by the prototypical 
checkpoint protein Rad9. Here, I show that mitotic cells treated with DNA break-inducing 
agents activate a ‘primary’ DDR, including ATM and DNA-PK-dependent H2AX 
phosphorylation and recruitment of MDC1 and the MRN complex to damage sites. 
However, downstream DDR events and induction of a DNA damage checkpoint are 
inhibited in mitosis, with full DDR activation only ensuing when damaged mitotic cells 
enter G1. In addition, I provide evidence that induction of a primary DDR in mitosis is 
biologically important for cell viability. The GINS complex is an evolutionarily conserved 
component of the DNA replication machinery and may represent an ideal candidate for 
transferring the DNA damage signal to the replication apparatus. Here, I show the 
identification of a consensus ‘SQ’ PIKK phosphorylation motif at the carboxyl end of the 
GINS complex subunit, Psf1. In Saccharomyces cerevisiae, switching the conserved serine 
to a glutamic acid is lethal, indicating that the site is crucial for the protein’s function. 
Moreover, in human cells, I identified UV-DDB, a heterodimeric complex involved in 
NER repair, as a binding partner that specifically interacts with the Psf1 C-terminus in 
vitro. Finally, I discuss my findings in characterizing functional interactions between Rad9 
and Chk1 in S. cerevisiae. I show that specific consensus CDK sites within Rad9 N-
terminus are essential to enable Chk1 phosphorylation and activation, and that MCPH1, a 
human homologue of Rad9, may share a conserved function in binding and activating Chk1, 
underscoring the evolutionarily conservation of checkpoint activation mechanisms.   
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1 GENERAL INTRODUCTION 
 
1.1 Foreword 
 
“ Homo mundus minor” 
Boethius (524 A.D.) 
 
A historical perspective on cancer aetiology needs to embrace the origins of multi-
cellularity, the secular evolutionary process that brought individual cells together. In the 
XVII century, Robert Hooke first uncovered the fundamental structural and functional unit 
of all living organisms, the cell; centuries of ongoing studies followed to unravel not only 
the mystery of how cells function and act, but also how they interact to form a living being. 
Cancer is a cellular phenomenon that stems from the breakdown of the universal laws of 
nature that govern multi-cellularity. Biological laws have evolved to enforce self-killing 
when a dysfunctional cell no longer contributes to the wellbeing of the organism as a 
whole. Selfishly, the cancer cell goes against these rules of co-existence and, if driven by 
an expansionistic pursuit, leads to the formation of a tumour that may result in the death of 
the organism. Such a short-sighted, egocentric plan initiated from a single cell occurs 
through circumventing rigid molecular restrains and is facilitated by modern lifestyle and 
the drastic, often evolution-independent, increase in longevity. As we keep postponing the 
antagonistic pleiotropy called ageing, we draw ourselves closer to the edge (of evolution), 
where cancer awaits.   
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1.2 The cell division cycle   
 
“ Therefore, I reasoned that study of the cell cycle responsible for the reproduction of  
cells was important and might even be illuminating about the nature of life” 
Sir Paul Nurse (Autobiography, 2001) 
 
The mammalian cell cycle describes the process whereby a cell replicates its DNA and 
divides to produce two genetically identical daughter cells. Essentially, two types of cell 
cycle control mechanisms exist: a cascade of protein phosphorylations that act as an 
“engine” to relay a cell from one stage to the next and a set of checkpoints that monitor 
completion of critical events and delay progression to the next stage if necessary.  
 
The first type of control involves a highly regulated protein family, the kinases. Activation 
requires the association between a cyclin, the core of each complex and the essential 
regulatory subunit, and a cyclin-dependent kinase (CDK), the catalytic subunit. The 
activity of the cyclin-CDK complexes is regulated by an intricate network of events 
including induction and degradation of the cyclin subunit, phosphorylation and 
dephosphorylation of the CDK subunit and binding of CDK inhibitors to the cyclin-CDK 
complex. The phosphorylation events regulate the length of each cell cycle phase and 
transition to the next phase (Collins et al., 1997; Funk, 1999). 
 
The second type of cell cycle regulation, the checkpoint control, involves complex signal 
transduction pathways at the G1/S, G2/M transitions and in S phase to mitosis to detect 
errors in DNA replication and chromosome segregation. When these checkpoints are 
activated, for example by DNA damage, signals are relayed to the cell cycle machinery to 
cause a delay in cycle progression and avoid acquisition of mutation. Therefore these 
checkpoints integrate cell cycle regulations with DNA repair, the integrity of which is 
essential to maintain genetic stability. Mutations in the checkpoint components may lead to 
aberrant cell cycle progression in the presence of stimuli such as DNA damage and 
eventually to genetic instability. 
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1.2.I The cell cycle phase of mitosis: brief but important  
 
 
“ Nothing we have learned about mitosis since it was discovered  
a century ago is as dazzling as the discovery itself ” 
(Mazia, 1987) 
 
The eukaryotic cell division cycle consists of four distinct phases: gap phase 1 (G1), 
synthesis phase (S-phase), gap phase 2 (G2) and mitosis (M-phase). G1, S and G2 phases 
are collectively termed interphase, characterized by cell growth and replication of the 
genetic material, of which the nucleus is the repository. The cell cycle culminates in the 
terminal phase of mitosis, whereby cell division results in two identical daughter cells. 
Although the fundamental aspects of cell duplication and division are similar in all 
eukaryotes, the duration of the cell cycle varies greatly between organisms. Budding 
yeasts, for examples, can complete an entire cell cycle in approximately 90 minutes 
(Forsburg and Nurse, 1991), whereas the mammalian cell cycle takes about 24 hours. 
Mitosis is the shortest cell cycle stage, lasting approximately one hour. Although brief, 
mitosis is a complex biological phenomenon, essential for the continuation of life. M-phase 
can be divided into two major events, karyokinesis and cytokinesis. Karyokinesis, the 
process of nuclear division, is commonly subdivided into different stages, based on 
changes in chromosome structure and behaviour. The onset of mitosis is defined by the 
condensation of nuclear chromatin into mitotic chromosomes and nuclear envelope 
breakdown, a stage called prophase. In pro-metaphase, kinetochores are formed on the 
centromeres of mitotic chromosomes, allowing microtubules attachment. In metaphase, 
chromosomes are aligned along the spindle equatorial plane by the spindle fibres. During 
anaphase, microtubules pull chromosomes apart at the kinetochores. As well as equal 
division of the genetic information, a successful mitosis must ensure that all other cellular 
 20 
components are distributed to the two daughter cells, through the process of cytokinesis. In 
telophase, cytokinesis and karyokinesis are completed, the cell physically splits in two, and 
the nuclear envelope reassembles around the two sets of chromatids located at opposite 
poles to re-establish a nuclear environment for each of the two daughter cells (Norbury and 
Nurse, 1992). Microscope observations of visually dramatic events during mitosis lead to 
an approximate subdivision into phases merely based on gross morphological changes. A 
new way of classifying mitotic transitions is based on the molecular dynamics of each step 
(Pines and Rieder, 2001). Indeed, mitosis is highly regulated by complex molecular 
mechanisms. The onset of mitosis is marked by the transition between G2 and M-phase, a 
crucial checkpoint for the cell. The G2/M boundary is susceptible to stress signals and 
initiates a reversible arrest, preventing cells from entering mitosis under challenged 
conditions and until DNA replication is completed (Bernhard et al., 1995). Once the G2/M 
boundary is overcome, chromatin is compacted, the nuclear envelope disassembles and the 
cell becomes committed to mitosis. 
   
Activation of the MPF (maturation/mitosis-promoting factor), a complex made of cyclin 
B/CDK1, is a critical step in driving cells into mitosis (Nurse, 1990). In interphase, newly 
synthesized cyclin B/CDK1 complexes are kept inactivated by Myt1 and Wee1 inhibitory 
phosphorylations on threonine 14 and tyrosine 15 of CDK1 (Parker and Piwnica-Worms, 
1992; Tuel-Ahlgren et al., 1996; Liu et al., 1997). In early mitosis, Cdc25, a dual-
specificity phosphatase, removes the inhibitory phosphorylations, enabling cyclin B/CDK1 
activation (Coleman and Dunphy, 1994; Lew and Kornbluth, 1996). Activated cyclin 
B/CDK1 complexes, in turn, phosphorylate specific substrates to promote events such as 
chromosome condensation and mitotic spindle assembly, enabling mitotic entry. 
Regulation of mitotic cyclin/CDK complexes is tightly controlled through positive and 
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negative feedback loops, involving a complex network of kinases and phosphatases 
(reviewed in(Perry and Kornbluth, 2007).  
 
Once the chromosomes are aligned in metaphase, a further checkpoint step, the so-called 
spindle assembly checkpoint (SAC), is in place to ensure that condensed sister chromatids 
are successfully attached to the spindle via their kinetochores before anaphase can proceed 
(Rieder and Salmon, 1998). The SAC directly inhibits the APC/C (anaphase promoting 
complex/cyclosome), a large ubiquitin ligase complex that targets selected substrates for 
ubiquitylation, mediating entry into anaphase and subsequent cytokinesis. Major effectors 
of the SAC are Mad2 and BubR1 that are enriched at loosely attached kinetochores, and 
prevent mitotic exit by inhibiting the APC from targeting Cyclin B and Securin for 
degradation. The cell remains arrested until the Mad2 and BubR1 signals are attenuated, 
when stable bipolar attachment of all chromosomes to the spindle is achieved. Once the 
SAC is satisfied, APC-mediated proteolysis of selected substrates drives cells into 
anaphase (Peters, 2006). The end of mitosis is marked by a rapid degradation of Cyclin B 
by the APC-Cdc20 complex, which causes the loss of CDK1 activity, allowing for the 
formation of a midbody and a new nuclear envelope (Kramer et al., 2000). The midbody is 
a transient structure made of compacted bundles of microtubules, containing proteins 
required for chromosome segregation and mitotic exit. Ultimately, cytokinesis completes 
the mitotic division into two identical daughter cells. Several molecular details remain to 
be elucidated in the complex series of events leading to cell division. In particular, the 
control of the APC complex during mitosis, including its ability to selectively recognise 
different substrates, is still largely unknown. 
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1.2.II Licensing replication: assembly and function of the pre-replicative 
complex 
 
In eukaryotic cells, regulatory mechanisms are in place to ensure that DNA synthesis 
occurs once every cell cycle to faithfully replicate each section of the nuclear genome 
(Blow and Laskey, 1988). The origins of replication are specific points in the genome 
licensed for replication initiation, which are fired once in a single S-phase. Eukaryotic 
origins of replication represent DNA platforms for the assembly of protein complexes, 
leading to the formation of two bi-directional DNA replication forks. Whereas bacterial 
chromosomes typically have a single origin of replication, eukaryotic cells initiate 
replication at multiple locations across the genome. Initiation of replication is a highly 
ordered and regulated process that involves a plethora of factors (reviewed in(Diffley and 
Labib, 2002). The pre-replicative complex (pre-RC) is a multi-protein complex first 
assembled on the replication origin during G1. The formation of the pre-RC in eukaryotes 
involves early replication factors such as ORC, Cdc6, Cdt1 and MCM2-7. The origin 
recognition complex (ORC) is made of six highly conserved protein subunits and is the 
earliest factor to bind to replication origins. ORC was first shown in Xenopus egg extracts 
to be essential for initiation of replication (Carpenter et al., 1996; Romanowski et al., 1996; 
Rowles et al., 1996), a function conserved across the eukaryotic domain. Loading of ORC 
to replication origins is a highly regulated process, influenced by DNA recognition and 
ATP binding and hydrolysis. Despite being structurally and functionally conserved, ORC 
mechanism and timing of interaction with origins varies between different eukaryotes. In 
Saccharomyces cerevisiae, ORC specifically recognizes a region of ~30 base pairs of DNA 
within an autonomously replicating sequence (ARS;(Bell and Stillman, 1992). Specific 
DNA elements, such as the ARS sequences have yet to be identified in higher eukaryotes, 
suggesting that DNA sequence alone does not define the origin of replication. In addition, 
 23 
although ORC is constitutively associated with DNA throughout the cell cycle in yeast, 
Xenopus and mammalian ORC is removed from chromatin in mitosis (Carpenter et al., 
1996; Romanowski et al., 1996; Natale et al., 2000; Tatsumi et al., 2000). ORC binding to 
DNA serves as a highly conserved assembly platform to recruit additional members of the 
pre-RC, including the loading factors Cdc6 (cell division cycle protein 6;(Nishitani and 
Nurse, 1995; Coleman et al., 1996; Tanaka et al., 1997) and Cdt1 (cdc10-dependent 
transcript 1;(Maiorano et al., 2000; Nishitani et al., 2000) that play a role in limiting DNA 
replication to once each cell cycle. Additional players are involved in positively and 
negatively regulating assembly of factors into the pre-RC. For instance, in Xenopus eggs 
and human cells, geminin was shown to be a negative regulator of Cdt1 and its rapid 
degradation at the metaphase-anaphase transition enables Cdt1 recruitment to early-
replicating origins (Wohlschlegel et al., 2000; Tada et al., 2001) and renders chromatin 
competent for replication initiation. Cdc6 and Cdt1, recruited independently by ORC, in 
turn, function synergistically to load the heterohexameric MCM (mini-chromosome 
maintenance) protein complex to chromatin. The MCM2-7 hexamer plays an 
evolutionarily conserved role in DNA replication initiation (for a comprehensive review, 
see(Kearsey and Labib, 1998). In addition to MCM’s role at the pre-RC as a component 
required to license DNA for replication, MCM functions at the replication fork as the 
replicative DNA helicase. Indeed, the MCM complex remains associated with the fork 
during S-phase and plays a role ahead of the fork as an helicase to unwind the DNA 
duplex, with a 3’ to 5’ polarity shown for the archaeal MCM (Kelman et al., 1999; Chong 
et al., 2000; Shechter et al., 2000). A plethora of biochemical data in archaea, yeast and 
more recently human cells have shown that a MCM sub-complex of MCM4, 6 and 7 
proteins possesses intrinsic, ATP-dependent, 3’ to 5’ helicase activity (Ishimi, 1997; You 
et al., 1999; Lee and Hurwitz, 2000). Elegant studies performed by Matthew Bochman and 
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Anthony Shwacha have found that, while both MCM2-7 and MCM4,6,7 are capable of 
binding to single stranded DNA (ssDNA), MCM4,6,7 binding to both ssDNA and double 
stranded DNA (dsDNA) is faster and more efficient. However, the MCM2-7 
heterohexamer does display helicase activity in vitro, but only when a putative MCM 2/5 
ATP-dependent gate is closed, suggesting that conformational changes, mimicked by 
removal of the MCM2 and 5 subunits, may have regulatory significance in controlling 
MCM enzymatic activity (Bochman and Schwacha, 2007; Bochman et al., 2008; Bochman 
and Schwacha, 2008).  
 
New data show that the MCM2-7 ring binds to Cdc45 and GINS, suggesting that the CMG 
(Cdc45-MCM2-7-GINS) super-complex may be responsible for DNA unwinding in 
eukaryotes (Diagram 1), with Cdc45 and GINS acting as cofactors of the helicase (Moyer 
et al., 2006). However, the mechanism of action of MCM as a replicative helicase is 
unclear. Nevertheless, several models have been suggested for the helicase action: (1) in 
the ‘wedge model’ or ‘steric-exclusion model’, one of the newly synthesized strand moves 
through the central helicase channel, preventing annealing at the DNA duplex junction 
(Diagram 1B;(Patel and Picha, 2000). This would be in agreement with data inferring that 
MCM preferably binds ssDNA. A variation of the wedge model is the ‘ploughshare model’ 
where MCM moves on dsDNA and another protein serves to separate the two strands as 
they exit from the helicase (Takahashi et al., 2005). A strong candidate for this role is the 
GINS complex (Diagram 1A). (2) In the ‘torsional model’, the MCM creates negative 
superhelical stress by rotating the DNA strands and inducing displacement of base pairing 
(Patel and Picha, 2000). (3) In the ‘rotatory pump model’, similarly to the torsional model, 
MCM acts as rotary motor but the rotatory movement along the DNA helical axis occurs at 
a distance from the replication fork. Fixed MCM complexes pump the DNA through the 
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ring in opposite directions, generating superhelical stress that unwinds the DNA placed 
between the two MCMs (Laskey and Madine, 2003). This is an appealing model that 
would reconcile data that MCM preferentially binds to unreplicated DNA (Madine et al., 
1995; Krude et al., 1996; Dimitrova et al., 1999) and that the MCM helicase does not co-
localize with the replication fork during S-phase (Madine et al., 1995; Krude et al., 1996; 
Ritzi et al., 1998; Dimitrova et al., 1999).  
 
DIAGRAM 1. Possible mechanisms of action of the CMG helicase complex 
during DNA unwinding 
 
 
Content not visible due to copyright limitations 
 
The CMG complex collaborates in the separation of the two DNA strands at the replication fork. 
Given GINS has been shown to have higher affinity to ssDNA, it is located in the replication bubble. 
In A, MCM2–7 pumps dsDNA through its inner channel by helical rotation in an ATP-dependent 
manner, destabilizing the double helix. In this model, GINS complex function more passively as a 
structural element resembling a strand displacement blade, or 'ploughshare' to sterically separate the 
two strands, preventing re-annealing of unwound DNA and providing room for the activity of the 
polymerases (A). On the other hand, in B, GINS is located in front of the MCM2–7 complex and play 
a more active role in DNA unwinding (B). To date, it is still unclear if the eukaryotic MCM acts as 
dsDNA translocase (A) or binds ssDNA during DNA unwinding. 
Image from(Boskovic et al., 2007) 
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In spite of a compelling amount of evidence pointing to a role for the MCM as the 
eukaryotic replicative helicase, additional details are required to clarify certain 
discrepancies and to fully elucidate MCM function as a helicase (reviewed in(Aparicio et 
al., 2006).  
 
1.2.III Entry into the synthesis phase 
 
Formation of pre-RCs and their activation are regulated in trans, by cell cycle-dependent 
control of replication licensing factors, and in cis, by structural features that aid selection 
of replication origins. Once the potential sites for replication are marked by the pre-RCs, 
CDK activity is required to enable single firing of each replication origin and timely 
initiation of DNA synthesis. It is noteworthy, however, that a differential regulation exists 
in the timing of origin firing. The so-called ‘early’ origins are activated as cells enter S-
phase, whereas the ‘late’ origins, often associated with heterochromatic regions, are fired 
later in S-phase (Bousset and Diffley, 1998; Donaldson et al., 1998) and often progress 
into G2 with ongoing replication. Licensed origins are activated for replication by CDK 
and DDK cell cycle kinases. In this context, CDK comprises Cdk2 associated with the S-
phase specific cyclins A and E (Krude et al., 1997). DDK (Dbf4-dependent kinase) follows 
an analogous mechanism of activation, where the catalytic subunit Cdc7 is activated upon 
cell cycle regulated accumulation of the Dbf4 regulatory partner at the G1/S boundary. 
When cells transit from G1 into S-phase, the pre-RCs are converted into pre-ICs (pre-
initiation complexes). In budding yeast, several proteins are localized at the pre-IC: 
Mcm10, Sld2, Sld3, Dpb11, Cdc45, DNA polymerase ε, GINS complex (consisting of 
Sld5, Psf1, Psf2 and Psf3) and replication protein-A (RPA; consisting of Rfa1, Rfa2 and 
Rfa3). The laboratory of Dr Hiro Araki has shown that in S. cerevisiae CDK activity is 
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required for the initiation of replication by phosphorylating two members of the pre-IC, 
Sld2 and Sld3 (Masumoto et al., 2002). Phosphorylated Sld2 binds to the twin BRCT 
(BRCA1 carboxyl-terminal) domains at the carboxyl terminus of Dpb11 (Tak et al., 2006), 
the homologue of fission yeast Cut5, that, in turn, regulates Sld2-Sld3 interactions. 
Phosphorylated Sld3, facilitated by the Dpb11-mediated interaction with Sld2 (Tanaka et 
al., 2007), recruits another important pre-IC factor, Cdc45 (Kamimura et al., 2001). Sld2 
and Sld3 are the major targets of CDK-dependent phosphorylation required for initiation of 
replication, because mimicking CDK-phosphorylation on Sld2 and Sld3 is sufficient to 
bypass the requirement for CDK in DNA replication (Zegerman and Diffley, 2007). In 
addition, Dpb11 plays an essential role in recruiting the GINS complex to the pre-IC 
(Takayama et al., 2003). In human cells, however, loading of MCM, GINS and Cdc45 
requires the Ctf4, RecQL4 and Mcm10 proteins, but not TopBP1, the human homologue of 
Dpb11 (Im et al., 2009), indicating that distinct but partially overlapping mechanisms exist 
in replication complex assembly across different species. The exact functions of many pre-
IC proteins are still largely unknown, although many remain associated with the replication 
machinery during replication fork elongation, suggesting that they may be required for 
helicase activity, such as mediated by MCM2-7, GINS and Cdc45, or contribute to DNA 
synthesis in other ways (Aparicio et al., 1997; Pacek et al., 2006). 
 
The final step in replication initiation is the loading of the replicative polymerases, DNA 
polymerase (pol) α, δ and ε (Hubscher et al., 2002). The pre-IC factor, Mcm10, recruits 
and stabilizes DNA pol α-primase at the replication fork (Ricke and Bielinsky, 2004; 
Chattopadhyay and Bielinsky, 2007; Zhu et al., 2007), which coincides with initiation of 
replication.  
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CDK activity not only promotes replication initiation at the G1/S transition but has also 
been shown to negatively regulate replication, in order to prevent re-replication and 
preserve genomic stability during S-phase. CDK-dependent phosphorylation events inhibit 
pre-RC formation as cells progress through the cell cycle by directly targeting members of 
the pre-RC complex. For example, in budding yeast, Cdc6 is phosphorylated and targeted 
for degradation in late G1 (Drury et al., 1997; Drury et al., 2000). ORC is also a target for 
CDK modification (Nguyen et al., 2001; Vas et al., 2001) although the mechanisms of 
ORC functional inhibition by CDK phosphorylation are unclear. Furthermore, the MCM 
complex’s cytoplasmic re-localization in G2 depends on CDK activity, as inactivation of 
CDK results in stable maintenance of the MCM complex in the nucleus (Labib et al., 1999; 
Nguyen et al., 2000). In addition, the MCM subunit Mcm2 is phosphorylated by DDK 
(Jiang and Hunter, 1997; Lei et al., 1997; Brown and Kelly, 1998; Weinreich and Stillman, 
1999). Possibly, this could act as a way to regulate activation of the MCM helicase, of 
which Mcm2 is allegedly an inhibitory subunit. 
 
1.2.IV The fork: elongation of DNA synthesis by the core DNA replication 
machinery 
 
The eukaryotic DNA polymerases α, δ and ε share similar conserved catalytic sites, yet 
play different roles in the elongation of the replication fork (Nasheuer et al., 2002; Takeda 
and Dutta, 2005). DNA pol α works in a four-subunit complex with DNA primase to 
synthesize short tracts of ribonucleotides that act as primers for leading and lagging strand 
synthesis. The RNA primer made by the primase enzyme is then extended by pol α. The 
function of DNA pol α in this process is a primary requirement for replication, being the 
only replicative polymerase that can perform de novo DNA synthesis on ssDNA. DNA pol 
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δ and DNA pol ε instead need a pre-existing 3′-OH priming DNA end onto which they can 
attach nucleotides (Hubscher et al., 2002). Due to the low processivity of DNA pol α (~30 
nucleotides) and lack of proofreading activity, most DNA synthesis is carried out by either 
pol δ and/or pol ε, which are more processive and contain proofreading exonuclease 
activities. Thus, after primer synthesis, a polymerase switch occurs with DNA pol α being 
replaced at the start of leading strand synthesis and during initiation of every fragment on 
the lagging strand (Takeda and Dutta, 2005). Inherently, DNA polymerases have a 5’ to 3’ 
DNA processivity, signifying that only one of the parental DNA strands will be replicated 
continuously; the so-called leading stand. On the other hand, the other strand, named 
‘lagging’, is replicated in relatively short ‘Okasaki’ fragments (Diagram 2b). Replication 
of leading and lagging strands requires a particularly robust coordination between DNA 
synthesis and unwinding, possibly achieved through factors, such as the GINS complex, 
which have been shown to bind both the MCM helicase and DNA polymerases. Although 
DNA pol δ has been implicated in lagging-strand replication (Garg and Burgers, 2005a) 
and DNA pol ε in leading-strand replication (Pursell et al., 2007), it is formally possible 
that the two polymerases participate in replicating both strands. The series of RNA-DNA 
hybrid fragments on the lagging strand require additional processing to promote their 
maturation into a continuous strand. The DNA-flap endonuclease Fen1 removes the RNA 
primers coordinately to the helicase/endonuclease activity of Dna2, and with RNase H; 
following DNA pol δ action, the Okasaki fragments are ligated by DNA ligase I (reviewed 
in(Garg and Burgers, 2005b).  
 
Association of the DNA polymerase auxiliary factor PCNA (proliferating cell nuclear 
antigen) is required to increase processivity of DNA synthesis (Jonsson and Hubscher, 
1997). The ring-shaped homotrimeric processivity factor PCNA encircles dsDNA and acts 
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as a ‘sliding clamp’ to prevent dissociation of polymerases from the DNA. The loading of 
the PCNA ring onto dsDNA is mediated by the conserved heteropentameric clamp loader 
protein complex called replication factor C (RFC), a member of the AAA+ family of 
proteins (Bowman et al., 2005), which recognizes RNA-DNA hybrids at the fork. RFC and 
PCNA, together with RPA, are required for the polymerase switch to DNA pol δ and DNA 
pol ε, thereby triggering ensuing replication. 
 
DIAGRAM 2. The eukaryotic replication fork 
 
 
 
 
 
 
 
Content not visible due to copyright limitations 
 
 
 
Origins of replication are marked by pre-RC on multiple distinct locations across the genome (a). 
Licensed replication origins are fired and replication is initiated (b). The MCM helicase complex 
remains associated with the fork during S-phase and plays a role ahead of the fork as a helicase to 
unwind the DNA duplex (see text for details). The eukaryotic replication fork comprises a plethora of 
proteins that contribute to DNA replication and its fidelity. MCM-dependent unwinding allows access 
to the DNA polymerases, pol α, in complex with the DNA primase, and the replicative polymerases δ 
and pol ε. Additional factors include the replication processivity clamp PCNA, loaded by the RFC 
complex, RPA, which binds ssDNA regions during fork progression, and factors that are involved in 
monitoring fork integrity. In S. cerevisiae, these are the checkpoint mediators Mrc1, Tof1, Csm3 and 
Rrm3. DNA topoisomerases I and II act to relieve the torsional stress caused by the DNA topology at 
the replication fork (c). 
Image from(Branzei and Foiani, 2010) 
 
Progression of the replication fork causes topological problems such as positive super-
coiling and concatenation ahead of the replication fork, counteracted by the action of 
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topoisomerases I and II, respectively, which nick the DNA backbone to release the 
torsional stress (Diagram 2c;(Nadal, 2007). Termination of replication occurs when two 
opposing forks meet and the newly synthesized DNA is ligated. 
 
1.3 DNA damage responses 
 
The maintenance of an intact genome is a pivotal aspect of cellular homeostasis. Upon the 
formation of DNA lesions, the cell promptly onsets a complex DNA damage response 
(DDR). The DDR network orchestrates a wide range of cellular events; these comprise 
sensing the lesion, arresting the cell cycle, coordinately with the repair of the damage, 
ultimately leading to resumption of the physiological cellular metabolism (Zhou and 
Elledge, 2000; Rouse and Jackson, 2002).  
 
On a daily basis, the DNA in the cell sustains a wide diversity of lesions, caused via 
exogenous as well as endogenous sources. DNA double strand breaks (DSBs) are breaks 
that encompass both strands of the DNA helix and are undoubtedly the gravest cytotoxic 
form of damage for eukaryotic cells (Khanna and Jackson, 2001). DSBs occur following 
exposure to ionizing radiations (IR) or radiomimetic drugs, including cancer 
chemotherapeutics. Physiological cellular processes, such as V(D)J recombination during 
immunoglobulin gene rearrangement and stalled replication forks during DNA synthesis, 
are also causes of DSBs (Bassing and Alt, 2004). Failure to repair DSBs causes genomic 
instability and can lead to tumourigenesis and other age-related diseases (reviewed 
in(Jackson and Bartek, 2009).  
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1.3.I Signalling cascades in response to DNA double strand breaks during 
interphase 
 
The molecular signal-transduction cascade that unfolds following DSB induction in 
mammalian cells has been intensively investigated in the context of interphase. 
Simplistically, the cascade comprises of two major stages and follows a hierarchical mode 
of activation: from an initial sensing of the lesion, activation of apical DDR kinases and 
amplification of the signal via mediator proteins, the signal is subsequently relayed to 
downstream effectors responsible for events leading to cell cycle arrest and DSB repair by 
homologous recombination (HR) or non-homologous end joining (NHEJ) pathways, before 
resumption of the cell cycle. 
 
At the apex of the DDR following a DSB, ‘sensor’ proteins are able to detect damaged 
DNA, possibly due to altered chromatin structure or perturbation in DNA-processing 
activities, such as replication and transcription. Although the exact molecular mechanisms 
are still unclear, the Mre11-Rad50-Nbs1 (MRN) complex is believed to directly sense 
damaged DNA and has been pinpointed as the upstream mediator in the activation of the 
DDR, being one of the first factors to be recruited to the DNA ends upon formation of a 
DSB (Mirzoeva and Petrini, 2001). Furthermore, the Ku70/Ku80 heterodimer, which 
displays high affinity for DNA ends in a sequence-independent manner (reviewed 
in(Downs and Jackson, 2004), also plays an early role in the DDR by sensing free DNA 
ends following DSB formation.  
 
The major apical protein kinase that orchestrates the intricate network of responses to 
DSBs is ATM (ataxia telangiectasia mutated;(Khanna et al., 2001; Shiloh, 2003). ATM is 
recruited to the site of break by interactions with the MRN sensor complex (Uziel et al., 
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2003; Falck et al., 2005) and becomes activated through auto-phosphorylation on serine 
1981 (S1981;(Bakkenist and Kastan, 2003; Abraham and Tibbetts, 2005; Lee and Paull, 
2005) and acetylation on lysine 3016 by the histone acetyltransferase (HAT) Tip60 (Sun et 
al., 2007). MRN-dependent DNA unwinding and tethering activities are required to recruit 
ATM firstly to the direct proximity of the DNA ends, and in turn, to promote ATM binding 
to the chromatin around the break (Williams et al., 2007). Furthermore, the MRN complex 
possesses nucleolytic activity, acting both as an exo- and an endonuclease (Paull and 
Gellert, 1998). Our laboratory has shown that MRN endonucleolytic activity is important 
for resection of the DSBs and it synergizes with another nuclease, CtIP (Sartori et al., 
2007), in response to DSBs. It is currently unclear whether MRN activity as a nuclease is 
directly involved in ATM activation. Evidence from the laboratory of Vincenzo Costanzo 
shows that in Xenopus, ssDNA oligonucleotides, generated as a by-product of MRN-
dependent resection, stimulate ATM activation (Jazayeri et al., 2008). 
 
Mutations in the ATM gene are responsible for ataxia telangiectasia (Savitsky et al., 1995), 
a recessive human genetic disorder characterized by immunodeficiency, hyper-sensitivity 
to radiation, genomic instability and cancer predisposition, impaired motor skills caused by 
cerebellar degeneration (ataxia) and red veins in the eyes (telangiectasias). The proximal 
kinase ATM belongs to the PIKK (phosphatidylinositol 3-kinase-like kinase) family of 
protein kinases. PIKK family members include ATM, ATR (ATM and RAD3-related), 
DNA-PKcs (DNA-dependent protein kinase catalytic subunit), TRRAP, mTOR/FRAP 
(mammalian target of rapamycin) and SMG1/ATX. The PIKK family is structurally 
unique. These large PIKK polypeptides, up to 450 kDa in size, display a highly divergent 
amino-terminus made of α-helical HEAT repeat units (Perry and Kleckner, 2003; 
Brewerton et al., 2004) and strong sequence homology in the carboxyl-terminal catalytic 
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domain. This kinase domain is flanked by two loosely conserved regions, the FAT 
(FRAP/ATM/TRRAP) and the FATC (FAT C-terminus) domain, residing at the very 
carboxyl end of the protein (Durocher and Jackson, 2001). 
 
DIAGRAM 3. Schematic structure of a prototypical DNA damage PIKK, ATM 
 
 
 
The schematic outline of ATM domain structure is shown. ATM is a 370 kDa phospho-protein, 
comprising 49 HEAT (Huntingtin, Elongation factor 3, A subunit of protein phosphatase 2A, and 
TOR1) repeats from the N-terminus to the C-terminus, up to amino acid 2661. The FAT, PIKK 
catalytic and FACT domains are located at the C-terminus and display strong sequence similarity. 
 
The nuclear PIKKs, ATM, ATR and DNA-PK serve as serine/threonine kinases in 
response to DNA damage. ATM and DNA-PK are directly activated by induction of DNA 
DSBs. By contrast, ATR activation requires generation of ssDNA, which may occur during 
replication stress, at sites of replication fork stalling or as a consequence of processing of 
DNA DSB ends, where ssDNA-binding protein RPA coats resected DNA breaks. 
However, the mode of recruitment of these DNA damage-induced PIKKs to the sites of 
DNA insults is analogous. A C-terminal PIKK interaction motif on Nbs1, ATRIP and 
Ku80 is required for the recruitment to DSBs of ATM, ATR and DNA-PKcs, respectively, 
and, importantly, for PIKK-dependent activation of the DNA damage signalling cascade 
(Falck et al., 2005). This outlines the close relationship between these protein kinases and 
provides a regulatory mechanism to control their recruitment to damaged chromatin.   
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A prime PIKK target at sites of DNA damage is the histone H2A variant H2AX, whose 
derivative phosphorylated on serine 139 (S139) is referred to as γH2AX. This post-
translational modification on H2AX C-terminus tail spreads over many kilo-bases of DNA 
flanking the DSB site and leads to amplification of the DNA damage signal (Celeste et al., 
2002; Celeste et al., 2003). γH2AX is regarded as a hallmark of DSBs and can be 
cytologically visualized by fluorescent microscopy as discrete nuclear punctate ‘dots’, 
called IR-induced foci (IRIF;(Rogakou et al., 1998). Phospho-S139 of γH2AX acts as a 
docking site for the recruitment of the DDR-mediator protein MDC1. MDC1 binds H2AX 
phospho-epitope via its C-terminal tandem BRCT domain (Stucki et al., 2005), creating 
megabase-sized γH2AX-MDC1 foci. MDC1 bound to γH2AX on the chromatin flanking 
the DSB promotes phospho-dependent recruitment of MRN-ATM, inducing a positive 
feedback loop to amplify the DNA damage signalling cascade (Stucki and Jackson, 2004). 
Indeed, MDC1 has been shown to bind to the MRN complex and to be required for its 
focal enrichment to DSBs and propagation of the DDR signalling (Diagram 4;(Goldberg et 
al., 2003; Stewart et al., 2003). It is noteworthy that, although MRN localizes to DSB sites 
earlier than MDC1 as a sensor complex, MRN enrichment to DSB-flanking DNA is 
mediated by interactions with MDC1. The dual role of MRN places the complex in two 
essential steps of the DDR: first, as a sensor of the damaged DNA, MRN promotes early 
recruitment of ATM to the immediate proximity of the break; and second, following an 
increase in the local concentration of activated ATM, H2AX phosphorylation and 
recruitment of MDC1, MRN acts as a mediator generating a landing platform for ATM, 
promoting ATM assembly at the DSB-flanking chromatin and amplifying the DNA 
damage signal. 
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DIAGRAM 4. Signalling cascade amplification 
 
 
 
DNA damage signalling cascade is amplified to relay the signal to downstream effectors. MRN senses 
the DNA DSB and binds to the broken DNA ends. MRN-dependent recruitment of ATM leads to its 
activation by auto-phosphorylation and formation of γH2AX (1). The ATM-dependent 
phosphorylation of H2AX recruits the (BRCT)2 domains of MDC1 on the chromatin flanking the 
DSB site (2). MDC1 contributes to amplification of the signalling cascade by promoting recruitment 
of MRN-ATM and inducing a positive feedback loop to amplify the DNA damage signalling (3). ‘P’ 
indicates phosphorylation.  
 
ATM targets a plethora of diverse substrates for phosphorylation in response to DSBs. 
ATM-mediated phosphorylation of MDC1 on ‘TQXF’ motifs is required for the 
subsequent recruitment of the RING-finger E3 ubiquitin ligase RNF8, via phospho-
dependent binding through RNF8 FHA domain (Huen et al., 2007; Kolas et al., 2007; 
Mailand et al., 2007). Similarly to tandem BRCT domains, the FHA domain is a phospho-
binding motif that regulates protein-protein interactions in an inducible manner in response 
to selected stimuli (Durocher et al., 1999). Several FHA- and BRCT-containing proteins 
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have been implicated in the DDR network, providing molecular interfaces for specific, and 
reversible, ligand binding. RNF8 produces DSB-associated ubiquitylations on histones 
H2A and H2AX, where a lysine side chain covalently binds to ubiquitin through an 
isopeptide linkage, creating a template for the recruitment of a second E3 ubiquitin ligase, 
RNF168, to DSB sites. RNF168 is retained to the DSB-flanking chromatin via its two 
UIMs (ubiquitin-interacting motifs). The ubiquitin-binding domains of RNF168 enable its 
focal accumulation on chromatin primed by RNF8-dependent ubiquitylation. In turn, 
similarly to RNF8, RNF168 interacts with the E2 conjugating enzyme Ubc13, and 
promotes additional ubiquitylation of damaged chromatin by catalyzing the formation of 
lysine 63-linked ubiquitin conjugates on H2A-type histones (Doil et al., 2009; Stewart et 
al., 2009). RNF8/RNF168-mediated ubiquitylation is postulated to impact on the 
chromatin arrangement surrounding the DSB, opening up the chromatin to allow 
recruitment of downstream factors, including the mediator protein 53BP1 (p53-binding 
protein 1) and another E3 ubiquitin ligase, BRCA1 (breast cancer protein 1). It is currently 
unclear whether the epistatic recruitment of the two RING-finger ubiquitin ligases RNF8 
and RNF168 and subsequent chromatin remodelling events are mediated by broadening the 
spectrum of substrates targeted for ubiquitylation or increasing the local concentration to 
reach a critical threshold in the ubiquitylation gradient. Nevertheless, the amplification of 
ubiquitin conjugates at the DSB-flanking chromatin is pivotal for local changes in 
chromatin structure near DNA-break sites and represents a turning point in the DDR 
cascade that enables localization of downstream proteins and propagation of the DSB 
signal. 
 
The aforementioned opening up of the chromatin is believed to allow the exposure of 
histone marks normally embedded into the globular domain of the nucleosome, such as 
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methylations on histone H4 lysine 20 (H4K20) and histone H3 lysine 79 (H3K79), which 
serve as docking sites for the 53BP1 tandem-Tudor domain to promote 53BP1 retention in 
IRIF (Huyen et al., 2004; Botuyan et al., 2006). Once at the site of damage, 53BP1 is 
phosphorylated by ATM in its N-terminal region and cooperates in the amplification of the 
DNA damage signalling pathway (Schultz et al., 2000; Anderson et al., 2001; Rappold et 
al., 2001). 53BP1 plays a role in the activation of the G2/M cell cycle arrest (DiTullio et 
al., 2002; Fernandez-Capetillo et al., 2002; Wang et al., 2002) and knock-down of 53BP1 
results in genomic instability (Ward et al., 2003). In addition, novel evidence points to a 
role for 53BP1 in increasing chromatin mobility and bringing DNA ends into close 
proximity, facilitating repair of DSBs by NHEJ (reviewed in(FitzGerald et al., 2009). 
53BP1 is postulated to play a similar role in physiological processes such as class switch 
recombination and long-range V(D)J recombination (Manis et al., 2004; Ward et al., 2004; 
Difilippantonio et al., 2008). 53BP1 also contains two tandem BRCT motifs at its C-
terminus. The BRCT domains of 53BP1 do not seem to be required for its recruitment to 
IRIF or for its repair function (Ward et al., 2006) and their significance in the context of 
the DDR is currently unclear.  
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DIAGRAM 5. 53BP1 structural features and domains 
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53BP1 contains several PIKK consensus phosphorylation sites (S/TQ) in its N-terminus. In vivo, 
ATM has been shown to target both serines 25 and 29. Similarly to other DDR mediators, 53BP1 
contains two tandem BRCT domains at its very C-terminus. In addition, 53BP1 contains a tandem 
Tudor domain that allows its recruitment to sites of damage as well as binding to the kinetochore 
during unperturbed mitosis. LC8 binding sites and two potential KEN (KENXXXN) motifs may 
represent sequences interacting with the APC. 
Image by(Adams and Carpenter, 2006) 
 
In addition to promoting 53BP1 recruitment, ubiquitylated templates enable Rap80-
dependent targeting of BRCA1/BARD1, Abraxas and Brcc36 to sites of DNA damage 
(Wang and Elledge, 2007). BRCA1 thereby initiates further ubiquitylation events that 
facilitate DNA damage signalling and DSB repair. The striking feature of the sequential 
recruitment of three E3 ubiquitin ligases to the sites of DNA damage emphasizes the 
importance of post-translational modifications, such as ubiquitylation, in regulating 
chromatin structure and fine-tuning the assembly of numerous DDR factors to the DSB-
flanking chromatin, to convey the DNA damage signal to the cell. In addition, recent data 
point to the coordination of ubiquitylation with SUMOylation events, where the attachment 
of small ubiquitin-related modifier (SUMO) to target proteins promotes the productive 
association of 53BP1, BRCA1 and RNF168 to DSB sites (Galanty et al., 2009; Morris et 
al., 2009). 
 
The temporal differences in the recruitment dynamics of various DDR factors are reflected 
in their accumulation at damaged sites within the IRIF focal structures. In cells treated with 
DSB-inducing agents, IRIF can be visualized indirectly by performing immunostaining 
with specific antibodies, or directly by expressing fluorescently-tagged proteins (van 
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Veelen et al., 2005). Within seconds, DSBs can thus be detected as large nuclear 
aggregates containing MRN, γH2AX, MDC1 and RNF8. The appearance of ubiquitin 
conjugates (stained by the FK2 antibody) and RNF168, as well as the assembly of 53BP1 
and BRCA1 into nuclear foci can be detected seconds after binding of the aforementioned 
early DDR factors to the DSB compartments and, kinetically, represent a second wave of 
recruitment.  
 
DIAGRAM 6. The two-step DDR signalling cascade 
 
 
Content not visible due to copyright limitations 
 
This diagram shows the early wave of chromatin assembly to follow a linear epistatic 
phosphorylation-driven cascade, initiated by ATM activation and H2AX phosphorylation, followed 
by the local accumulation of MDC1, MRN and RNF8 to the DSB-flanking chromatin. RNF8-
regulated transition depends on ubiquitylation of H2A-type histones for the recruitment of RNF168 to 
the DSB. The RNF8/RNF168-mediated ubiquitin-dependent chromatin alterations render the local 
chromatin permissive for the assembly of DDR factors belonging to the late wave of recruitment, such 
as 53BP1 and BRCA1. Thus, the recruitment to sites of DNA damage of 53BP1 and BRCA1 can be 
envisaged as part of a second step in the DDR, subsequent to an RNF8-regulated transition. 
Image by(Mailand et al., 2007) 
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DNA insults induce temporary halts of cellular proliferation at specific points during the 
cell cycle, providing time for the DNA damage repair machinery to mend the lesion before 
the cell resumes proliferation (Hartwell and Weinert, 1989). These so-called cell cycle 
checkpoints can occur at the G1/S boundary in order to prevent replication of damaged 
DNA, at the G2/M transition to avoid propagation of DNA lesions and unreplicated DNA 
to the progeny cells, and can act within S-phase to monitor and maximize high fidelity 
DNA replication. The proximal PIKK kinases ATM and ATR, together with other 
mediating factors, enable the recruitment and activation of the downstream checkpoint 
kinases. In mammalian cells, two checkpoint effector kinases have been identified: Chk1 
and Chk2 (reviewed in(Bartek and Lukas, 2003). Chk2 is mainly activated by ATM, a step 
involving Chk2 dimerization and in trans auto-phosphorylation, and functions to activate 
G1/S and intra-S-phase checkpoints. On the other hand, Chk1 is mainly subjected to ATR 
phosphorylation and plays a more prominent role in the G2/M checkpoint and in response 
to perturbed replication. Nevertheless, it is noteworthy that a certain degree of cross-talk, 
along with partial functional redundancy, exists between Chk1 and Chk2 (Bartek and 
Lukas, 2003). The activation of these checkpoint kinases is pivotal to channel the DDR 
signal to downstream targets, mediating arrest in the cell cycle, as well as a variety of 
nuclear and cellular responses, including transcriptional modulation. On the other hand, a 
permanent DNA damage signal, as emanated from an unrepairable lesion, may activate 
cellular phenomena like apoptosis or senescence (Jackson and Bartek, 2009).   
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1.3.II Maintaining genome integrity during DNA replication: DNA damage 
in S-phase  
 
DNA replication is undoubtedly one of the most fascinating processes in biology. In 
human cells, the 3.4 billion base pairs of the haploid genome are faithfully duplicated to 
ensure error-free transmission of the genetic information to the next generation. During 
eukaryotic replication, several mechanisms of surveillance exist that monitor replication 
fork initiation, progression, fidelity, termination and continuation into G2 and mitosis upon 
completion of DNA replication. The inherently fragile nature of the DNA and its handling 
by the replication fork may represent sources of mutational damage that impact both on 
cellular and organismal survival. The concerted effort of S-phase checkpoint pathways 
normally ensures preservation of genome stability during DNA synthesis. Three types of 
S-phase checkpoints exist depending on their triggering stimuli. First, the replication 
checkpoint is initiated in response to stalling of replication forks due to alteration in the 
DNA structure, deoxyribonucleoside triphosphates (dNTPs) depletion or tortional stress 
caused by fork-to-fork or fork-to-transcription complex collision. Second, the intra-S-
phase checkpoint is activated any time during S-phase when DNA damage is generated, 
even at a distance from the replicons. ATR plays a major role in activating the replication 
checkpoint, which depends on the replication fork. On the other hand, the intra-S-phase 
checkpoint is primarily signalled by ATM kinase (reviewed in(Bartek et al., 2004). Finally, 
the existence and molecular nature of the checkpoint that prevents mitotic entry until DNA 
synthesis is completed is still under debate. In human cells, Cdc6 has been suggested to 
monitor completion of DNA replication before entry into mitosis (Clay-Farrace et al., 
2003). 
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Replication forks can stall upon encountering protein-DNA complexes or due to depletion 
of the nucleotide pools. These pause sites, where a barrier in replication fork progression is 
met, can become fragile sites in the genome (Casper et al., 2002), highly susceptible to 
breakage and recombination. Additionally, unusual or highly repetitive DNA sequences 
may create DNA secondary structure that induce replication slow zones, which are also 
highly prone to chromosome fragility (for review, see(Labib and Hodgson, 2007). 
Progression of the replication fork through these regions is slowed down and paused by the 
replisome components Mrc1 and Tof1 (orthologues of vertebrate Claspin and Timeless, 
respectively). Mrc1 and Tof1 are involved in modulating the pace of DNA synthesis in 
unperturbed circumstances and are especially important during replication of expanded 
triplet nucleotide repeats (Shishkin et al., 2009; Voineagu et al., 2009).  To prevent fork 
collapsing, leading to formation of a highly cytotoxic DNA DSBs, stalled forks are 
maintained stable by activation of the replication checkpoint. Central to this response are 
ATM and ATR. In yeast, these are Mec1 and Tel1 (S. cerevisiae) or Rad3 and Tel1 
(Schizosaccharomyces pombe). While ATM responds mostly to DSBs to prevent 
recombination events at the replication forks, ATR acts at stalled replication forks, where 
the presence of ssDNA-binding protein RPA mediates ATR stabilization (Zou and Elledge, 
2003). Also, RPA serves as a recruiting platform for the checkpoint clamp loader Rad17, 
which, in turn, recruits the PCNA-like checkpoint complex 9-1-1 (Rad9-Rad1-Hus1). 
Phosphorylation of the 9-1-1 complex by ATR serves to amplify the checkpoint signal and 
relay it to the transducer kinases Chk1 and Chk2. These factors trigger a global checkpoint 
response throughout the nucleus by targeting substrates for phosphorylation, preventing the 
firing of late replication origins and entry into mitosis (see review by(Branzei and Foiani, 
2010). Furthermore, the checkpoint kinases act to further promote fork stability and 
preventing replication fork demise (Donaldson and Blow, 2001). In budding yeast, 
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Mec1/ATR and Rad53/Chk2 are also required to prevent fork collapse and replisome 
disassembly from the stalled forks. Finally, the replication checkpoint signals for 
replication fork restart and is directly involved in controlling the process of replication 
resumption (Kai and Wang, 2003; Liberi et al., 2005; Sabbioneda et al., 2005; Lopes et al., 
2006). 
 
The action of unwinding DNA ahead of the replication fork induces torsional stress that 
manifests itself as positive supercoils in front of the fork or precatenates between the 
replicated duplexes, resolved by Top1 and Top2 topoisomerases, respectively (reviewed 
in(Wang, 2002). Additional topological strains are exerted when the replication fork meets 
the transcription machinery. The proximity between two replication bubbles increases 
topological stress and slows down fork progression. In this case, Top1 releases the positive 
supercoils (Tuduri et al., 2009), while Top2 seems to be involved in the formation of 
chromatin loops to protect the transcription apparatus during DNA replication (Bermejo et 
al., 2009). The collisions between the transactions of replication and transcription can be 
head-on or in-line (Cook, 1999). The latter, co-directional collision occurs when the fork at 
the leading strand makes contact with the rear of the RNA polymerase; although 
replication is slowed down, the fork does not collapse, as the mRNA transcript can be used 
as a primer to resume DNA synthesis (Pomerantz and O'Donnell, 2008). On the other 
hand, a head-on collision represents the opposite scenario, when the front of the RNA 
polymerase collides with the fork at the lagging strand. Head-on collisions can cause fork 
collapse, leading to DSBs and transcription-associated recombination that may cause 
genomic instability (Olavarrieta et al., 2002). 
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In addition to intrinsic barriers to replication fork progression, the replisome can encounter 
sites of DNA damage arising from endogenously-occurring or exogenously-induced DNA-
damage. Such lesions include bulky lesions, such as UV photoproducts, covalent DNA 
crosslinks and DSBs. These DNA insults can be produced at DNA loci outside the active 
replicon and can be met by the fork during elongation. When encountering DNA damage, 
the semi-discontinuous DNA replication becomes discontinuous on both strands. The 
formation of new primers allows the replication fork to leave a gap on both strands where 
the DNA is damaged and progress, leaving the lesion behind the fork. The damage is then 
dealt with by two DNA damage tolerance pathways, translesion synthesis (TLS) 
polymerases or the template switch pathway characterized by HR repair (for a 
comprehensive review, see(Kogoma, 1997). More complex lesions, like inter-strand cross-
links, are repaired by a concerted effort of three pathways: the Fanconi anemia, HR and 
TLS polymerase pathways (Niedzwiedz et al., 2004). In S-phase, DSBs may also arise as a 
consequence of replication fork collapse, when the entire replisome becomes dissociated 
from the fork or, perhaps, physiologically as a consequence of topological strain. 
Formation of DSBs during S-phase activates the ATM/ATR-dependent intra-S-phase 
checkpoint, which leads to the unfolding of the DDR signalling cascade, activation of 
Chk1 and Chk2 kinases, and cell cycle delay (Chapter 1.3.I). In addition, ATM- and ATR-
dependent inhibition of Cdk2/Cyclin E and Cdc7/Dbf4 S-phase kinases induces silencing 
of late replication origins (Santocanale and Diffley, 1998). This appears to be at least in 
part mediated by ATM-dependent inhibitory phosphorylation on Cdk2 preventing loading 
of Cdc45 and firing of new origins (Costanzo et al., 2000). Additionally, the ATM-
dependent checkpoint pathway acts together with the nuclease Sae2 and Mre11 to prevent 
formation of cruciform DNA structures when the elongating forks encounters an 
unrepaired DSB (Doksani et al., 2009). Although the fork encountering the break is 
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irreversibly dismantled, the other forks within the replicon can continue replication 
(Branzei and Foiani, 2010).  
 
Interestingly, the responses activated by DSBs during replication are also involved in 
monitoring timing of DNA synthesis and origin firing in the absence of DNA damage. 
Novel data in Xenopus extracts suggests that ATM and ATR regulate inhibition of Cdk2 
and Cdc7 S-phase kinases through a negative feedback loop to physiologically inhibit 
origin firing following initiation of replication in unchallenged conditions (Shechter et al., 
2004).  
 
1.4 DNA, chromatin, chromosomes: organization of the genetic information  
 
The processes of DNA replication, DNA repair, transcription and other long-range DNA 
transactions in the nucleus are coupled with genome-wide disruption and reorganization of 
chromatin. In all eukaryotic cells, DNA is tightly compacted into a hierarchically 
organized structure called chromatin. The basic unit of chromatin is the nucleosome. The 
nucleosome core particle consists of 146 base pairs of DNA wrapped around an octamer of 
two each of the histones H2A, H2B, H3, H4. The resulting structure is a 10 nm chromatin 
fibre often referred to as ‘beads-on-a-string’ (Kornberg, 1974). A more compact and 
repressive higher order chromatin structure is known as the 30 nm fibre, which is achieved 
through recruitment of the linker histone H1 or “architectural” chromatin-associated 
factors such as heterochromatin protein 1 (HP1). The exact organization of the 30 nm fibre 
is under considerable debate. In general, either “solenoid” models, wherein the 
nucleosomes are gradually coiled around a central axis, or more open “zig-zag” models 
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that adopt higher-order self-assemblies, have been described (Allis et al., 2007). Recent 
evidence, including X-ray structures using model systems involving four nucleosomes 
point towards a fibre arrangement more consistent with a zig-zag arrangement 
(Khorasanizadeh, 2004). Organization into higher order chromatin domains (300-700 nm) 
also occurs, although the extent to which these associations give rise to meaningful 
functional “chromosome territories” remains unclear (Allis et al., 2007). 
 
DIAGRAM 7. From DNA to chromatin to chromosomes through multiple 
compaction steps  
 
 
Content not visible due to copyright limitations 
 
DNA undergoes several levels of compaction to be packaged inside the 0.1 µm of the human nucleus; 
the DNA double helix-core histones complex is tightly packed into chromatin fibres. Chromatin is 
coiled into higher-order structures, up to being compacted into a typical metaphase chromosome.   
Image modified from micro.magnet.fsu.edu/cells/nucleus/chromatin.html 
 
Higher order structures of chromatin have historically been defined as either euchromatic 
or heterochromatic, based on the nuclear staining pattern of dyes used to visualize DNA in 
cells. Euchromatin is decondensed chromatin and may be transcriptionally active or 
inactive, whereas heterochromatin is generally defined as highly compacted and silenced 
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chromatin. It may exist as permanently silent chromatin (constitutive heterochromatin) or 
repressed (facultative heterochromatin) in some cells, during a specific cell cycle or 
developmental stage (Allis et al., 2007). 
 
1.4.I The impact of chromatin environment over DDR and repair  
 
Higher-order chromatin structure may hinder accessibility of proteins to the DNA. In 
numerous nuclear processes, including replication, transcription and DNA repair, it is 
essential for their respective molecular machineries to be able to rapidly access individual 
regions of the genome. Although transactions on the DNA helix require more than simply 
increased accessibility to the DNA, modulation of the chromatin template is a critical step 
in all these processes. The inherent flexibility of chromatin and the dynamic nature of the 
nucleosome allow modulation of the steric hindrance between core histones and DNA, 
improving accessibility.  
 
Covalent post-translational modifications (PTMs) impact on chromatin organization in an 
antithetic manner, to promote or hinder accessibility to DNA. PTMs include reversible 
chemical modification of histones and may be removed, subsequently re-establishing the 
original chromatin environment. Numerous enzymatic regulatory complexes are 
responsible for a wide range of PTMs, including acetylation, methylation, phosphorylation, 
SUMOylation and ubiquitylation (Kouzarides, 2007). Any single core histone can 
accommodate distinct PTMs in a large number of combinations. The combinatorial pattern 
of PTMs and its functional outcome is at the centre of the histone code hypothesis (Strahl 
and Allis, 2000), where an epigenetic marking system functions to regulate ‘chromatin-
templated processes, with far reaching consequences for cell fate decisions’ (Jenuwein and 
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Allis, 2001). In addition, cross-talk between the distinct modifications adds yet another 
layer of complexity in deciphering the histone codes in physiological and pathological 
contexts. Often, priming PTMs are required to allow further modifications to take place, 
regulating functional outcome in an epistatic manner. For instance, cell cycle dependent 
phosphorylations of Chk2 by Plk3 on sites adjacent to the ATM-target residue threonine 68 
(T68) primes DNA damage-dependent phosphorylation, facilitating Chk2 activation 
(Bahassi el et al., 2006). Epigenomes can be encoded by combinations of PTMs that act 
not only on histones but also on non-histone proteins.  
 
DNA damage repair is a DNA-dependent activity that has to overcome the chromatin 
accessibility barrier. A paradigmatic example of PTMs occurring following the induction 
of a DSB is the phosphorylation of the histone variant, H2AX. γH2AX accumulates at sites 
of DSBs and extends up to a megabase of DNA flanking the DSB, generating domains 
visible via fluorescent microscopy within minutes post-IR and may persist for several 
hours (Rogakou et al., 1998), playing a role in the amplification of the DDR signalling 
cascade. Although the exact significance of this chromatin modification upon DSB 
formation is still unknown, functional studies revealed that cells lacking γH2AX repair 
damage more slowly and display gross chromosomal rearrangements than control cells, 
indicating a role for γH2AX in maintenance of genomic stability (Celeste et al., 2002). 
Furthermore, core histones in the proximity of the break are subjected to extensive 
modifications by E3 ubiquitin ligases that increase the local concentration of ubiquitin, 
impacting on chromatin conformation. The joined effort of RNF8 and RNF168 at the 
chromatin flanking the DSB site surpasses the threshold of ubiquitylation required to 
enable opening of the chromatin and recruitment of downstream mediators, like 53BP1 and 
BRCA1. The timely recruitment of these E3 ubiquin ligases to the break site serves to alter 
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chromatin-binding requirements in a way to tailor the protein recruitment dynamics, 
offering a multilayered spatio-temporal regulation through promoting chromatin 
remodelling events.  
 
As aforementioned, DSB-induced PTMs play a key role in local restructuring of chromatin 
to enable access of the DDR machinery and repair of the lesion. PTMs can promote 
physical changes in histone distribution, including displacement, exchange, sliding and re-
assembly of the nucleosome. Penny Jeggo’s laboratory has recently provided several lines 
of evidence indicating that DSBs associated with heterochromatic regions are particularly 
reliant on ATM signalling to induce remodelling of dense chromatin regions and provide 
accessibility to the DNA break, ultimately enabling its repair (Goodarzi et al., 2008). 
Therefore, the status of chromatin directly impacts on propagation of DNA damage signals 
and on the physical mending of the DNA insult. Conversely, it is tempting to speculate that 
chromatin plasticity facilitates genomic surveillance. This notion is strengthened by data 
from Oscar Fernandez-Capetillo and colleagues, which engineered a murine stem cell 
system expressing reduced levels of the linker histone H1. The linker histone H1 enables 
compaction of the nucleosomal array into tightly packaged chromatin fibres; thus, cells 
expressing 50% the physiological level of H1, displayed a more open chromatin 
configuration. The increased plasticity of chromatin directly correlated to a hyper-
responsiveness to DSBs, displaying enhanced DDR signalling and hyper-activated 
checkpoint. The cells were hyper-resistant to DNA damaging agents and showed faster 
repair kinetics than control cells. These phenotypical changes were recapitulated by using 
TSA (trichostatin A), a HDACi (histone de-acetylase inhibitor) that induces chromatin 
relaxation. This work complements previous work showing that deletion of S. cerevisiae 
linker histone Hho1 leads to a hyper-HR phenotype (Downs et al., 2003). These and other 
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experimental data substantiate the existence of a profound cross-talk between regulation of 
chromatin conformations by PTMs and unfolding of the DDR, and are especially relevant 
in view of DSBs being reported to trigger DDR-dependent global relaxation processes (Ziv 
et al., 2006; Goodarzi et al., 2009). Such global relaxation of chromatin could facilitate 
responses to DNA breaks by enabling faster access of DDR factors to the DSB sites to 
facilitate genomic surveillance and repair. An intriguing scenario recently presented is the 
‘breathing’ chromatin status typical of pluripotent stem cells. Transcriptional up-regulation 
of chromatin remodellers, such as Chd1 (Gaspar-Maia et al., 2009), increases openness of 
chromatin. In parallel, stem cells are characterized by faster dynamics in their DDR than 
other cells, together with accelerated and high fidelity repair of DSBs by prefentially using 
HR. Such findings also suggest that chromatin conformation acts as a switch to select 
between repair pathways. A more rigid and compacted DNA conformation may hinder 
resection of DSBs and recruitment of HR promoting factors, such as BRCA1, leading to 
NHEJ repair. On the other hand, a more open chromatin status may favour resection of 
DNA and enables HR. 
 
 Recently, Evi Soutoglou and Tom Misteli (2008) engineered a novel way to trigger a 
complete DDR cascade in the absence of DNA damage. In their system, immobilization of 
DDR factors on chromatin was sufficient to onset a typical DDR response, leading to 
checkpoint activation. They monitored the outcome of the stable tethering of factors 
including Nbs1, Mre11, MDC1 and ATM to DNA, which caused phosphorylation of 
γH2AX and activation of the full physiological downstream cascade. This phenomenon 
was ATM and DNA-PK dependent (Soutoglou and Misteli, 2008). This work emphasizes 
the importance of the association between molecules and chromatin in the activation, 
amplification and maintenance of the DNA damage response. 
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1.4.II Work presented in this thesis 
 
The maintenance of genomic integrity is of critical importance to living organisms, 
because DNA contains the genetic instructions essential for life. Cells are endowed with 
remarkably complex pathways that help repair the damage to protect genomic stability.  
 
In this thesis, I explore how DNA damage responses change depending on the cell cycle 
stage and examine the cross-talk between the cell cycle machinery and the DNA damage 
response network. In chapter 3, I uncover the signalling cascade in response to DNA 
damage during mitosis in human cells, outline the complex inter-relationship between 
DDR and chromatin structural and epigenetic statuses, and show that the mitosis-specific 
DDR is biologically important for cell viability. In chapter 4, I analyze the role of Psf1, a 
subunit of the GINS complex, in human and yeast cells; I also characterize a consensus 
DNA damage phospho-motif at the C-terminus of the protein, which is important for cell 
viability in budding yeast. Finally, chapter 5 includes the analysis of S. cerevisiae Rad9 
regulation by CDK and how this impacts on the activation of the checkpoint kinase Chk1.  
 
The results presented here underlie the complex relationship between cellular pathways 
required for genomic stability and those needed for cell cycle progression, and furthermore 
suggests that additional, as yet, undiscovered mechanisms work to influence, regulate and 
coordinate these molecular networks to promote cellular homeostasis.  
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2 MATERIALS AND METHODS 
 
2.1 Sources for chemicals, buffers and solutions  
 
All chemicals were purchased from Sigma Aldrich, Acros Organics or Fisher Scientific. 
Radiochemicals were from Amersham Biosciences. Restriction enzymes and modifying 
enzymes were purchased from Roche or New England Biolabs. Stock solutions, buffers for 
molecular biology, buffers and solution for SDS-PAGE or other biochemical techniques 
were prepared as described in Sambrook et al., (1989), unless otherwise stated. 
  
2.2 Antibodies 
 
The antibodies listed in Table 1 were used in this thesis for immunoblotting (IB; chapter 
2.6.V), immunofluorescence (IF; chapter 2.7.I) and/or immunoprecipitation (IP; 2.6.VI). 
 
TABLE 1. Antibodies  
 
Antigen Species Reference/Supplier Dilution 
53BP1 Rabbit Novus Biologicals IF 1:500 /IB 1:1000 
53BP1 pS25 Rabbit Bethyl IB 1:1000 
α-tubulin Mouse Sigma IF 1:500/IB 1:1000 
β-actin Mouse Abcam IB 1:5000 
γH2AX Mouse Upstate IF 1:1000/IB 1:1000 
γH2AX Rabbit Cell Signalling IF 1:250 
ATM Rabbit Calbiochem/Merck IP 2 µg/IB 1:100 
ATM pS1981 Mouse Cell Signalling IB 1:1000 
BRCA1 (D20) Rabbit Santa Cruz IF 1:250/IB 1:1000 
 56 
Table 1, cont’d…  
    
Antigen Species Reference/Supplier Dilution 
CENP-F Rabbit Abcam IF 1:500 
Chk1 Mouse Santa Cruz IB 1:1000 
Chk1 pS345 Rabbit Cell Signalling IB 1:1000 
Chk2 Rabbit Abcam IB 1:1000 
Chk2 pT68 Rabbit Cell Signalling IB 1:1000 
DDB1 Goat Abcam IB 1:1000 
DDB2 Rabbit (El-Mahdy et al., 2006) IB 1:1000 
DNA-PKcs pT2609 Rabbit Abcam IB 1:1000 
FLAG (M2) Mouse Sigma IP 2 µg/IB 1:1000 
GST Mouse Santa Cruz IB 1:1000 
H2A acidic patch Rabbit Upstate IB 1:1000 
H2AX Rabbit Abcam IB 1:5000 
H3 pS10 Mouse Abcam IF 1:500/IB 1:2000 
H3K79me2 Rabbit Abcam IB 1:1000 
H4 Mouse Abcam IB 1:2000 
H4K20me2 Rat Abcam IB 1:1000 
HA Mouse Covance IP 2 µg/IB 1:2000 
KAP1 Rabbit Santa Cruz IB 1:1000 
KAP1 pS824 Rabbit Bethyl IB 1:125 
scMCM2 (y-N19) Goat Insight Biotechnology IP 2 µg/IB 1:500  
MCM7 (141.2) Mouse Santa Cruz IB 1:500 
MCPH1 Rabbit Bethyl IB 1:1000 
MDC1 Rabbit (Goldberg et al., 2003) IB 1:5000 
MDC1 pS329pT331 Rabbit (Chapman and Jackson, 2008) IF 1:250 
MRE11 (12D7) Mouse Genetex/Abcam IB 1:1000 
NBS1 (1D3) Mouse Genetex/Abcam IB 1:1000 
scPGK1 Mouse Invitrogen IB 1:1000 
PSF1 Rabbit Steve Bell IF 1:200/IB 1:1000 
PSF1 pS173 Rabbit This study; Eurogenetec IB 1:500 
PSF2 Rabbit Steve Bell IB 1:500 
scRad9 Rabbit Noel Lowndes IB 1:10000 
RAD50 (13B3) Mouse Genetex/Abcam IB 1:2000 
scRad53 Rabbit Noel Lowndes IB 1:5000 
RPA (RPA2/34) Mouse Lab vision IB 1:2500 
RNF168 Rabbit (Stewart et al., 2009) IB 1:1000 
RNF8 Rabbit (Tuttle et al., 2007) IB 1:1000 
SLD5 Rabbit Steve Bell IB 1:500 
SMC1 Rabbit Bethyl IB 1:10000 
SMC1 pS966 Rabbit Bethyl IB 1:5000 
TopBP1 Rabbit Abcam IB 1:1000 
Ub-H2A Mouse Upstate IB 1:1000 
Ub-conjugated (FK2) Mouse  BIOMOL IF 1:250 
 
All antibodies are raised against human proteins, unless denoted by the prefix ‘sc’ (S. cerevisiae). 
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2.3 Plasmids 
 
Plasmids used in this study are shown in Table 2. 
 
TABLE 2. Plasmid constructs   
 
# Plasmid Source Description 
1 pcDNA 3.1 Addgene Mammalian expression vector 
2 Psf1-2HA  This study hPsf1 N-terminally double-HA-tagged cloned 
XhoI/BamHI into pcDNA 3.1  
3 Psf1-2HA-A  This study hPsf1 S173A in pcDNA 3.1 (#2 derived) 
4 Psf1-2HA-E  This study hPsf1 S173E in pcDNA 3.1 (#2 derived) 
5 pGEX-4T.3 GE Healthcare Bacterial expression vector 
6 Psf1-GST This study hPsf1 cloned XhoI/BamHI into pGEX-4T.3 
7 Psf1-GST-A  This study hPsf1 S173A in pGEX-4T.3 (#6 derived) 
8 Psf1-GST-E  This study hPsf1 S173E in pGEX-4T.3 (#6 derived) 
9 pRS413 Stratagene Yeast shuttle vector containing a CEN/ARS 
replication system and HIS3 marker gene 
10 pRS416 Stratagene Yeast shuttle vector containing a CEN/ARS 
replication system and URA3 marker gene 
11 Psf1-3HA 
(URA3) 
This study  scPsf1 N-terminally triple-HA-tagged cloned 
XhoI/EcoRI into pRS413 
12 Psf1-3HA 
(HIS3) 
This study scPsf1 N-terminally triple-HA-tagged cloned 
XhoI/EcoRI into pRS416 
13 Psf1-3HA-A This study scPsf1 S187A in pRS413 (#12 derived) 
14 Psf1-3HA-E This study scPsf1 S187E in pRS413 (#12 derived) 
15 pRS414 Stratagene Yeast shuttle vector containing a CEN/ARS 
replication system and TRP1 marker gene 
16 Rad9-3HA A. Hammet scRad N-terminally triple-HA-tagged cloned 
into pRS414 
17 Rad9-3HA-1 This study scRad9 S83A in pRS414 (#16 derived) 
18 Rad9-3HA-2 This study scRad9 T110A in pRS414 (#16 derived) 
19 Rad9-3HA-3 This study scRad9 T125A in pRS414 (#16 derived) 
20 Rad9-3HA-4 This study scRad9 T143A in pRS414 (#16 derived) 
21 Rad9-3HA-4M This study scRad9 S83A, T110A, T125A, T143A in 
pRS414 (#16 derived) 
22 Rad9-3HA-5M This study scRad9 S56A, S83A, T110A, T125A, T143A 
in pRS414 (#16 derived) 
23 Rad9 This study scRad9 cloned XhoI/EcoRI into pRS414 with 
1.2 kb promoter and 1 kb terminator 
24 Rad9-1 This study scRad9 S83A in pRS414 (#23 derived) 
25 Rad9-2 This study scRad9 T110A in pRS414 (#23 derived) 
26 Rad9-3 This study scRad9 T125A in pRS414 (#23 derived) 
27 Rad9-4 This study scRad9 T143A in pRS414 (#23 derived) 
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Table 2, cont’d… 
    
# Plasmid Source Description 
28 Rad9-4M This study scRad9 S83A, T110A, T125A, T143A in 
pRS414 (#23 derived) 
29 Rad9-5M This study scRad9 S56, S83A, T110A, T125A, T143A in 
pRS414 (#23 derived) 
30 Rad9  
N-term-GST 
This study scRad9 1-498 bp N-terminus fragment cloned 
XhoI/EcoRI in pGEX-4T.3 
31 MCPH1  
N-term-GST 
This study  hMCPH1 1-756 bp N-terminus fragment 
cloned in pGEX-4T.1 
32 Rad9hMCPH1 
hybrid 
This study hMCPH1 N-terminus (1-609) and scRad9 
(435-end) in pCR® Blunt II TOPO® vector 
33 Rad9ggMCPH1 
hybrid 
This study ggMCPH1 N-terminus (1-557) and scRad9 
(435-end) in pCR® Blunt II TOPO® vector 
 
2 .4 Synthetic peptides  
 
Biotinylated synthetic peptides used for pull-downs experiments in this study (Table 3). 
All peptides were synthesized by Pepceuticals (Bristol, UK), except for the H2AX and 
γH2AX peptides made by Graham Bloomberg (Department of Biochemistry, University of 
Bristol, UK). 
 
TABLE 3. Synthetic peptides  
 
Name  Synthetic peptide 
H2AX Biotin-SGS-ATVGPKAPSGGKKATQASQEY-COOH 
γH2AX  (pSer139) Biotin-SGS-ATVGPKAPSGGKKATQA(pS)QEY-COOH 
MDC1  Biotin-SGS-AVQSMEDEPTQAFML-NH2 
MDC1 (pT719)  Biotin-SGS-AVQSMEDEP(pT)QAFML-NH2 
Psf1  Biotin-SGS-GTSCVLLKKNSQHFLPR-NH2 
Psf1 (pS173) Biotin-SGS-GTSCVLLKKN(pS)QHFLPR-NH2 
Psf1 (pS173, F176A) Biotin-SGS-GTSVLLKKN(pS)QHALPR- NH2 
Psf2  Biotin-SGS-YKLRTNLQPLESTQSQDF-COOH 
Psf2 (pS182) Biotin-SGS-YKLRTNLQPLESTQ(pS)QDF-COOH 
 
SGS indicates a serine-glycine-serine flexible linker; (pS) denotes the phosphorylated residue.  
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2.5 Nucleic acid methods 
2.5.I Quantitation 
 
Nucleic acids were quantified by spectrophotometry using a NanoDrop ND-1000 
Spectrophotometer (Labtech International) and measured at OD260nm. Concentrations were 
calculated using the following formula: 1 OD260nm = 37 ng/µl. 
 
2.5.II Polymerase Chain Reaction (PCR) 
 
PCRs contained 100 ng template DNA, 5 µl 10x reaction buffer without MgCl2, 1.5 mM 
MgCl2, 1 mM dATP, 1 mM dCTP, 1 mM dGTP, 1 mM dTTP, 500 nM of each primer and 
3 units (U) polymerase and H2O to 50 µl final volume. Expand High Fidelity PCR System 
(Roche) was used. Reactions were performed in a Dyad Peltier thermal cycler according to 
the standard conditions: 94°C, 2 min (1 cycle); 94°C, 1 min; primer dependent annealing 
temperature, 1 min; 72°C, 1.2 min per kb amplification of predicted product (30 cycles); 
72°C, 10 min final elongation. 
 
2.5.III Site directed mutagenesis 
 
Site directed mutagenesis was performed according to the QuickChange site directed 
mutagenesis procedure (Stratagene) but with a maximum of 10 complementary bases 
between the oligonucleotide primers. Oligonucleotides harbouring the respective altered 
bases were ordered from Sigma Aldrich. The PCR reaction mixture was amplified using 
the following standard conditions: 94°C, 30 sec (one cycle); 94°C, 1 min; 52°C 1 min; 
68°C, 1 min per 1 kb plasmid (16 cycles). 10 U DpnI was added to the mixture and the 
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reaction incubated for 1 hour at 37°C. XL-1 Blue or TOP10 chemically competent E. coli 
bacterial cells were then transformed with 5 µl of the digestion (Chapter 2.9.I). 
  
2.5.IV Agarose gel electrophoresis and DNA purification 
 
DNA was electrophoresed in a 0.8%-1.0% agarose gel, made in 1x TBE (89 mM Tris-
borate, 2 mM EDTA) containing 1 µg/ml ethidium bromide, using an agarose gel 
apparatus. Samples were diluted in 6x loading buffer (25% glycerol, 0.125% w/v 
bromophenol blue, 0.125% w/v xylene cyanol). DNA was visualised by UV illumination. 
DNA was extracted from agarose gels using the Qiaquick gel extraction kit (Qiagen) 
according to the manufacturer’s instructions.  
 
2.5.V Restriction digestion analysis 
 
PCR products and plasmid DNA were digested in a total volume of 25 µl containing 5 U of 
each restriction enzyme (Roche or New England Biolabs) and 2.5 µl of 10x incubation 
buffer supplied by the manufacturer and incubated at 37°C for 1 hour. Vector DNA was 
purified by agarose gel electrophoresis followed by extraction with the Qiaquick gel 
extraction kit (Qiagen).  
 
2.5.VI DNA ligation  
 
Gel purified and digested PCR products were mixed with target digested and 
dephosphorylated vector DNA at a molecular ratio of 5:1. 2x ligation buffer and 1 U of T4 
rapid DNA ligase (Roche) were added and reactions incubated for 60 min at room 
temperature (RT). 
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2.5.VII DNA sequencing and sequence analysis 
 
DNA sequencing reactions were performed by John Lester in the DNA sequencing facility 
of the Department of Biochemistry, University of Cambridge, UK. Computational analysis 
of the chromatographic data was performed by using Sequencer (Gene Codes Corporation) 
and DNA Strider (CEA, France). All plasmid constructs used or constructed for the work 
in this thesis were confirmed by sequencing analysis.  
 
2.6 Analytical biochemistry and protein methods 
2.6.I Measurement of protein concentration 
 
The concentration of proteins present in extracts was determined by the BioRad protein 
assay. Typically, 1 µl of extract was added to 1 ml of a 5x dilution of BioRad protein assay 
dye reagent. To determine the protein concentration, the absorption at a wavelength of 595 
nm was determined with a Pharmacia Ultraspec 2100 spectrophotometer.  
 
2.6.II SDS-PAGE  
 
Protein electrophoresis was by using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and the BioRad Mini-Protean II or Criterion midi-gel 
apparatus. Standard recipes for stacking and separating gels were used (Sambrook et al., 
1989) and were polymerized by addition of 0.1% ammonium persulphate (APS) and 0.1% 
TEMED. All samples/extracts were diluted in 2x SDS sample buffer (100 mM Tris-HCl 
pH 6.8, 20% glycerol, 4% SDS, 715 mM β-Mercaptoethanol, 0.2% w/v bromophenol blue) 
and denatured by incubation at 95°C for 5 min immediately before loading. 
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Electrophoresis was at 90-180V in 1x protein running buffer (25 mM Tris-base, 190 mM 
glycine, 0.1% SDS) until SeeBlue (Invitrogen) and Precision Plus Dual Color (BioRad) 
protein standard markers migrated at the appropriate position on the separating gel.  
 
2.6.III Coomassie staining 
 
The SDS-PAGE gel was incubated with Coomassie blue staining solution (0.25% w/v 
Coomassie brilliant blue R250, 10% isopropanol, 10% acetic acid) for at least 1 hour at 
RT. The staining solution was removed and destaining solution (5% acetic acid) was added 
in repeated 30 min washes until the non-protein background staining was removed. 
  
2.6.IV Silver staining 
 
The SDS-PAGE gel was fixed in a solution of 50% methanol, 12% acetic acid, 0.5 ml/l 
formaldehyde (37%) overnight. After two 30 min washes in 50% methanol, the gel was 
incubated 1 min with 0.2 g/l sodium thiosulphate (Na2S2O3) solution, followed by three 30 
sec washing steps in double distilled water (ddH2O). The gel was incubated in silver 
solution (2 g/l AgNO3, 0.75 ml/l 37% formaldehyde) for 40 min at 4°C. After two 30 sec 
washes, the gel was developed in staining solution (60 g/l sodium carbonate, 4 mg/ml 
sodium thiosul phate and 0.5 ml/l 37% formaldehyde) for 1-15 min. The reaction was 
stopped by incubation in 1% glacial acetic acid. Careful handling using sterile plastic-ware 
was used to avoid contamination with keratins throughout this procedure. 
 
2.6.V Protein transfer and western blotting 
 
Proteins from SDS-PAGE were transferred onto nitrocellulose membrane (Protran BA85, 
Schleicher & Schuell) in transfer buffer (25 mM Tris-base, 190 mM glycine, 20% 
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methanol) for 70-90 min at 300 mA by the Mini-Protean 2 apparatus (BioRad). Transfer 
efficiency and sample loading were confirmed using Ponceau protein stain (0.2% w/v 
Ponceau S, 3% w/v TCA, 3% w/v 5-sulphosalicylic acid). Ponceau staining was removed 
by washing with Tris buffered saline (pH 7.5) containing 0.1% Tween 20 (TBS-T) before 
western blotting. The membrane was blocked in TBS-T supplemented with 5% w/v non-fat 
dried milk or 3% w/v bovine serum albumin (BSA) for 30-60 min. The membrane was 
then incubated for 1 hour at RT or overnight at 4°C in primary antibody (Table 1; IB) 
diluted in the desired blocking solution. The membrane was washed three times for 15 min 
with TBS-T and incubated with secondary antibody (Dako/Sigma) diluted 1/10000 in 
TBS-T plus 5% milk for 1 hour. The membrane was washed three times for 15 min before 
antibody detection by chemiluminescence using the ECL or ECL-Advance system 
(Amersham Biosciences) according to supplied protocol and X-ray medical films (AX, 
Konica), processed using a Compact X4 developer (Xograph). Immunoblotted membranes 
were stripped in buffer (2 % SDS, 62.5 mM Tris-HCl pH 6.7, 100 mM β-Mercaptoethanol) 
for 45 min at 50°C and washed extensively in TBS-T, before blocking.  Western blotting 
was performed again as described above. 
 
2.6.VI Immunoprecipitation 
 
Cells were harvested and lysed on ice in lysis buffer (20 mM HEPES pH 7.9, 450 mM 
NaCl, 1.5 mM MgCl2, 1 mM EGTA, 0.1% Tween20, 10% glycerol) or Benzonase lysis 
buffer (25mM Tris pH 7.5, 2 mM MgCl2, 0.5% NP-40 and 40 mM NaCl for 10 min, then 
increased to 450 mM NaCl for 30 min), supplemented with phosphatase (Sigma-Aldrich) 
and protease (Roche) inhibitor cocktails. Lysates were cleared by centrifugation at 14,000 
revolutions per minute (rpm) for 15 min at 4°C and diluted to 150 mM NaCl. Extracts were 
subsequently incubated with Protein A- or G-coated Dynabeads (Invitrogen) pre-bound to 
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2 µg of antibody for 2 hour at 4°C. Beads were extensively washed and then boiled for 5 
min in SDS-sample buffer (0.0625 M Tris-HCl pH 8.7, 2% SDS, 5% β-Mercaptoethanol, 
10% glycerol, 0.01% Bromophenol Blue). 
 
2.6.VII Peptide pull-downs 
 
1 mg of U2OS whole cell extract (WCE) – obtained by lysing cells in lysis buffer as 
described in 2.6.VI – or HeLa nuclear extract (CilBiotech) was diluted in an equal volume 
of binding buffer (TBS, 10% glycerol, 1 mM DTT) and incubated with 10-40 µl of 
streptavidin Dynabeads (Dynal) saturated with biotinylated peptides (Table 3) for 1 hour at 
4°C. Beads were washed extensively with TBS-T and bound proteins were eluted in SDS-
sample buffer. Phosphatase (Sigma-Aldrich) and protease (Roche) inhibitor cocktails were 
added to all buffers used. 
 
2.6.VIII GST pull-downs 
 
Purified GST-protein fusions on glutathione-sepharose 4B beads (GE Healthcare; see 
2.11.II) were washed with and resuspendend in equal volume of TEN100 buffer (20 mM 
Tris pH 7.4, 0.1 mM EDTA and 100 mM NaCl). GST-protein fusion on beads was 
incubated with the extract of choice for 1 hour at 4°C. Beads were washed four times with 
NTEN buffer (20 mM Tris pH 7.4, 0.1 mM EDTA, 300 mM NaCl and 0.5% NP40) and 
bound proteins were eluted by boiling for 5 min in SDS-sample buffer and visualized by 
Coomassie staining (2.6.III) or western blotting (2.6.V).   
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2.6.IX In vitro phosphorylation and kinase assays 
 
1 µg of purified GST-fusion proteins was incubated with 95 µM of ATP (adenosine 
triphosphate), 0.37 MBq of [γ32P]-ATP (10 µCi/µl; Amersham) or 1 µg of purified Cyclin 
A/CDK2 (Upstate) or Chk1 (provided by Melanie Blasius) in GST pull-down buffer 
(Chapter 2.6.VIII) for 30 min at 30°C. After GST pull-down, samples were resolved by 
SDS-PAGE followed by western blotting, except for experiments using [γ32P]-ATP that 
were followed by autoradiography with autoradiography films (Hyperfilm MP, 
Amersham). 
 
2.7 Immunofluorescence and imaging 
2.7.I Immunostaining 
 
Cells were grown on coverslips or harvested by mitotic shake-off and attached to poly-L-
lysine-coated coverslips with a cytospin centrifuge at 500 rpm for 5 min. All following 
procedures were performed at RT. Cells were fixed with 2% paraformaldehyde for 20 min, 
washed three times with phosphate buffered saline (PBS), permeabilised with 0.2% Triton 
X-100 in PBS for 5 min and blocked with 5% BSA in PBS/0.1%Tween-20 for 10 min. 
Primary antibodies used are listed in Table 1 (IF). Incubation with primary antibodies was 
for 45 min followed by three washes with PBS and a 30 min incubation with the 
corresponding secondary antibodies: Alexa-Fluor 488 (green), 594 (red) and 647 (far red) 
at 1:1000 (Invitrogen). Coverslips were washed three times with PBS and mounted with 
Vectashield mounting medium containing 4,6 diamidino-2-phenylindole (DAPI; Vector 
Laboratories). 
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2.7.II Imaging and processing 
 
Images were acquired with a Radiance 2100 confocal microscope (BioRad) with a 40x or 
60x objective and processed by Photoshop (Adobe). Foci counting and fluorescent 
intensity were automatically performed using Volocity software (Improvision). 
 
2.8 Flow cytometry 
2.8.I Analysis of DNA content and cell cycle distribution 
 
Approximately 1x105 human cells or 1x107 yeast cells were harvested and fixed with 70% 
ethanol at 4°C overnight, followed by washes with PBS and incubation for 30 min with 
RNase A (250 µg/ml) and propidium iodide (PI; 12.5 µg/ml) at 37°C. Human and yeast 
cells were analyzed by FACS (fluorescence activated cell sorting) on a CyAn flow 
cytometer (Beckman Coulter) or with a Beckman Coulter FACSCalibur machine with BD 
CellQuest software. Data were analyzed with FlowJo software (Tree Star, Inc.).  
 
2.8.II Cell cycle regulation of protein expression   
 
1x106 human cells were harvested and the Flow Kit staining protocol was followed (BD 
Biosciences). In brief, cells were washed by adding 1 ml staining buffer, containing 
Dulbecco's phosphate-buffered saline (DPBS) with 2% w/v heat-inactivated foetal bovine 
serum (FBS) and 0.09% w/v sodium azide, pH 7.4. (0.2 µm-pore filtered). Centrifugation 
at 1000 rpm for 3 min was followed by resuspension into 80 µl BD Cytofix/Cytoperm 
buffer for 30 min at RT. Cells were washed with 1 ml of BD Perm/Wash buffer and then 
incubated with primary antibodies in 50 µl of BD Perm/Wash buffer for 1 hour, followed 
by a wash and incubation with 1:100 dilution of Alexa-fluorescent secondary antibodies 
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for 1 hour. A final wash was followed by treatment with RNase and staining with PI and 
processing by FACS, as described above (2.8.I). 
 
2.9 Bacteria related techniques 
2.9.I Bacterial transformation 
 
Autoclaved Luria-Bertani media (LB; 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl, pH 
7.5) were used to grow liquid bacterial cultures by shaking at 225 rpm at 37°C for 12 
hours. To select for bacteria transformed with a plasmid conferring resistance to 
antibiotics, a final concentration of 50 µg/ml of amplicillin or 35 µg/ml of kanamycin were 
included in liquid cultures or plates prior to incolutation or streaking. Heat shock was used 
to transform chemically competent XL-1 Blue cells (Stratagene) or TOP10 cells 
(Invitrogen) and amplify E. coli-yeast shuttle vectors, cloning products and site directed 
mutagenesis products. 50 µl of cells were thawed on ice and gently mixed with plasmid 
DNA and incubated on ice for 30 min. The tube was then placed in a water bath for 30 sec 
and chilled on ice for 1 min. 250 µl of SOC (Invitrogen) were added and the bacterial 
culture incubated at 37°C at 225 rpm for 1-2 hours before plating all on LB/agar plates 
containing the appropriate antibiotic for selection. Single colonies were grown into ~5 ml 
LB liquid medium, containing the appropriate antibiotic, overnight and harvested by 
centrifugation. Plasmid DNA was isolated by mini-prep procedure using a Qiaprep 
miniprep kit (Qiagen) according to the manufacturer’s instructions. 
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2.9.II Recombinant protein expression and purification  
 
Expression of recombinant protein was done with BL21 (DE3) pLysS cells (Invitrogen). A 
single colony of bacteria was used to inoculate a 20 ml LB culture (supplemented with the 
appropriate selective antibiotic) and grown overnight shaking at 37°C. In the morning, 
culture was inoculated to a starting OD600nm of 0.06. Cells were then grown to an OD600nm 
of 0.6 before being cooled in a shaking water incubator for 30 min at 15°C before 
isopropyl-β-D-thiogalactopyranoside (IPTG) was added at final concentration of 0.1 mM. 
Cells were then incubated at 37°C for 3-4 hours or at 15°C overnight and harvested by 
centrifugation. Cells were resuspended in ice-cold PBS, sonicated with Bioruptor 
sonication device at 40% amplitude, lysed with 20% Triton X-100 and centrifuged. Soluble 
and pellet fractions were analyzed by SDS-PAGE followed by coomassie staining. 20-40 
µl of a 50% slurry of glutathione sepharose beads was added to the supernatant for 1 hour 
at 4°C and beads were recovered by centrifugation and used for GST pull-down 
experiments. 
 
2.10 Human tissue culture methods 
2.10.I Cell culture 
 
U2OS, HeLa, BJ and MRC5 cells were cultured in standard Dulbecco modified Eagle's 
minimal essential medium (DMEM; Sigma-Aldrich) supplemented with 10% FBS 
(BioSera), 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin (Sigma-
Aldrich). The medium for U2OS cells stably expressing GFP-MDC1 (Kolas et al., 2007), 
GFP-RNF8 (Mailand et al., 2007), GFP-53BP1 and GFP-RNF168 (Yaron Galanty) was 
supplemented with 0.5 mg/ml G418 (Gibco, Invitrogen).  
 69 
2.10.II Treatment with DDR inhibitors and DNA-damaging agents 
 
ATM (KU-55933) and DNA-PK (NU-7441) inhibitors were from KuDOS Pharmaceuticals 
and Chk1/2 inhibitor AZD7762 was from AstraZeneca (Zabludoff et al., 2008). IR 
treatment was with a Faxitron X-ray machine (Faxitron X-ray Corporation, Illinois, USA). 
Phleomycin (Duchefa Biochemie) was added at 30 µg/ml. Where appropriate, ATM and 
DNA-PK inhibitors (20 µM and 2 µM, respectively) were applied to culture medium 1 
hour prior to DSB induction. Chk1 inhibitor was added (50 nM final concentration) 3 
hours prior to phleomycin treatment.  Cells were processed for analyses 30 min after IR or 
phleomycin treatment. 
 
2.10.III Transfection of plasmid DNA 
 
Human cells plated for a 25-50% confluency and washed into 2 ml of DMEM low-serum 
Q-only (DMEM supplemented with 5% w/v FCS and glutamine) before transfection. 
Chemical transfection was performed using Fugene 6 (Roche), or Lipofectamine 2000 
(Invitrogen) reagents according to manufacturer’s instructions. Briefly, DNA-transfection 
complexes were prepared in 0.5 ml Optimem (Invitogen) by the addition of 12 µl of 
Fugene 6 reagent, and 2-5 µg of plasmid DNA, incubating at room temperature for 15 min. 
DNA-transfection complex mixture was gently and evenly added to the plate. Cells were 
monitored for optimal protein expression at ~24 and ~48 hours following transfection. 
 
2.10.IV Transfection of siRNA 
 
All siRNA duplexes were purchase from MWG-Biotech or Dharmacon (Thermo) and were 
transfected into cells at ~25% confluency by using Oligofectamine reagent (Invitrogen) 
according to manufacturer’s instructions, to a final concentration of 80 nM. Typically, cells 
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were left in DMEM low-serum Q-only transfection medium for 24 hours, before washing 
into standard medium. Cells harvested for experiments ~48 or ~72 hour post-transfection. 
 
2.10.V Cell synchronization techniques 
 
The thymidine-nocodazole method includes 16-22 hours pre-synchronization with a single-
thymidine-block using 2.5 mM of thymidine, followed by cells being extensively washed 
and released into fresh medium. After 8-10 hours, nocodazole was added to a final 
concentration 40 ng/ml for 3-4 hours to accumulate cells in early mitosis. For nocodazole-
only synchronization, cells were incubated with 100 ng/ml nocodazole for 18-20 hours. 
 
2.10.VI Cell survival assay 
 
Mitotic cells obtained by shake-off of the cultures pre-synchronised by thymidine-
nocodazole were treated with ATM and DNA-PKcs inhibitors for 1 hour and irradiated 
with 0.5, 1, 2 or 4 Gy. 30 min later, cells were extensively washed to remove inhibitors 
and/or nocodazole, counted and plated. Asynchronous cells were plated 24 hours prior to 
the treatments. Cells were left for 10-14 days at 37°C to allow colony formation. Colonies 
were stained with 0.5% crystal violet/20% ethanol and counted. Results were normalized 
to plating efficiencies. Statistical analysis was performed using the R Language for 
Statistical Computing. Coefficients and corresponding p-values were calculated separately 
for mitotic and asynchronous cells, using the linear modelling function in R by the 
following model:  log(y) = β0 +β1IR + β2IR2 + β3t + β4IR * t, where y is the percentage of 
cells surviving, IR is the radiation level in Gy, and t is the treatment (encoded as 0 for 
DMSO and 1 for ATMi/DNA-PKi). The quadratic term was included since the response 
curve is nonlinear. 
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2.11 Yeast materials and methods 
2.11.I Yeast media 
 
Yeast was grown in autoclaved YPA medium or autoclaved THULL synthetic medium 
(Table 4) supplemented with 2% glucose unless otherwise indicated. THULL medium was 
used to select for the marker genes URA3, TRP1, HIS3 or LEU2 where indicated. Unless 
otherwise stated, cells were grown at 30°C. For long-term storage at -80°C, 15% glycerol 
was added to a saturated culture. For short-term storage, yeast strains were stored on yeast 
extract–peptone–dextrose medium with adenine (YPAD) agar plates at 4°C.  
 
TABLE 4. Yeast culture media  
 
Medium  Recipe 
YPAD  Per litre: 20 g bactopeptone, 10 g yeast extract, 40 mg adenine 
hemisulphate. Glucose was added to 2% after autoclaving. 20 g 
of bactoagar was added for media plates. 
THULL  Per litre: 1.2 g yeast nitrogen base (without amino acids), 5 g 
ammonium sulphate, 10 g succinic acid, 6 g NaOH, 0.8 g 
amino acid (aa) dropout mix. Glucose was added to 2% after 
autoclaving. 20 g of bactoagar was added for plates. 
Aa dropout mix 1 g of each adenine, arginine, cysteine, threonine, and 0.5 g of 
each asparagines, isoleucine, methionine, phenylalanine, 
proline, serine, tyrosine, valine. 
100X aa stock  Per litre: 10 g aa (tryptophan, histidine, leucine or lysine) were 
dissolved in 1 litre of ddH2O. For uracil, 10 g were dissolved in 
0.1 M NaOH. Solutions were filter sterilised.  
SC-URA  Per litre: As THULL, plus 100 mg each of leucine, tryptophan, 
histidine and lysine added from 100X stocks after autoclaving. 
SC-LEU  Per litre:As THULL, plus 100 mg each of uracil, tryptophan, 
histidine and lysine added from 100X stocks after autoclaving. 
SC-TRP  Per litre: As THULL, plus 100 mg each of leucine, uracil, 
histidine and lysine added from 100X stocks after autoclaving. 
SC-HIS Per litre: As THULL, plus 100 mg each of leucine, tryptophan, 
uracil and lysine added from 100X stocks after autoclaving. 
5-FOA Per 250 ml: 0.25 g 5-FOA, 0.5 g aa dropout mix, 1.7 g yeast 
nitrogen base without aa, 25 mg leucine, 25 mg lysine, 25 mg 
tryptophan, 25 mg histidine, 12.5 mg uracil, 25 ml 20% 
glucose, 100 ml sterile ddH2O, 5 g bactoagar, cooled to 55°C. 
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2.11.II Yeast strains and genotypes 
 
TABLE 5. Yeast strains used in this study   
 
Strain Background Genotype Reference/Source 
W303-1A MATa  ade2-1 can1-100 his3-11,15 
leu2-3,112  trp1-1ura3-1 RAD5             
W303 Robert Driscoll 
W303-1B MATα ade2-1 can1-100 his3-11,15 
leu2-3,112  trp1-1ura3-1 RAD5             
W303 Robert Driscoll 
W303  Diploid of W303-1A and W303-1B  W303 This study 
SGY01 MATa 3HA-PSF1::HIS3 W303 This study 
SGY02 MATa 3HA-psf1-S187A::HIS3 W303 This study 
SGY03 MATa 3HA-psf1-S187E::HIS3 W303 This study 
SGY04 MATa HIS3:: W303 This study 
SGY05  Diploid psf1∆::kanMX6 / PSF1  W303 This study 
SGY06 psf1∆::kanMX6 3HA-PSF1::URA3 W303 This study 
SGY07 psf1∆::kanMX6 3HA-PSF1::HIS3 W303 This study 
SGY08 psf1∆::kanMX6 3HA-PSF1::URA3  
3HA-PSF1::HIS3 
W303 This study 
SGY09 psf1∆::kanMX6 3HA-PSF1::URA3 
3HA-psf1-S187A::HIS 
W303 This study 
SGY10 psf1∆::kanMX6 3HA-psf1-S187A::HIS W303 This study 
SGY11 psf1∆::kanMX6 3HA-PSF1::URA3 
3HA-psf1-S187E::HIS 
W303 This study 
YYT4 MATa ade2-1 can1-100 his3-11, 15 
leu2-3,112 trp1-1 ura3-1 bar1 psf1-1 
W303 (Takayama et al., 
2003) 
SGY12 psf1-1 3HA-PSF1::HIS3 W303 This study 
SGY13 psf1-1 3HA-psf1-S187A::HIS3 W303 This study 
SGY14 psf1-1 3HA-psf1-S187E::HIS3 W303 This study 
SGY15 psf1-1 HIS3:: W303 This study 
YSC1178 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
HIS3MX6 PSF1-TAP 
W303 (Ghaemmaghami et 
al., 2003) 
RDY072 mec1∆::TRP1 sml1-1  W303 Robert Driscoll 
SGY16 rad9∆::URA3 3FLAG-CHK1  W303 This study 
SGY17 As SGY16 + RAD9::TRP1 W303 This study 
SGY18 As SGY16 + rad9-S83A::TRP1  W303 This study 
SGY19 As SGY16 + rad9-T110A::TRP1 W303 This study 
SGY18 As SGY16 + rad9-T125A::TRP1  W303 This study 
SGY19 As SGY16 + rad9-T143A::TRP1 W303 This study 
SGY20 SGY16 + rad9-S83A, T110A,T143A::TRP1 W303 This study 
SGY21 As SGY16 + rad9-S83A, T110A, 
T125A, T143A::TRP1 
W303 This study 
SGY22 As SGY16 + rad9-S56A,S83A,T110A, 
T125A,T143A::TRP1 
W303 This study 
Cdc28as1 ura3-1, leu2-3,112, trp1-1, his3-11,15, 
ade2-1, can1-100, GAL+cdc28as1 
W303 (Bishop et al., 
2000) 
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2.11.III Construction of yeast strains 
 
Deletion of genes was carried out using PCR-mediated targeted gene disruption method 
(Baudin et al., 1993). Double mutants were created where possible by crossing MATa and 
MATα strains to create a heterozygous diploid, and subsequent sporulation of this diploid 
to form tetrads was followed by dissection and replica plating to determine correct 
genotype of the resulting spores. 3x FLAG-epitope tagged genes were created by PCR-
mediated targeted gene tagging. p3FLAG-KanMX was used as template for generation of a 
PCR product that introduces three copies of the FLAG epitope just upstream of the 
termination codon of the CHK1 gene by HR (Gelbart et al., 2001), using especially 
designed primers. PCR products were gel-purified and transformed into yeast cells 
(Chapter 2.11.IV). Gene disruption was confirmed by diagnostic PCR from genomic DNA 
prepared from resistant colonies (Chapter 2.11.VI) using primers upstream of the disrupted 
gene and inside the disruption cassette. Gene tagging was confirmed by western blotting. 
 
2.11.IV Yeast transformation 
 
A modified version of the lithium acetate procedure (Ito et al., 1983) was used. 
Approximately 1x108 logarithmically growing yeast cells were harvested by centrifugation 
at 3000 rpm for 3 min, washed in 1 ml H2O, followed by one wash in 1 ml 1x TE/LiAc 
(0.1 M lithium acetate, 10 mM Tris-HCl pH 7.5, 1 mM EDTA). Cells were resuspended in 
50 µl 1x TE/LiAc and 1-2 µg of plasmid DNA or disruption construct were added. 25 µl of 
sonicated salmon sperm DNA (10 mg/ml, previously denatured at 95°C for 5 min before 
being placed on ice) and 300 µl of PLATE solution (40% polyethylene glycol 3350, 0.1 M 
lithium acetate, 10 mM Tris-HCl pH 7.5, 1 mM EDTA) were added, before incubation at 
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30°C for 1 hour. The yeast suspension was then heat-shocked at 42°C for 15 min before 
washing and resuspension in 0.5 ml ddH2O. Aliquots of 200 µl were plated on appropriate 
media plates containing or lacking the required selection and grown for 2-3 days at 30°C. 
 
2.11.V Plasmid shuffle 
 
The plasmid shuffle method (Bender and Pringle, 1991) consists of using a null mutation 
in chromosomal gene PSF1, rescued by the wild-type version on a URA3 selectable 
plasmid. Because psf1Δ is lethal, diploid cells heterozygous for psf1 null allele were 
transformed with wild-type PSF1-containing URA3 plasmid and sporulated. The strain 
containing the wild-type plasmid and null mutation for PSF1 was selected by replica-
plating on 5-fluoro-orotic acid (5-FOA); 5-FOA is a chemical toxin that kills Ura+ yeast 
cells. This strain was transformed with plasmids that contain mutant variants of psf1 or 
wild-type PSF1 on a HIS3 plasmid. The PSF1-Ura+ plasmid can be shuffled out of the 
transformed cells by selecting against the presence of URA3 in 5-FOA-containing medium. 
Mutant alleles may rescue the lethality of the chromosomal psf1 mutation and can thus be 
studied further.  
 
2.11.VI Genomic DNA preparation 
 
Yeast genomic DNA was prepared as described by Kaiser et al. (1994). In brief, 5 ml of 
saturated cultures were resuspended in 0.5 ml of 1 M sorbitol, 0.1 M EDTA pH 8.0 and 
incubated with 12.5 µl of 4 mg/ml Zymolyase 100-T (ICA) for 1 hour at 37°C. Following 
centrifugation, the pellet was resuspended in 0.5 ml of 50 mM Tris-HCl pH 7.4, 20 mM 
EDTA, 1% SDS and incubated at 65°C for 30 min. 0.2 ml of 5 M potassium acetate was 
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added and incubated on ice for 1 hour. Supernatant resulting from centrifugation was 
added to one volume of 100% isopropanol, and then incubated for 5 min at room 
temperature before brief centrifugation. Precipitated DNA was air-dried and resuspended 
in 0.3 ml of TE (10 mM Tris-HCl pH 7.4, 1 mM EDTA). 15 µl of a 1 mg/ml solution of 
RNase A was added and incubated at 37°C for 30 min. Precipitate resulted from adding 
0.03 ml of 3 M sodium acetate and 0.2 ml of 100% isopropanol followed by centrifugation. 
The pellet was air-dried before resuspension in 0.2 ml of TE pH 7.4.  
 
2.11.VII Denatured whole cell extracts with TCA preparation  
 
Denatured protein extracts were prepared by trichloroacetic acid (TCA) extraction (as 
described by(Foiani et al., 1994). 1x108 cells of log phase cultures were centrifuged at 
3000 rpm for 3 min at 4°C and resuspended in 100 µl of 20% TCA with an equal volume 
of acid-washed glass beads. The cells were lysed in a FastPrep (setting 4.5; Bio101) for 50 
sec and the supernatant recovered in a fresh microcentrifuge tube. The glass beads were 
washed with 200 µl of 5% TCA and the supernatants combined and then centrifuged for 10 
min at 13200 rpm. The pellet was then resuspended in 100 µl of SDS-sample buffer, boiled 
at 95°C for 5 min before loading, typically 10-15 µl, on SDS-PAGE gels.  
 
2.11.VIII Preparation of native whole cell extract 
 
Native protein extracts were prepared from mid-log yeast cultures (500 ml) harvested by 
centrifugation, washed twice with H2O and resuspended in an equal volume of 2x 
extraction buffer (200 mM Hepes-KOH pH 7.9, 300 mM potassium acetate, 20 mM 
magnesium acetate, 0.2% NP-40, 4 mM EDTA, 20% glycerol, 2x protease inhibitors, 2 
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mM DTT) before disruption in a Constant Cell Disruption System (Constant Systems) at 
20000 pounds per square inch (psi) and 4°C. The recovered extract was centrifuged at 
13500 rpm for 15 min at 4°C, the supernatant removed to a fresh tube and stored at -80°C.  
 
2.11.IX Yeast cell cycle synchronization in G1 
 
To arrest cells in G1, MATa cells were grown from OD600nm of 0.06 to 0.2-0.3 and treated 
10 µg/ml of α-factor for 1-2 hour (Paulovich and Hartwell, 1995). The efficiency (>95%) 
of the arrest was confirmed by light microscopy, determining the ratio of un-budded to 
budded cells. Cells were then either harvested directly or synchronously released into the 
cell cycle by washing with YPAD to eliminate the α-factor. 
 
2.11.X Purification of TAP-tagged proteins 
 
6-10 litres of yeast culture expressing tandem affinity purification (TAP) tagged protein 
were processed as described in 2.13.VIII. Supernant was added to pelleted and 
resuspended in same volume of Tampon A (50 mM Tris pH 7.5, 100 mM NaCl, 1.5 mM 
MgCl2, 0.15% NP40, 1x protease and phosphatase inhibitors) with 50% IgG sepharose 
overnight at 4°C. Washed with Tampon de Corte (Tampon A + 1 mM DTT) and added 1 
ml Tampon de Corte and 100 U of TEV protease overnight at 4°C. Supernatant was 
filtered through a chromatography column (BioRad) and 3 ml Tampon B (10 mM Tris pH 
8, 150 mM NaCl, 1 mM Mg-Acetate, 2 mM CaCl2, 10 mM β-Mercaptoethanol, 1 mM 
Imidazole, 0.1% NP40) with 3 µl 1M CaCl2 and 300 µl 50% calmodulin beads were added 
overnight at 4°C. Beads were washed on column with Tampon B and TAP-tagged proteins 
were eluted in Tampon B plus 5 mM EGTA.   
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2.11.XI Growth curves 
 
For growth curves, cells were grown overnight to saturation in 5 ml YPAD. Cultures were 
then diluted to an OD600nm of 0.06 and grown to an OD600nm of 0.3 in 10 ml YPAD. 
Cultures were then re-diluted to an OD600nm of 0.06 in 10 ml YPAD and the absorbance 
measured for 3-8 hours.  
 
2.11.XII Sensitivity assays 
 
Sensitivity assays of different yeast strains to increased temperature, DNA damaging 
agents, IR and ultra-violet radiation (UV) were carried out by inoculating a single colony 
and incubating the culture overnight at 30°C to saturation. Cells were then diluted to a 
density of 1.75x107 in sterile ddH2O and ~5 µl of 5- or 10-fold serial dilutions were spotted 
onto YPAD or the appropriate synthetic selective medium containing hydroxyurea (HU), 
methane methylsulphonate (MMS), camptothecin (CPT) or phleomycin as required. Cells 
were similarly diluted on YPAD plates and allowed to dry before IR and UV irradiation. 
Plates were incubated for 2-3 days at 30°C, or 23°C and 37°C for temperature-sensitivity 
analysis. 
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3 DNA DAMAGE SIGNALLING IN RESPONSE TO DSBs 
DURING MITOSIS  
3.1 Summary  
The DDR comprises an intricate network of pathways that coordinates cellular reactions to 
DNA insults. Cellular responses to DNA damage range from arrest of the cell cycle, repair 
of DNA lesions, to the re-establishment of cellular homeostasis. In mammalian cells, the 
signalling cascade initiated in response to DSBs has been extensively investigated in 
interphase cells. Yet, the molecular events following induction of DSBs during mitosis are 
still somewhat elusive.  
 
Here, I show that mitotic cells treated with DSB-inducing agents activate a ‘primary’ DDR 
comprised of early signalling events including activation of the protein kinases ATM and 
DNA-PK, histone H2AX phosphorylation together with recruitment of MDC1 and the 
Mre11-Rad50-Nbs1 (MRN) complex to damage sites. However, mitotic cells display no 
detectable recruitment of the E3 ubiquitin ligases RNF8, RNF168 and BRCA1, or 
accumulation of the mediator protein 53BP1, at DSB sites, indicating that ‘secondary’ 
DNA damage responses are inhibited in mitosis. Furthermore, DNA damage signalling is 
attenuated in mitotic cells, with full DDR activation only ensuing when a DSB-containing 
mitotic cell enters G1. In addition, induction of DSBs does not trigger a DNA damage 
checkpoint arrest once the cell is committed to mitosis. Accordingly, I show that 
phosphorylation of certain downstream ATM substrates in response to DSB induction, 
including the DNA damage checkpoint kinases Chk1 and Chk2, is impaired during  
mitosis. 
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Finally, I provide evidence that induction of a primary DDR in mitosis, including γH2AX 
marking of DSBs and MRN-mediated end-tethering, is biologically important for cell 
viability, as it may facilitate the induction of a full DDR and repair of the DNA lesion in 
the more favourable chromatin environment of the G1 cell. 
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3.2 Introduction 
3.2.I DNA damage responses in mitosis: a one hour long gap in our 
knowledge 
 
Albeit extensively investigated in the context of interphase cells, the precise mechanisms 
and functions of the DDR in mitotic cells are still poorly understood. During the 1960s, 
analyses of living cells following irradiation revealed the existence of defined points of 
arrest in the progression through the cell cycle. Remarkably, irradiation of cells that 
displayed a mitotic status, visually identified by marked chromatin condensation and 
absence of nuclear envelope, failed to halt cell cycle progression and continued through the 
process of cell division, giving rise to two daughter cells (Swann, 1957; Mazia, 1961). The 
observations that mitotic cells seemed unresponsive to IR prompted speculations that no 
checkpoint, and therefore no DNA damage responses, existed in mitosis. Interestingly, the 
time frame after the G2/M transition when cells became unresponsive to irradiation was 
named a ‘point of no return’ (Mazia, 1961). This dramatic appellation emphasized the 
early understanding of the potentially detrimental repercussions for the cell to ignore DNA 
lesions and continue to orchestrate the series of events that lead to cell division. More 
recent studies have shown that vertebrate cells can delay mitosis, or even reverse mitotic 
progression if exposed to IR during a newly defined ‘antephase’ point – between late G2 to 
mid prophase – when chromatin condensation is actively taking place in preparation for 
entry into mitosis and cell division (Pines and Rieder, 2001; Matsusaka and Pines, 2004; 
Chin and Yeong, 2009). The antephase checkpoint has acquired increasing importance 
over recent years. It acts to complement two established checkpoints: the prior G2/M 
checkpoint that acts to monitor completion of DNA replication and absence of DNA 
damage before preceding into mitosis; and the spindle assembly checkpoint (SAC), which 
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ensures accurate spindle assembly on all mitotic chromosomes, before allowing the 
transition into anaphase and mitotic exit.  Knowledge of the existence of an antephase 
checkpoint stems from experimental observations showing that exposure to stress signals 
in early prophase cells that have initiated chromatin compaction yet retain an intact nuclear 
envelope, triggers a temporal delay and a reversion into a G2 status (Carlson, 1969a; 
Carlson, 1969b; Rieder and Cole, 1998; Matsusaka and Pines, 2004)and my own 
observations). Following antephase, and once the cell has passed the ‘point of no return’, 
marked by nuclear envelope breakdown in late prophase, the cell becomes committed to 
completing mitosis even in the presence of DNA damage (Rieder and Cole, 1998). 
Nonetheless, the rate of mitotic progression can be affected by the amount of DNA 
damage: whilst relatively low levels of damage do not delay M-phase exit, more 
substantial damage can interfere with the structure and functions of kinetochores, resulting 
in a significantly prolonged mitosis due to the need to satisfy the SAC (Mikhailov et al., 
2002). Thus, DNA breaks per se do not hinder mitotic progression and do not appear to 
induce activation of a DNA damage checkpoint (Rieder and Salmon, 1998), unless they 
affect spindle assembly and kinetochore attachment, leading to activation of the SAC.  
 
Laboratory induction of DNA damage on cultured cells is an artificial scenario that may 
mimic particularly challenging in vivo conditions, including exposure to chemotherapy, 
radiotherapy and highly mutagenic compounds. On the other hand, the understanding of 
how cells deal with DSBs that arise endogenously during physiological progression into 
mitosis is also of high relevance. The mitotic spindle itself can cause DSBs by a breakage-
fusion-bridge mechanism, as marked by the appearance of γH2AX local accumulation. 
Recent evidence suggests that the DSBs are specifically localized at centromeres, 
particularly vulnerable sites subjected to the spindle-induced tensional forces during 
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mitosis. Furthermore, spindle-generated DSBs are mainly found in centromere-containing 
micronuclei (Guerrero et al., 2009). As both spindle defects and increased γH2AX signals 
correlate with aneuploidy, these phenomena may underlie malignant transformation, 
promoting tumourigenesis.   
 
It is noteworthy that a defined threshold exists in the number of DSBs required to elicit the 
activation of the G2/M checkpoint. About 10-20 DSBs are the minimum required to induce 
cell cycle arrest and prevent entry into mitosis (Deckbar et al., 2007). It is therefore 
possible to envisage a scenario where less than 20 DSBs, endogenously arising after 
completion of S-phase or during G2 and following exposure to less than 0.4 Gy of IR, may 
be carried through into mitosis. Experimental evidence shows that cells containing less 
than 20 DSBs can complete mitosis in a timely manner, suggesting that low numbers of 
DSBs, enough to slip under the radar of the G2/M checkpoint, would not reverse entry into 
mitosis through activation of the ‘antephase’ checkpoint nor the SAC. It would be 
interesting to continue monitoring these cells during subsequent cell cycles to establish 
whether the presence of a few DSBs is compatible with error-free segregation or if it will 
lead to chromosomal imbalances. 
  
Interestingly, several DDR components have been found to play roles in regulating 
chromosome segregation in the absence of DNA damage. The recruitment of DDR factors 
to mitotic structures during unperturbed mitosis has been reported; for example, ATM, 
ATR, DNA-PKcs, p53, TopBP1, BRCA1, Chk1 and Chk2 associate with centrosomes in 
mitosis (Hsu and White, 1998; Tsvetkov et al., 2003; Reini et al., 2004; Tritarelli et al., 
2004; Zhang et al., 2007), while 53BP1 is found at kinetochores (Jullien et al., 2002). 
These mitotic compartmentalisations correlate to functional activity of these proteins in the 
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process of cell division. 53BP1, for instance, is loaded to the kinetochore during prophase, 
where it co-localizes with CENP-E. In metaphase, it is released only if all chromosomes 
are aligned correctly on the equatorial plate, suggesting that 53BP1 may play a 
physiological role in controlling mitotic progression into anaphase (Jullien et al., 2002). 
Another report also pinpointed Xenopus 53BP1 as a suppressor of mitotic catastrophe (Xia 
et al., 2001). In addition, Chk1 is directly regulated by CDK1-dependent phosphorylation 
(Shiromizu et al., 2006) and is required for several aspects of cell division, ranging from 
regulation of the SAC, transcriptional inhibition of mitotic cyclin/CDK genes, to 
controlling chromosome segregation and cytokinesis (Kramer et al., 2004; Zachos et al., 
2007; Peddibhotla et al., 2009). MDC1 was also recently shown to directly bind the APC/C 
(anaphase-promoting complex/cyclosome;(Coster et al., 2007) and to regulate mitotic 
progression by enabling cdc20-mediated activation of the APC in the metaphase-to-
anaphase transition (Townsend et al., 2009). These data further underscore the link 
between cell cycle regulation and the DNA damage cascade. 
 
In budding yeast, canonical DNA damage components such as the apical DDR kinases 
Mec1 (the yeast homologue of ATR) and Tel1 (homologous to ATM) directly influence 
mitotic progression in the presence of DNA damage, and are interlinked with intrinsic 
mitotic checkpoints, promoting activation of the SAC upon cytotoxic stress (Kim and 
Burke, 2008). Nevertheless, to date, there is no clear evidence to suggest a DNA damage-
dependent role for these DDR factors in the mitosis of mammalian cells.   
 
Collectively, these data point toward a scenario whereby DSBs fail to activate a DNA 
damage checkpoint and to elicit DNA damage responses in the context of mitosis in 
mammalian cells. Nevertheless, the presence of γH2AX foci in mitotic cells treated with IR 
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(Nakamura et al., 2006; Kato et al., 2008) suggests that DSBs generated during mitosis are 
not left unnoticed by the DDR machinery. Indeed, it would be difficult to envisage a 
scenario where the presence of extremely cytotoxic lesions such as DSBs is uncared for 
while meticulous multistep regulations act to maintain mitotic fidelity.  
 
3.2.II Mitosis and cancer: clinical relevance 
 
Just like normal cells, all cancer cells multiply through the process of cellular division. 
Therefore, mitosis is fundamental to propagation of life and, at the same end, to the process 
of tumourigenesis. A main cellular feature of cancer cells is the abnormal hyper-
proliferation. Human cells have implemented a plethora of molecular machineries to 
ensure faithful duplication of an undamaged genome and accurate partitioning during cell 
division. Thus, the fast paced rate of division typical of many cancers does not warrant 
controlled proliferation and fidelity of duplication. Cancer often results from the 
accumulation of mutational damage in genes that control cell cycle progression, arrest, as 
well as cell death. Therefore, deregulation of the cell division cycle is a causative trait of 
cancer cells. Moreover, mitotic index values are used to measure the proliferative 
capacities of a specific cell type within a tissue. High mitotic index is regarded as a 
biological marker for aggressive and often invasive tumours. For these reasons, mitosis has 
been an important target for anti-cancer therapy (reviewed in(Sudakin and Yen, 2007). 
Currently, aside from surgery, systemic chemotherapy represents the main line of action 
for the treatment of cancer. Anti-mitotic drugs are chemotherapeutics that disrupt assembly 
of the mitotic spindle, affecting cell division. Active classes of drugs in cancer treatment, 
such as taxanes and vinca alkaloids, are anti-mitotic toxins that stabilize and depolymerize 
microtubules, respectively. However, these conventionally developed anti-mitotic agents 
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affect all dividing cells, causing severe toxicity to healthy tissues. Furthermore, intrinsic or 
acquired resistance to anti-mitotic drugs is observed when cancer cells tolerate gross 
chromosomal instability and continue to divide. Chromosomal instability is associated with 
poor patient prognosis and causes further exacerbation of cancer cell abnormalities. 
Notably, however, a new generation of anti-neoplastic drugs is being investigated, using 
novel classes of anti-mitotics that target functional aspects of the mitotic regulatory 
system. Inhibitors against mitotic kinases, including Polo-like kinases, Aurora and others, 
are currently entering clinical trials. Being over-expressed in cancer, new compounds 
against these proteins have high potential as targets for anticancer treatment and may 
reduce side effects compared to conventional treatments.  
 
Another important aspect of mitosis in the context of cancer treatment is the inherent 
ability of mitotic cells to trigger cell death through induction of mitotic catastrophe (MC). 
MC is a mechanism of delayed reproductive death caused by abnormal mitosis that leads to 
micronucleation. The pathway of MC may be activated as an anti-proliferative response of 
tumour cells or may be induced by anti-mitotic and cytotoxic agents and is particularly 
relevant in absence of p53 and when apoptotic pathways are impaired. However, cells may 
escape death through MC via a so-called mitotic restitution pathway, activating endocycles 
and resulting in giant polyploid cells. This mechanism of survival may also cause 
resistance to anti-mitotics (Erenpreisa and Cragg, 2001). 
 
In light of the extreme radio-sensitivity of mitotic cells (our observations and(Stobbe et al., 
2002), mitosis is an ideal target for anti-cancer treatment. Fast-dividing cells subjected to 
mitotic DNA damage readily undergo cell death. On the other hand, mitosis may also have 
a causative effect other than merely an incidental role, in disrupting genomic integrity and 
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promoting tumourigenesis. In fact, damaged mitotic cells may over-ride the cell death 
pathway, leading to malignant transformations. Therefore, several mechanisms exist by 
which aberrant mitotic control affects both the onset and continuance of tumourigenesis as 
well as responses to anti-mitotic chemotherapy and cancer prognosis. Strikingly, while 
anti-mitotic agents are at the forefront in developing novel strategies in cancer control, 
little is known about the molecular mechanisms following induction of DNA damage in 
mitosis. Therefore, more data are urgently required to gain a better understanding of the 
mitotic process and the molecular details subsequent to its perturbation.   
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3.3 Results 
 
3.3.I Analyzing DNA damage responses in the context of mitosis: a matter of 
synchronization 
 
The study of molecular events occurring during mitosis is hindered by the brevity of this 
cell cycle phase. Generally, the distribution over the cell cycle of an asynchronous 
population of cultured human osteosarcoma cancer cell line U2OS, as monitored by FACS, 
shows that a majority of cells is found in G1 (up to 50%); the remaining fifty percent is 
divided between S-phase and G2/M, with approximately 35-40% of cells in S-phase versus 
~15% for G2/M (Figure 1A and 1B). However, a major limitation of cell cycle analysis 
using flow cytometry techniques is that it does not allow discrimination between G2 and 
M-phases of the cell cycle, as the DNA content is the same. Histone H3 phosphorylated on 
serine 10 (H3 pS10) is a post-translational modification highly enriched during chromatin 
compaction at the onset of prophase and marks chromosomes throughout mitosis, 
representing a canonical marker of mitotic cells. Immunofluorescence staining of this 
modification with antibodies against H3pS10 allows readily detection and discrimination 
of mitotic cells within an asynchronous population. Mitotic indices, measured manually by 
quantification of H3 pS10-positive cells using immunostaining, or by automated analysis 
via flow cytometry (Juan and Darzynkiewicz, 2004), revealed that approximately 1.5-3% 
of asynchronously growing U2OS cells were undergoing mitosis at any one time (Figure 
1C and data not shown). This small proportion makes it hard to study cells during mitosis. 
Thus, before presenting data on the mitotic DNA damage signalling in response to DSBs, I 
will briefly present novel methodologies that I have developed to overcome specific 
limitations in the study of the mitotic DDR. 
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A major issue in analyzing DNA damage related events in mitosis is the negative effect 
that DNA damaging agents exert over the mitotic index. The mitotic population is 
drastically reduced upon treatment with DSB-inducing agents, including IR and 
phleomycin (Figure 1D and Figure 2B), a DNA-intercalating agent known to cause DSBs 
throughout the cell cycle (Moore, 1988). If the damage were inflicted before antephase, 
robust activation of the G2/M checkpoint would prevent entry of damaged cells into 
mitosis. On the other hand, cells damaged during mitosis can progress through mitosis and 
back into G1 within 1 hour post-treatment, due to the absence of a mitotic DNA damage 
checkpoint. Therefore, the analyses performed in my studies do not exceed a 30-minute 
incubation following treatment with DNA damaging agents, allowing retention and 
monitoring of cells damaged during mitosis. Limiting incubation to 30-minutes post-
damage and use of H3 pS10 to mark mitotic cells allowed visualization of an adequate 
number of mitotic cells in immunofluorescence analyses, without need for synchronization. 
Thus, for all immunofluorescences shown in this study, asynchronous cell populations 
were used.  
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FIGURE 1. Impact of DNA damage on cell cycle distribution in U2OS cells  
 
 
 
FACS profile of untreated, asynchronously growing U2OS cells (A) and corresponding quantification 
using two cell cycle modelling algorithms: the Watson Pragmatic, blue line (G1 = 47%; S = 32.4%; 
G2/M = 14.9%) and the Dean/Jett/Fox method, green line (G1 = 45.5%; S = 36.2%; G2/M = 13.1%) 
(B). Mitotic cells, as measured by H3 pS10 (purple boxes), are about 1.52% in untreated 
asynchronous U2OS cells (C) and decrease to 0.4% after 2 hours treatment with phleomycin (D).  
 
Harvesting of a large numbers of mitotic cells was required for cell extracts, western 
blotting and for flow cytometry analyses. Given that mitotic cells represent such a minor 
proportion of an asynchronous culture, I used synchronization methods to enrich for the 
mitotic population. Initially, I used the microtubule depolimerizing agent, nocodazole, to 
arrest cells at prophase. Nocodazole-arrested cells displayed a chromosomal arrangement 
typical of prophase cells (Figure 2C), due to their inability to align chromosomes on the 
metaphase equatorial plate and progress into metaphase. U2OS cells were incubated in the 
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presence of 100 ng/ml of nocodazole for 20 hours and synchronization was monitored by 
flow cytometric analysis of the DNA content: 74% of cells were found in G2/M post-
synchronization, with 11% and 15% of cells remaining in G1 and in S-phase, respectively 
(Figure 2A).  
 
Nocodazole is extensively used to synchronize cells in mitosis; yet, microtubule-disrupting 
agents have been previously shown to induce p53-dependent stress responses in human 
cells (Tishler et al., 1995). Indeed, nocodazole caused severe stress to the cells, as 
monitored by an increased γH2AX signal (Figure 2B). DAPI staining of several U2OS 
cells exposed to prolonged nocodazole treatment revealed disrupted cellular morphology, 
abnormal chromatin arrangement and obvious multinucleation, indicative of apoptosis 
(Figure 2C, 2D and 2E). Chromosomal aberrations caused by prolonged SAC activation 
and, eventually, escape from the nocodazole block and endoreduplication are highly 
relevant in the context of chemotherapeutic treatments with anti-mitotic drugs (Dalton and 
Yang, 2009). Thus, the nocodazole-induced stress signal, as monitored by extensive 
γH2AX phosphorylation in western blotting (Figure 2B) and in immunofluorescence (data 
not shown), rendered the use of synchronization by prolonged exposure to nocodazole 
unsuitable for investigation of DNA damage signalling in mitosis.  
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FIGURE 2. Consequences of prolonged nocodazole treatment in U2OS cells 
with or without DNA damage induction 
 
 
Content not visible due to copyright limitations 
 
U2OS cells were incubated with or without 100 ng/ml nocodazole for 20 hours, followed by treatment 
with 5 Gy of IR or mock irradiation. Cells were then collected for FACS, IF and WB analyses. 
Nocodazole-induced synchronization arrested a high proportion of cells in G2/M (74%), and this was 
unchanged after irradiation (A). Arrest of U2OS cells with nocodazole gives rise to γH2AX detection 
via WB. However, the γH2AX signal is further increased upon treatment with 5 Gy of IR. It is 
noteworthy that the reduction seen in H3 pS10 levels upon IR treatment of asynchronous cells reflects 
a reduction in the proportion of mitotic cells following DNA damage (B; panel B from Collaborator). 
DAPI staining of DNA after nocodazole arrest in prophase (C). Certain cells show broken 
chromosomes (arrow) and abnormal DNA conformations (D). Bulky, multinucleated cells, possibly in 
the process of apoptosis, were also observed in nocodazole-arrested samples (E).  
 
To minimize exposure of cells to nocodazole, other methods of synchronization were 
tested. I optimized a synchronization protocol using a thymidine-nocodazole method. 
Thymidine is commonly used to arrest cells at the G1/S boundary. As thymidine also 
induces cytotoxic stress, cells were subjected to a single thymidine block of 16 hours. 
Following release from thymidine, cells took from 8 to 10 hours to progress into S-phase 
and reach G2/M (Figure 5). Therefore, after thymidine pre-synchronization, cells were 
released into fresh medium for approximately 8 hours. After the release, a short incubation 
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with nocodazole – from 3 to a maximum of 4 hours – formed a mitotic trap, where cells 
progressing into mitosis were blocked in prophase. This novel single-thymidine-
nocodazole block gave a much more efficient mitotic arrest, as shown by FACS (in HeLa 
cells, Figure 25; and in U2OS, Figure 27), a drastic reduction in abnormal and 
multinucleated cells, and a partial reduction in the levels of γH2AX signal compared to 
nocodazole synchronization (data not shown). Therefore, the single thymidine-nocodazole 
arrest was the preferred choice of synchronization in subsequent experiments, except for 
immunofluorescences where asynchronous cells were used. In addition, to obtain an 
essentially pure mitotic population, mitotic shake off of synchronized cells was performed 
at all times.  
 
Multiple cell lines were used during the course of this study, to confirm that the results 
obtained were not cell line specific. The human cervical cancer cell line HeLa was 
subjected to similar synchronization methods as U2OS and responded in a comparable 
manner. In addition, asynchronous populations of BJ and MRC5 primary fibroblasts were 
used for immunofluorescence experiments to verify certain key molecular mechanisms in 
untransformed cells offering a cellular scenario closer to the physiological environment. 
 
3.3.II Phosphorylation of histone variant H2AX in mitosis: differences and 
similarities to interphase 
 
γH2AX is a robust read-out of the presence of DNA DSBs in cells. In interphase cells 
exposed to DSB-inducing agents, histone H2AX becomes rapidly and extensively 
phosphorylated in the chromatin flanking the damaged regions. This phosphorylation is 
PIKK-dependent and is a hallmark of unrepaired DSBs (Rogakou et al., 1998; Paull et al., 
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2000). In mitosis, it is unclear whether γH2AX signal is associated with substantial 
changes in chromatin compaction under unchallenged conditions. It has hitherto been 
shown that ATM-dependent phosphorylation of H2AX can occur during unperturbed 
mitosis and this is thought to be unrelated to the DDR (Huang et al., 2005b; Ichijima et al., 
2005; McManus and Hendzel, 2005; Kato et al., 2008). Immunofluorescence analysis of 
untreated mitotic cells arising from an asynchronous population did not show an overt 
H2AX staining in any of the cell lines used (Figure 4). Therefore, the reported pan-nuclear 
γH2AX staining, and especially its intensity in mitosis, may be a cell-line specific 
phenomenon or may be due to the method of synchronization, including prolonged 
nocodazole incubation, used in many studies. However, I cannot exclude that detection of a 
subtle increase in γH2AX staining during mitosis may require sensitive analytical methods, 
often incompatible with the use of non-synchronized samples. To address physiological 
H2AX phosphorylation by western blotting, HeLa cells were released from thymidine 
block in G1/S and their progression was monitored for 12 hours. A mild increase in 
γH2AX levels occurred after 9 hours, concomitantly with an increase in H3pS10 signal and 
chromatin compaction induced upon entry into mitosis (Figure 3). Therefore, a small 
amount of H2AX phosphorylation may be constitutively induced upon entry into mitosis in 
certain cell lines. Accordingly, a recent report showed that ATM is constitutively activated 
upon entry into mitosis in the absence of DNA damage (Oricchio et al., 2006).  
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FIGURE 3. A slight increase in γH2AX levels during mitosis in HeLa cells 
 
 
Content not visible due to copyright limitations 
 
 
HeLa cells were released from incubation with 2.5 mM of thymidine and progression through the cell 
cycle was monitored by FACS (Simona Giunta; numbers on FACS images were left unmodified, 
although small, not to interfere with the images) and using cell cycle markers in WB (Collaborator). 
Cyclin D3 levels increase as cells entered S-phase. Cyclin B stabilization and H3 S10 phosphorylation 
indicate entrance into mitosis.  
 
To monitor how mitotic cells respond to DNA damaging agents, I assessed γH2AX focus 
formation in mitotic cells arising from asynchronously growing human U2OS, HeLa, BJ 
and MRC5 cell cultures (Figure 4). Importantly, multiple discrete γH2AX foci were 
detected only in mitotic cells that had been exposed to IR or the radiomimetic drug 
phleomycin, but were not readily observed in untreated mitotic cells (Figure 4). Thus, 
genotoxic agents specifically induce γH2AX focal accumulation in mitotic cells, indicative 
of DSBs. Similar to interphase cells, a few γH2AX foci were observed in mitotic cells 
under untreated conditions, possibly representing DSBs arising from endogenous sources 
(Deckbar et al., 2007; Kato et al., 2009).  
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FIGURE 4. γH2AX forms foci in response to DNA damaging agents during mitosis
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Asynchronous U2OS, HeLa, BJ and MRC5 cells were co-stained for γH2AX together with histone H3pS10 to mark mitotic chromosomes. In 
untreated samples, mitotic cells do not show γH2AX staining, similarly to cells in interphase. Upon treatment with 5 Gy of IR or 30 μg/ml phleomy-
cin (Phleo) and harvesting after 30 minutes, formation of γH2AX foci occurs in both mitotic and interphase cells in all cell lines analyzed.                                                                                                                  
.
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Collectively, the above findings indicate that the early γH2AX focus formation at sites of 
damage is a common feature of both the mitotic and the interphase DDR. Nonetheless, 
differences exist in the basal level of H2AX phosphorylation; low levels of constitutively 
phosphorylated γH2AX and active ATM might occur in mitotic cells to produce an 
underlying DDR signal. While the function, if any, of this is unknown, one possibility is 
that it increases the sensitivity of genome surveillance, leading to the ready activation of 
the DDR upon the presence of genotoxic stress in mitosis.          
 
Although my studies indicated that DNA damage-induced γH2AX foci form in mitotic 
cells with similar kinetics to interphase cells, quantification of γH2AX mean fluorescent 
intensity per focus performed using Volocity software (Improvision, Coventry, UK) 
indicated that γH2AX foci in mitosis display stronger fluorescent intensity than in 
interphase cells (Figure 5). Similar observations have been described in mitotic 
chromosomes of mouse germ cells (Forand et al., 2004), suggesting that this is not a 
human cancer cell-specific phenomenon. Although this observation may simply correlate 
with a brighter DAPI signal due to highly compacted DNA, it may also suggest that the 
peculiar chromatin conformation of mitotic cells may aid, rather than impede, the 
spreading of the γH2AX modification forming larger DSB foci in mitosis. The histone 
variant H2AX is estimated to be present once every ~10 nucleosomes (Rogakou et al., 
1998). It is therefore tempting to speculate that the close proximity of nucleosomes in 
compacted mitotic chromatin could facilitate the spreading and extent of H2AX 
phosphorylation.  
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FIGURE 5. γH2AX foci have brighter fluorescent intensities in mitotic cells 
than in interphase cells 
 
 
 
Automated quantification of γH2AX average fluorescent intensity per focus, comparing interphase 
cells (n = 42) versus mitotic cells (n = 43). The error bars indicate the standard deviation within the 
mean of the data-set collected. 
 
In addition to the above differences in fluorescence intensity, γH2AX foci in mitosis versus 
interphase cells differ in relation to H3 pS10 localization. Strikingly, I observed that 
γH2AX foci in interphase cells do not co-localize with H3 pS10 stained regions (see 
examples of cells in Figure 6A). In interphase, H3 pS10 marks genomic regions that are 
transcriptionally active (Espino et al., 2006). Therefore, the exclusion of γH2AX foci from 
H3 pS10-stained regions represents a novel read-out to corroborate recent findings 
showing that actively transcribed regions are refractory to γH2AX spreading (Iacovoni et 
al., 2010). The difference between γH2AX being excluded from transcription regions 
marked by H3 pS10 in interphase and γH2AX foci being embedded in H3 pS10 stained 
mitotic chromosomes during M-phase prompted me to evaluate the reasons for these cell 
cycle differences. It is possible that transcription, occurring within H3 pS10-stained areas 
in interphase, prevent H2AX phosphorylation. Accordingly, transcription inhibition during 
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mitosis allows γH2AX foci formation. In this regard, histone modifications other than H3 
pS10 may be responsible for exclusion of γH2AX foci from regions of active transcription. 
Alternatively, H3 pS10 is further modified in mitosis and these additional modifications 
might render the H3 pS10 marked chromatin accessible for H2AX modifications following 
DNA damage. My observation that a highly modified form of H3 pS10 arises specifically 
in mitotic cells (Figure 6B) would favour the latter hypothesis. 
 
FIGURE 6. H3 pS10 localization and modifications in interphase and mitosis 
and its relationship to γH2AX foci 
 
 
 
Immunofluorescence staining with phospho-antibodies against γH2AX and H3 pS10. H3 pS10 
displays a speckled staining in interphase cells, marking transcription sites; these are refractory to 
γH2AX foci, formed after treatment with 30 µg/ml of phleomycin. In mitosis, H3 is globally 
phosphorylated, marks mitotic chromosomes and co-localizes with γH2AX (A). H3 pS10 is enriched 
in samples synchronized using the thymidine-nocodazole method (M) and can be detected strongly at 
16 kDa. Moreover, H3 pS10 is differentially modified specifically in mitotic cells displaying a strong 
band at ~30 kDa (asterisk), possibly due to SUMOylation (one SUMO moiety is ~15 kDa) or to 
ubiquitylation by a short chain of ubiquitins (each ubiquitin is about 8 kDa).  
 
The formation of mitotic DNA bridges between anaphase chromosomes that interconnect 
the two sister chromatids is a hallmark of genomic instability. The DNA bridges 
supposedly originate from concatenated, late-replicating DNA, carried into mitosis before 
duplication of the site by DNA synthesis is completed. In mitosis, the decatenation 
checkpoint is in place to resolve mitotic structures where entangled or catenated DNA 
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prevents chromosome segregation (reviewed in(Damelin and Bestor, 2007). The 
decatenation process that resolves mitotic DNA bridges requires factors such as the WRN 
and BLM helicases and DNA topoisomerases – including Topo II and III – that release 
DNA coiling (Holm et al., 1989; Franchitto et al., 2003; Seki et al., 2006a). During my 
analyses, I noticed that some U2OS cancer cells displayed mitotic DNA bridges in 
anaphase. This phenomenon readily increased upon treatment with genotoxins. 
Interestingly, I found that, in cells treated with DNA damaging agents such as phleomycin, 
mitotic bridges are coated by γH2AX foci, indicating the presence of DNA breaks on this 
fine DAPI-stained chromatin fibres (Figure 7). This infers that DSB found in the bulk of 
the mitotic chromosomes or on fine DNA bridges between the sisters chromatids are 
equally marked by the focal accumulation of γH2AX.   
 
FIGURE 7. DSBs on mitotic DNA bridges are marked by γH2AX foci 
  
 
 
In asynchronous samples treated with phleomycin, mitotic cells found interconnected by DNA bridges 
between the anaphase/telophase chromosomes display γH2AX foci. The concatenation must be 
resolved to avoid failure in chromosome segregation, eventually leading to mitotic catastrophe and 
cell death.  
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3.3.III Activation of apical PIKK kinases ATM and DNA-PK leads to H2AX 
phosphorylation in mitosis 
 
To understand the dependencies of γH2AX focus formation in mitotic cells, I examined the 
role of the apical PIKK kinases, ATM and DNA-PK, during mitosis. In interphase cells, 
these kinases act semi-redundantly to phosphorylate the H2AX C-terminal tail in 
chromatin flanking DSB sites (Burma et al., 2001; Hickson et al., 2004; Stiff et al., 2004; 
Wang et al., 2005). I assessed whether IRIF formation in mitotic cells required ATM and 
DNA-PK kinase activities, by using small-molecule inhibitors specific to each kinase 
(Hickson et al., 2004; Leahy et al., 2004). Partial redundancy between the two kinases in 
mediating H2AX phosphorylation and IRIF formation were observed (Figure 8). 
Consistent with previous studies in interphase cells, ATM inhibition markedly reduced 
IRIF intensity (data not shown), whereas combined treatment using ATM and DNA-PK 
inhibitors completely abrogated IRIF in M-phase cells (Figure 8). By contrast, DNA-PK 
inhibition alone did not markedly affect H2AX phosphorylation and IRIF formation (data 
not shown); however, DNA-PK inhibitor’s additive effect on abolishing γH2AX foci 
indicates that DNA-PK kinase can be activated in mitosis and acts in a compensatory 
manner in the absence of ATM. 
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FIGURE 8. ATM and DNA-PK mediate γH2AX IRIF formation in mitosis. 
 
 
 
Asynchronous U2OS were co-stained for γH2AX and DAPI. Upon treatment with 5 Gy of IR 
formation of γH2AX foci occurs and this is abrogated in both mitotic and interphase cells when cells 
are pre-treated for 1 hour with combination of ATM and DNA-PK inhibitors before irradiation.  
 
In order to verify ATM activation during mitosis, I monitored the presence of the auto-
phosphorylated form of ATM on S1981 (Bakkenist and Kastan, 2003). Because most 
commercial phospho-antibodies against ATM pS1981 are not highly specific and mainly 
recognize various ATM target protein phosphorylations, such as those on 53BP1, I 
performed an ATM IP from asynchronous and thymidine-nocodazole mitotic extracts in 
the presence or absence of DNA damage. In line with DNA damage leading to ATM 
activation in interphase cells (Bakkenist and Kastan, 2003), ATM S1981 was found to be 
phosphorylated in extracts from IR-treated mitotic cells (Figure 9A and(van Vugt et al., 
2010). To further corroborate the finding that ATM is fully active in mitotic cells, I 
collaborated with Rimma Belotserkovskaya, a postdoctoral researcher in Steve Jackson 
laboratory. We assessed ATM-dependent phosphorylation of targets other than histone 
H2AX in a DNA damage-induced manner. Phosphorylation of KAP1 on serine 824, an 
ATM-dependent modification, showed a similar profile to γH2AX, where a weak signal is 
present in the untreated mitotic samples while, following treatment with 2 Gy of IR, the 
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phospho-signal in the mitotic sample increased significantly, and to essentially the same 
extent as it did in the asynchronous cells (Figure 9B).  Collectively, these data indicate that 
a basal level of activated ATM is present in mitotic cells (Figure 9A), possibly due to 
constitutive activation of ATM during mitosis (Oricchio et al., 2006) and/or to the 
synchronization method. However, upon induction of DNA damage, ATM becomes fully 
activated and it promotes robust DNA damage dependent phosphorylations of selected 
targets, to similar levels as those seen in interphase cells.  
 
FIGURE 9. ATM is activated by DNA damage and phosphorylates selected 
substrates in mitosis  
 
 
Content not visible due to copyright limitations 
 
 
ATM is auto-phosphorylated on S1981 following IR (2 Gy) treatment of either asynchronous (AS) or 
mitotic (M) cells. ATM was immunoprecipitated with anti-ATM antibody (Table 1) and then detected 
with an antibody recognizing phosphorylated S1981 (top panel). Although a background phospho-
band is observed in untreated samples, the phospho-signal increases after irradiation. The lower level 
of total ATM (lower panel) IPed from mitotic cells and a mild phoshorylation-induced smear suggests 
that the proportion of phosphorylated ATM is similar to that in interphase (A). BioRad molecular 
weight markers are shown (BRMr). Phosphorylation of KAP1 on ATM-target site serine 824. KAP1 
is phosphorylated to the equivalent extent after irradiation in mitotic (M) and interphase cells (AS). A 
faint phospho-signal is detected before damage in mitosis (B; panel B from Collaborator). 
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3.3.IV Mitotic MDC1 is recruited to IRIF and is competent to bind γH2AX  
 
MDC1 acts as a mediator protein in the DDR cascade, inciting signal transduction events 
following induction of a DSB. MDC1 is one of several DDR mediators, like BRCA1, 
53BP1 and TopBP1, to contain BRCT domains. BRCT domains are autonomously folding 
modules consisting of about 100 amino acids capable of mediating protein-protein 
interactions (Callebaut and Mornon, 1997). MDC1 tandem twin BRCTs, located at the C-
terminus of the protein, have specific affinity for the γH2AX phospho-epitope (Stucki et 
al., 2005). Since phosphorylated S139 of H2AX creates a docking site for MDC1, I 
assessed whether MDC1 was recruited to DSB sites in mitosis. By using two different anti-
MDC1 antibodies, as well as cells stably expressing a green-fluorescent protein (GFP)-
MDC1 fusion protein, I found that MDC1 formed foci in mitotic cells that had been treated 
with IR or phleomycin (Figure 10A, 10B and 10C) and co-localized with γH2AX (Figure 
10A and 10B). MDC1 foci were also detected in mitotic cells arising from asynchronously 
growing HeLa and BJ cells (Figure 10C).  
 
MDC1 foci were not as easily discerned as γH2AX foci in mitotic cells (Figure 13E), as 
well as in interphase cells, due to a diffuse pan-nuclear staining that partially hindered foci 
visualization. To overcome this issue, I used a phospho-antibody raised against MDC1 
phospho-SDTD motifs (pS329 and pT331;(Chapman and Jackson, 2008) that was found to 
selectively detect MDC1 associated with DSB-flanking chromatin with reduced pan-
nuclear background (Figure 10A prophase and prometaphase panels) compared to the 
antibody against the total protein (Figure 10A, metaphase panel). Detailed analyses with 
this antibody revealed that γH2AX and MDC1 IRIF were present and co-localized in all 
mitotic stages (Figure 10A).  
Prophase
Prometaphase
Metaphase
Anaphase
Telophase
U
2O
S + IR
U
2O
S
H
eLa
BJ
MDC1                       H3 pS10                    MergeCγH2AX        MDC1                     Merge
B
γH2AX            GFP-MDC1                 Merge 
IR
A
FIGURE 10. MDC1 localizes to sites of DSB after induction of DNA damage during mitosis
MDC1  co-localizes with γH2AX foci in various mitotic  stages of  U2OS  cells  after IR (5 Gy; A). Prophase and  pro-
metaphase  panels  were  co-stained  for  γH2AX  and  MDC1  phospho - SDTD  antibody,  while the  other  panels  
show the diused pan-nuclear staining of MDC1total antibody underlying the IR foci (A). GFP-MDC1 accumulates  
in  γH2AX  foci  upon IR treatment (B). Formation of MDC1 IRIF in U2OS, HeLa and BJ  cells upon DSB induction by 
30 μg/ml phleomycin (Phleo) but not in untreated cells. Cells  were  grown on coverslips, treated as indicated and 
processed  for  immunouorescence  30 min  after  treatments. Mitotic chromosomes were co-stained for histone 
H3pS10 (C). 
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To confirm the capability of mitotic MDC1 to physically bind to the phosphorylated S139 
epitope of γH2AX, I performed in vitro peptide pull-down experiments with synthetic 
peptides corresponding to the unmodified and phosphorylated H2AX C-terminus. 
Consistent with the above observations, I found that the hyper-phosphorylated, slower 
migrating forms of MDC1 derived from mitotically-arrested cells (Xu and Stern, 2003) 
were capable of binding to the γH2AX peptides, as was MDC1 from asynchronous cell 
extracts  (Figure 11).  
 
FIGURE 11. The hyper-phosphorylated mitotic MDC1 binds to γH2AX 
 
 
 
 
 
Mitotic MDC1 is competent to bind to the γH2AX phospho-peptide, in spite of its hyper-
phosphorylated mitotic status, as shown. Phosphorylated H2AX C-terminal, but not the unmodified 
peptides, pulls down MDC1 from all extracts. Inputs represent 10% of the total protein. The whole 
cell extracts were prepared from asynchronous (AS) and mitotic (M) cells, or using commercially 
available HeLa nuclear extract (HNE).  
 
Next, I assessed ATM-dependent phosphorylation of mitotic MDC1 on threonine 719 
within a consensus ATM target motif (TQXF) by using a phospho-specific antibody 
directed against this site (Kolas et al., 2007). MDC1 was constitutively phosphorylated in 
untreated mitotic cells and this phosphorylation increased upon irradiation (data not 
shown), with similar phosphorylation profiles displayed by other ATM targets, such as 
γH2AX and KAP1 (Figure 9B). These data imply that MDC1 recruitment to the site of 
DSBs is fully proficient in mitosis and occurs in the same molecular fashion as in 
interphase cells.  
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3.3.V The Mre11-Rad50-Nbs1 complex localizes to DSB sites in mitosis and 
may serve to hold DNA ends together  
 
The MRN complex is a heterotrimeric unit composed of Mre11, Rad50 and Nbs1. The 
activity of MRN is important for multiple steps in the DDR. MRN acts as a sensor and is 
also essential for full ATM activation (Uziel et al., 2003). MRN-dependent DNA 
unwinding and tethering activities are required to recruit ATM firstly to the direct 
proximity of the DNA ends (Williams et al., 2007), and in turn, promote ATM binding to 
the chromatin around the break via MRN ability to bind MDC1, aiding DDR propagation. 
 
In accord with ATM activation being mediated by the MRN complex, I wanted to verify 
MRN recruitment to DSB sites in mitosis. In collaboration with Rimma Belotserkovskaya, 
we monitored the localization of Nbs1 before and after DNA damage. Antibodies against 
total Nbs1 show high levels of background signal, which hinders detection of nuclear foci 
following DNA damage in both mitotic and interphase cells. To circumvent this problem, 
we performed pre-extraction to remove the pan-nuclear Nbs1 and retain only the chromatin 
bound fraction of Nbs1 localized at DSB sites. Thymidine-nocodazole synchronized U2OS 
cells were collected by mitotic shake-off and, following CSK pre-extraction, a cytospin 
centrifuge was used to attach mitotic cells to a poly-L-lysine-coated coverslip and permit 
their detection by immunostaining analysis. We observed focal accumulation and co-
localization of Nbs1 with γH2AX on mitotic chromosomes after irradiation (Figure 12). 
Similarly to its role in interphase cells, the MRN complex recruitment to DSBs during 
mitosis might serve as a scaffolding platform for enrichment and spreading of ATM, 
γH2AX and MDC1 into the chromatin flanking the DSB, to regulate ATM activation and 
carry out initial resection steps at the DSB site. Furthermore, the physical structure of the 
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MRN complex could serve to hold ends together via the DNA end tethering activity of 
Mre11 (Williams et al., 2008) Altogether, these data show that mitotic DSBs are marked 
by PIKK-dependent γH2AX, MDC1 and MRN foci formation during mitosis. 
 
FIGURE 12. The MRN subunit Nbs1 is recruited to IRIF in mitosis 
 
 Content not visible due to copyright limitations 
 
Nbs1 co-localizes γH2AX in mitotic cells treated with IR (5 Gy; image from Collaborator). After 
treatment, cells were harvested by mitotic shake-off, CSK pre-extracted, and attached to coverslips by 
cytospin for 5 minutes at 500 rpm before co-staining with γH2AX and Nbs1.  
 
3.3.VI 53BP1 fails to be recruited to sites of DNA damage during mitosis 
 
Having demonstrated that mitotic cells respond to DSB induction by ATM activation, 
phosphorylation of γH2AX and by the recruitment of MDC1 and MRN to the DSB sites, I 
next examined the behaviour of another mediator protein, 53BP1. Although live imaging 
of interphase cells has shown that 53BP1 binds within seconds after DSB formation 
(Bekker-Jensen et al., 2005), its visualization within foci requires accumulation of many 
molecules, spreading over a large chromatin domain surrounding the lesion and follows 
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chromatin rearrangements (Schultz et al., 2000), placing it in the ‘second wave’ of DDR 
recruitment. 
 
A striking feature of mitotic cells exposed to DNA damage is the failure to recruit 53BP1. 
Using an anti-53BP1 antibody, I found that endogenous 53BP1 not only failed to be 
recruited to IRIF and did not co-localize with γH2AX and MDC1 after irradiation or 
treatment with phleomycin, but was also mostly excluded from chromatin during mitosis in 
U2OS cells (Figure 13A and 13B). Indeed, in mitotic cells, 53BP1 antibodies faintly stain 
a diffuse smear surrounding the chromatin, before and after damage, suggesting that 
mitotic 53BP1 is unable to bind to DNA. Using U2OS cells stably expressing GFP-53BP1, 
no focal recruitment or chromatin co-localization of GFP-53BP1 was observed after 
irradiation (data not shown), indicating that failed detection of 53BP1 foci was not due to 
impaired antibody penetrability. In line with exclusion of 53BP1 from IRIF in mitotic 
U2OS cells, 53BP1 also did not form readily discernible IRIF in mitotic HeLa, BJ or 
MRC5 cells (Figure 13C). Thus, 53BP1 exclusion from mitotic chromatin is not a cell-line 
specific phenomenon.  
 
Immunoblot analyses demonstrated that 53BP1 protein levels were similar throughout the 
cell cycle and, in agreement with an earlier study (Jullien et al., 2002), mitotic 53BP1 
displayed slower gel mobility due to hyper-phosphorylation in M-phase (Figure 13F). 
Thus, the overall low intensity of 53BP1 immunostaining observed in mitotic cells is not 
caused by reduced proteins level but can be explained by dispersal of the protein 
throughout the whole volume of the cell upon nuclear envelope breakdown.  
 
 
53BP1           γH2AX        Merge with DAPI
Untr
IR
Untr
IR
Untr
IR
U
2O
S
M
RC5
H
eLa
BJ
U
2O
S
U
2O
S
A 53BP1         H3 pS10         Merge with DAPI
Untr
IR
Phleo
C
Untr
Phleo
53BP1         γH2AX                  Merge with DAPID
E
F
Untr
IR
Phleo
B                 53BP1         γH2AX              Merge with DAPI
               53BP1             MDC1              Merge with DAPI 
γH2AX               MDC1              53BP1    
   
IR
IF
-p
os
iti
ve
 m
ito
tic
 c
el
ls
FIGURE 13. 53BP1 is excluded from DNA damage-induced foci during mitosis
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Co-staining for 53BP1 and H3pS10 before or after irradiation (5 Gy) or phleomycin treatment of asynchronously growing U2OS cells (A). 
Co-staining of either mock- or IR-treated cells with 53BP1 and γH2AX antibodies; phleomycin-treated cells co-stained for 53BP1 and MDC1 (B). 
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Enlarged mitotic cell images show lack of co-localization between the punctate 53BP1 staining and γH2AX damage foci (D). The histogram 
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(n>200). Error bars indicate standard deviation (E). Immunoblot of 53BP1 in asynchronous (AS), si53BP1-transfected and synchronized mitotic 
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In addition, and consistent with the previously reported 53BP1 association with 
kinetochores (Jullien et al., 2002), I observed a fine, punctuated staining of 53BP1 on 
condensed pro-metaphase chromosomes in both untreated and irradiated cells (Figure 
13D); however, those foci never co-localized with γH2AX (Figure 13D). Thus, even 
though γH2AX, MDC1 and MRN form foci in mitotic cells in a similar manner and with 
similar dynamics to those in interphase cells, 53BP1 is never recruited to mitotic chromatin 
(Figure 13E), in marked contrast to its behaviour in interphase cells. 
 
To determine whether 53BP1 is actively excluded from IRIF upon mitotic entry, I 
irradiated asynchronously growing U2OS cells in the presence or absence of AZD7762, an 
inhibitor of the DNA damage checkpoint kinases Chk1/2 (Zabludoff et al., 2008), and then 
measured mitotic indices by FACS with H3pS10 antibody (Juan and Darzynkiewicz, 
2004). Chk1 inhibitor was used to override the G2/M checkpoint and allow damaged 
interphase cells to enter mitosis. In the undamaged samples, both untreated and treated 
with the Chk1 inhibitor, approximately 1.5% of cells were in mitosis (Figure 14). A small 
increase in the mitotic index of samples treated with Chk1 inhibitor alone may be due to a 
minor proportion of asynchronously growing cells suffering endogenous DNA damage, yet 
failing to activate the G2/M checkpoint in the absence of Chk1, and entering mitosis. After 
a two-hour phleomycin treatment, however, the mitotic index dropped to 0.4% because the 
G2/M checkpoint prevents damaged cells proceeding into mitosis, while a large proportion 
of cells damaged in mitosis progress into G1 within the two-hour time frame. By contrast, 
when the G2/M checkpoint was inactivated by pre-incubating cells with the Chk1 inhibitor 
prior to phleomycin treatment, the mitotic index was restored to 1.2% (Figure 14), as has 
been observed previously in combination with other DNA damaging agents (Zabludoff et 
al., 2008). These data thereby imply that in the latter situation the majority of such mitotic 
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cells would have arisen from damaged G2 cells progressing into mitosis within the two-
hour phleomycin treatment. Under these experimental settings – where damaged cells with 
an inhibited G2/M checkpoint entered mitosis – I still did not observe 53BP1 foci in 
mitotic cells (Figure 14). These data are in agreement with a recent report demonstrating 
that 53BP1 dissociates from endogenously arising DSBs at the G2/M boundary (Nelson et 
al., 2009), and suggest that 53BP1 is actively removed from mitotic chromatin. 
 
FIGURE 14. 53BP1 is actively excluded from IRIF upon entry into mitosis 
 
 
 
Active exclusion of 53BP1 in mitotic cells (white arrows). Asynchronously growing U2OS cells were 
left untreated (Untr; 1) or treated with 30 µg/ml of pleomycin for 2 hours (Phleo; 3). Following a 3-
hour incubation with 50 nM of Chk1 inhibitor (Chk1i; 2), cells were treated with phleomycin for 2 
hours (Chk1i + Phleo; 4) and co-stained for 53BP1 and γH2AX. Mitotic indices (purple boxes) were 
determined by FACS analysis of cells co-stained with PI (x axis) and H3pS10 antibody (FITC, y 
axis).  
 
In parallel with the above studies, live-cell imaging of asynchronous U2OS cells stably 
expressing GFP-53BP1 was used to assess 53BP1 localization when cells irradiated during 
mitosis re-entered G1. Interphase cells present in the field next to M-phase cells formed 
53BP1 foci within few minutes following irradiation. By contrast, 53BP1 staining 
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remained diffuse in mitotic cells until division was complete and nuclei re-formed as cells 
entered G1, at which stage 53BP1 started accumulating within IRIF. Equivalent results 
were also obtained for cells treated with the DSB-inducing agent neocarzinostatin (data not 
shown). Collectively, these findings suggested that inhibition of 53BP1 recruitment to 
DSBs is limited to mitosis, and that association of 53BP1 with IRIF is concomitant with 
nuclear envelope formation and chromatin decompaction in G1.  
 
3.3.VII Investigating the mechanisms of 53BP1 exclusion in mitosis 
 
To gain further insight into the mechanisms of 53BP1 exclusion from mitotic chromatin, I 
collaborated with Rimma Belotserkovskaya to examine whether 53BP1 requirements to 
bind to the damaged chromatin were satisfied in mitosis. In interphase cells, 53BP1 focal 
accumulation is a multifactorial process, which is influenced by a plethora of upstream 
events and epigenetic modifications, including phosphorylation, ubiquitylation, acetylation 
and methylation. Constitutive epigenetic marks such as di-methylated H3K79 and H4K20 
are a prime chromatin requirement for binding and retention of 53BP1 to the sites of DNA 
damage by the Tudor domain (FitzGerald et al., 2009). Firstly, we monitored the presence 
of the methylated form of these histone marks in mitosis and their dynamics during the cell 
cycle. H3K79me2 and H4K20me2 are present in mitosis (Figure 15) and their levels are 
maintained constant throughout the cell cycle.  
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FIGURE 15. Methylated marks on histones H3K79 and H4K20 are retained in 
mitosis 
 
 
Content not visible due to copyright limitations 
 
 
 
Di-methylated histones H4K20 and H3K79 epigenetic marks serve for 53BP1 to bind to chromatin 
and are present on mitotic chromatin at similar levels as in interphase cells; also, their levels do not 
show overt changes before and after IR (5 Gy; image from Collaborator).  
 
Next, we examined the role of mitosis-specific PTMs in preventing 53BP1 
recruitment. 53BP1 has slower electrophoretic gel migration properties during M-phase 
(Figure 13F), likely reflecting hyper-phosphorylation in mitosis that is characteristic of 
many proteins (Poon, 2007). Hence, we reasoned that induction of mitotic-specific 
phosphorylations might hamper the ability of 53BP1 to bind to DSBs.  
 
 
 
 
 
 
Content not visible due to copyright limitations 
 
 
Our analyses of the epigenetic marks and 53BP1 mitosis-specific PTMs did not elucidate 
the underlying mechanisms of 53BP1 exclusion from mitotic chromatin. However, 
although methylated histone marks are present in mitosis, highly compacted chromatin, 
typical of mitotic chromosomes, may mask methylated histones rendering them 
inaccessible; indeed, 53BP1 exclusion is timed with the compaction of DNA into mitotic 
chromatin in early prophase. In addition, other requirements for 53BP1 IRIF retention may 
not be fulfilled. 
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3.3.VIII Impact of mitotic chromatin structure on the DDR 
 
To assess whether the recruitment of 53BP1 to DSB in mitosis was hampered by physical 
inaccessibility to damaged DNA due to chromatin compaction in mitosis, the chromatin 
conformation was manipulated with several chromatin-disrupting agents. Chromatin 
organization in mitotic cells can be altered by chloroquine, HDAC inhibitors and 
hypotonic conditions to induce relaxation of chromatin in the context of mitotic 
chromosomes. On the other hand, Okadaic acid, calyculin A and taxol are used to mimic 
mitotic state by causing premature chromatin condensation in interphase. 
 
Calyculin A is an inhibitor of serine/threonine protein phosphatases that induces PCC in 
interphase cells within minutes of treatment. During PCC, the chromatin increases in 
compaction, mimicking mitotic DNA (Ishida et al., 1992; Alsbeih and Raaphorst, 1999; 
Kanda et al., 1999). I used Calyculin A to induce PCC and monitor the ability of 53BP1 to 
form IRIF under these conditions. Although Calyculin A has been shown to impact on 
γH2AX phosphorylation, DNA damage-induced γH2AX foci formation is not 
compromised following calyculin A treatment (my own observation and(Svetlova et al., 
2007). The use of calyculin A for less than 10 minutes was sufficient to induce rounding of 
cells due to chromatin compaction, visible under light microscope. Next, U2OS cells were 
treated with phleomycin for 45 minutes, in the presence of calyculin A. Although calyculin 
A treatment per se induced MDC1 and 53BP1 staining in the absence of DNA damage, an 
obvious accumulation of DDR foci was observed in most PCC cells treated with 
phleomycin. The DDR factors monitored were recruited to DDR foci in spite of the 
compacted chromatin induced by calyculin A (Figure 17), suggesting that the physical 
barrier enforced by the compacted mitotic chromatin cannot be the only factor responsible 
for the exclusion of 53BP1 from DNA damage foci in mitosis.  
γH2AX             MDC1                      Merge with DAPI
53BP1             MDC1                      Merge with DAPI
γH2AX             MDC1                      Merge with DAPI
53BP1             MDC1                      Merge with DAPI
Caly A
Caly A
+ Phleo
FIGURE 17. 53BP1 forms IRIF following Calyculin A-induced premature chromosome condensation
in interphase cells
 
A
B
DNA damage foci formation following induction of PCC by treatment with 2nM of Calyculin A. 
Calyculin A alters the DNA morphology of asynchonous U2OS cells, causing a visible compaction of chroma-
tin, as shown by the bright DAPI staining of the prematurely compacted DNA and the change in nuclear 
morphology, closely resemblying those of mitotic cells  (A and B).  Treatment with Calyculin A was 
performed for 40 minutes to match the prolonged treatment in damaged samples. Immunouorescence 
analyses were performed using γH2AX, MDC1 and 53BP1 antibodies. 53BP1 formed sparse foci, whereas 
MDC1 showed a faint diused staining in Calyculin A cells in absence of DNA damaging agents (A). However, 
cells that underwent 10-minutes treatment with Calyculin A, followed by 30 minutes co-treatment with 30 
μg/ml of phleomycin, showed obvious γH2AX, MDC1 and 53BP1 foci formation at damage sites during PCC.
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These results were confirmed using GFP-MDC1 and GFP-53BP1 stable cell lines (data not 
shown). In addition, upon calyculin treatment, 53BP1 exhibited slower gel mobility, likely 
reflecting its hyperphosphorylated status (calyculin is a potent inhibitor of protein 
phosphatases 1 and 2A). 53BP1 phosphorylation status following calyculin treatment 
mimicked that in mitotic cells. Yet, hyper-phosphorylated 53BP1 remained associated with 
IRIF, even after PCC induction. I therefore concluded that calyculin-induced chromatin 
compaction and non-specific protein hyperphosphorylation are not sufficient to render 
53BP1 refractory to recruitment into IRIF.  
 
Nevertheless, chromatin manipulation by calyculin A presented several experimental 
caveats. Firstly, being a phosphatase inhibitor, calyculin A altered the dynamic equilibrium 
of protein phosphorylation, possibly leading to DDR activation in the absence of DNA 
damage. It is also unclear whether calyculin A induces chromatin compaction in all stages 
of the cell cycle and uniformly compacts all regions of DNA within the nucleus. PCC is 
rapidly induced upon calyculin A treatment in S-phase and G2, but possibly not to the 
same extent in G1, due to low cyclin B levels (Kanda et al., 1999). In my experiments, all 
cells displayed a similar rounded morphology, with visibly compacted chromatin. 
Nonetheless, I could not assess if the DNA of cells residing into S-phase at the time of the 
analysis was compacted to the same extent as G1 and G2 cells. Furthermore, induction of 
PCC by calyculin A treatment affected the balance between the amounts of chromatin-
bound and soluble 53BP1 (data not shown), suggesting it does not only impinges on 
chromatin structure.  
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In parallel with the above studies, I used the intercalating agent chloroquine to induce 
relaxation of mitotic chromatin by partial unwinding of DNA. However, the treatment 
severely altered both chromatin and cellular morphology and lead to activation of ATM 
and γH2AX in a non-DSB related manner (data not shown). These conditions rendered 
unsuitable the use of chloroquine for the purposes of this analysis. These and other 
attempts to manipulate chromatin conformation by HDAC inhibitors- and chloroquine-
mediated chromatin relaxation led to inconclusive results.  
 
The data showing that 53BP1 is capable of binding to condensed chromatin outside of 
mitosis indicates that the mitotic chromatin status is unlikely to represent a physical 
limitation to 53BP1 recruitment per se, especially considering that chromatin is not 
maximally condensed during mitosis and retains a certain degree of plasticity. 
 
3.3.IX Association of ubiquitin conjugates with DNA damage sites is absent 
during mitosis 
 
Ubiquitylation of local nucleosomes is a main epigenetic mark of DNA DSBs. Given 
ubiquitylation represents one of the chief requirements for 53BP1 recruitment, I next 
assessed the ubiquitylation status of cells during mitosis. Previous work has shown that 
ubiquitylated H2A (ubH2A) is essentially absent from mitotic chromatin (Wu et al., 1981) 
and that active H2A de-ubiquitylation by the ubiquitin-processing protease USP16 at the 
G2/M transition is required for chromatin condensation (Matsui et al., 1979; Cai et al., 
1999; Joo et al., 2007). The ubH2A appears to be mutually exclusive with phosphorylation 
of H3 S10, indicating that H2A deubiquitination is critically involved in cell cycle 
progression (Joo et al., 2007). In agreement with these data, a drastic reduction in the 
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immunoblotting signals for ubiquitylated H2A, and also for H2AX, was observed in 
mitotic cells, whether or not they had been irradiated (Figure 18B). Although 
ubiquitylation of H2AX partially increased after DNA damage, it did not reach the level of 
asynchronous damaged samples. Focal accumulation of ubiquitin induced by DNA damage 
can be cytologically visualised as nuclear aggregates in interphase cells using FK2 
antibody that detects protein-ubiquitin conjugates. In mitotic cells, however, no protein-
ubiquitin foci detected by the FK2 antibody were observed in spite of the presence of 
γH2AX foci, implying that ubiquitin conjugates are not effectively formed in DSB foci 
during mitosis (Figure 18A). Furthermore, FK2 staining was excluded from DAPI stained 
chromosomes, indicating the absence of ubiquitin onto mitotic chromatin.  
 
FIGURE 18. Ubiquitin conjugates do not accumulate to IRIF in mitotic cells 
 
 
Content not visible due to copyright limitations 
 
Ubiquitin conjugates are marked using FK2 antibody staining. FK antibody does not detect ubiquitin 
conjugates on mitotic chromosomes upon irradiation and do not co-localize with phosphorylated 
H2AX foci or DAPI stained regions in mitosis (A). Histones H2A and H2AX are de-ubiquitylated in 
mitosis. Arrows point to non-ubiquitylated forms and asterisks mark ubiquitylated forms of the 
proteins. Asynchronous (AS) and M-phase cells where left untreated or treated with 5 Gy of IR. The 
robust increase in ubiquitylated γH2AX after irradiation of asynchronous cells does not take place in 
mitosis (B; panel B from Collaborator).  
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These data showing failed co-localization of FK2 staining with mitotic chromatin and 
exclusion of ubiquitin conjugated to H2A-type histones in mitosis, prompted me to verify 
changes in the level of free and conjugated ubiquitin during the cell division cycle. 
Although conjugated ubiquitin moieties are in a constant status of rapid dynamic 
equilibrium with the pool of free ubiquitin during progression through the cell cycle, to the 
best of my knowledge, it had not been tested whether their levels changed during the cell 
cycle. Using flow cytometry, I was able to show that levels of ubiquitin, of both the free 
ubiquitin pool and conjugated ubiquitin aggregates, are unchanged throughout the cell 
cycle. Moreover, levels of free and conjugated ubiquitin were equal when directly 
comparing mitotically-arrested cells to asynchronous cells (Figure 19).  
 
FIGURE 19. Free and conjugated ubiquitin levels are constant during the cell cycle  
 
 
 
Flow cytometry of asynchronous (A/S; in blue) and thymidine-nocodazole synchronized (M; in green) 
cells co-stained for PI (DNA) and FITC-FK2 antibody (for mono- and poly-ubiquitin conjugates; A) 
or FITC-ubiquitin antibody (monitoring free ubiquitin; B). Negative control samples are stained for 
PI-only and represent background signal, shown in red. For conjugated ubiquitin levels (A), the 
antibody gave a better staining, as higher above the background signal, compared to the free ubiquitin 
antibody (B), whose signal is just above background. However, in both cases, the level of 
fluorescence intensity of the FITC signal is the same for A/S, from G1, S, to G2/M (blue), and M-cells 
(green), in both graphs, indicating that ubiquitin levels are unchanged throughout the cell cycle.   
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Thus, these novel observations show that ubiquitylation events are not globally impaired in 
mitosis, yet productive association of conjugated ubiquitin to the sites of DSBs is 
defective. Lack of sufficient ubiquitylation localized at DSBs may be contributory factor 
for failed 53BP1 recruitment to damage loci in mitotic cells.  
 
3.3.X Localization analysis of the E3 ubiquitin ligases RNF8, RNF168 and 
BRCA1 in unperturbed and challenged mitosis 
 
To address the underlying reasons for failed formation of 53BP1 and ubiquitin foci upon 
irradiation of mitotic cells, I went on to investigate the recruitment of the E3 ubiquitin 
ligases that participate in the DDR. In interphase cells, the sequential recruitment of three 
E3 ligases RNF8, RNF168 and BRCA1 to IRIF induces local accumulation of ubiquitin 
conjugates at the site of breaks, mediating effective cellular responses to genotoxic stress. 
Histones primed by RNF8-mediated ubiquitylation serve as docking sites for the 
recruitment of the second E3 ligase in the cascade, RNF168, which synergize with RNF8 
to augment ubiquitin conjugates at DSBs. Ubiquitin-mediated conformational changes 
allow for recruitment of the third E3 ligase, BRCA1, and also 53BP1, to DSBs (reviewed 
in(Stewart, 2009). The complex regulation of the ubiquitylation pattern induced by DNA 
breakage is ultimately required for repair of the lesion and restoration of genome integrity.  
 
3.3.XI The E3 ubiquitin ligases RNF8 is not recruited to mitotic IRIF 
 
A major player that mediates a key transition in the DNA damage signalling cascade is 
RNF8. Remarkably, RNF8 contains two structurally relevant modules found in other DDR 
proteins, a phospho-threonine-binding FHA domain at the amino-terminus and a RING 
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finger domain at the carboxyl end. RNF8 RING finger domain is required to 
simultaneously bind the E2 ubiquitylation enzymes, including UBC13, and the substrates, 
conjugating K48 and K63 polyubiquitin chains (Ito et al., 2001; Plans et al., 2006). In 
interphase, RNF8 association with chromatin flanking the break site requires the ATM-
dependent phosphorylation of MDC1 TQXF clusters. MDC1 phosphorylated TQXF 
motifs, in turn, serve as a docking site for RNF8 FHA domain. Then, chromatin-associated 
RNF8 induces ubiquitylation events on H2A-type histones that mediate chromatin 
rearrangements for the access of downstream mediators to the damaged template. 
Interestingly, RNF8 has also been implicated in controlling mitotic exit. Its ubiquitin ligase 
activity is required for mitotic arrest following treatment with nocodazole and modulates 
the rate of completion of mitosis by controlling timely degradation of cyclin B1 (Tuttle et 
al., 2007; Plans et al., 2008).  
    
I used U2OS cells stably expressing GFP-RNF8 to investigate the nuclear localization of 
RNF8 in mitosis, before and after DNA damage. Strikingly, I found that RNF8 was 
excluded from mitotic chromatin and did not co-localize with γH2AX foci upon IR or 
phleomycin treatment (Figure 20A and data not shown). In addition to RNF8 localization 
to the midbody as previously shown (Tuttle et al., 2007; Plans et al., 2008), further 
examinations revealed that GFP-RNF8 associated with two other mitotic structures: 
centrosomes  (Figure 20A and 20B) and kinetochores, as evidenced by co-localization with 
CENP-F (Figure 20C). These data, together with the previously described function of 
RNF8 in mitotic-exit control (Tuttle et al., 2007; Plans et al., 2008), suggest that RNF8 
plays an important role in the regulation of mitosis that might be independent of its 
involvement in the DDR. A previous study reported a drastic reduction in RNF8 levels in 
late mitotic stages (Plans et al., 2008). To verify whether the reason for failed RNF8 
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recruitment to DNA damage foci was due to lack of RNF8 in mitosis, I performed 
immunoblot analysis using two different RNF8 antibodies and GFP-RNF8 cell extracts to 
monitor the endogenous levels of RNF8 and to check protein turn-over. No marked 
changes were observed in RNF8 levels during mitosis (Figure 20D), indicating that failed 
recruitment to IRIF was not due to sub-optimal protein levels in mitosis. However, I cannot 
exclude that dispersal of proteins in mitosis due to nuclear envelope breakdown may 
hinder adequate local accumulation of certain factors; a critical threshold may be required 
for sufficient RNF8 concentration and foci detection.  
 
FIGURE 20. RNF8 accumulates to mitotic structures, centrosomes and 
kinetochores, but does not co-localize with γH2AX IRIF in mitosis 
 
 
IF of GFP-RNF8 stably expressed in U2OS cells, stained for γH2AX and treated with 5 Gy of IR. 
White arrows indicate mitotic cells (A). RNF8 association with nuclear structures in mitosis shown by 
localization at centrosomes (A, and zoomed in B), indicated by red arrows (B) and co-localization 
with CENP-F at kinetochores (C). Levels of endogenous RNF8 in extracts from asynchronous (A/S) 
and thymidine-nocodazole arrested mitotic (T&N) cells show that RNF8 is present in mitosis. 
siLuciferase (siLuc) and siRNF8 laemmli extracts are included. A small mobility shift of mitotic 
RNF8 is visible compared to A/S cells. High exposure (h.e.) of the RNF8 WB is shown (D). Scale 
bars are 10 µm. 
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To gain additional insight into the underlying reasons for RNF8 failed recruitment, I 
performed peptide pull-downs using MDC1 synthetic peptides with the phosphorylated and 
unphosphorylated form of T719, one of the MDC1 TQXF clusters phosphorylated by 
ATM in interphase and mitotic cells after DNA damage. Mitotic RNF8 was capable of 
binding MDC1 phospho-peptide in a similar fashion to RNF8 from asynchronously-
derived extracts and the association was unchanged before and after DNA damage (Figure 
21A). These in vitro data indicate that the FHA domain of RNF8 has strong affinity for the 
MDC1 phospho-epitope and does not necessitate post-translational modifications on RNF8 
to promote DNA damage dependent binding to MDC1. RNF8 is extensively 
phosphorylated in mitosis, as shown by a shift in gel mobility (Figure 21A and 20D). In 
mitosis, RNF8 post-translational modifications could possibly contribute to its exclusion 
from mitotic IRIF. Although pull-down experiments suggest that RNF8 mitotic hyper-
phosphorylation does not inhibit binding to MDC1 peptides, I cannot exclude that high 
concentration of phosphorylated epitopes in vitro might override potential regulatory 
mechanisms that exist in vivo to inhibit these interactions during mitosis. 
 
To address the ability of mitotic RNF8 to bind to the full length MDC1 protein during 
mitosis, I performed peptide pull-downs using γH2AX phospho-peptides. γH2AX peptides 
avidly pull-down MDC1. Phosphorylated MDC1 from damaged extracts should bind to 
RNF8. However, due to the RNF8 being a very low abundance protein in the cell, no 
RNF8 was detected in pull-downs using γH2AX peptides from U2OS whole cell extracts, 
as previously reported (Kolas et al., 2007). To enrich for RNF8, following γH2AX peptides 
pull-downs of MDC1 from untreated and irradiated asynchronous and M-phase extracts, 
the complex was incubated with HeLa nuclear extracts to assess ability of RNF8 to bind 
(Figure 21C). Unexpectedly, RNF8 bound to γH2AX-MDC1 complexes from all extracts 
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(Figure 21B). However, using a peptide for a phosphorylated SQXF motif on Psf1 similar 
to γH2AX site as negative control, I also pulled-down a small amount of RNF8 (Figure 
21B), indicating that RNF8 may have some specificity to bind γH2AX and other similar 
phospho-epitopes directly, rendering pull-downs experiments unsuitable for further 
investigations.     
 
FIGURE 21. Mitotic RNF8 is competent to bind to MDC1 phospho-peptides 
 
 
 
Mitotic RNF8 binds to MDC1 phospho-peptides; MDC1 phosphorylated (pTQxF) or 
unphosphorylated (TQxF) peptides were used to pull-down from 1 mg of untreated or irradiated (5 
Gy) asynchronous (A/S) or thymidine-nocodazole -arrested mitotic (T&N) extracts. RNF8 over-
exposure (O.E.) shows that RNF8 levels are not decreased in mitotic samples but appear less due to 
mitotic phospho-dependent gel shift (A). Pull-downs using γH2AX phospho-peptides (γH2AX), 
unphosphorylated H2AX peptide (H2AX), Psf1 phospho-SQXF peptides (Psf1) or beads-only 
(Beads). γH2AX peptides selectively pulls-down MDC1 and Nbs1 from the indicated extracts (1 mg). 
After incubation in HeLa nuclear extract (3 mg/ppd; C), WB for RNF8, Nbs1 and MDC1 is shown 
(B). siL stands for siLuciferase; siRNF8 (siR8) lane indicates RNF8-corresponding band (marked by 
asterisks, red in A and black in B). 
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Further experimental analyses on RNF8 failed recruitment in mitosis were hindered by 
RNF8’s mitotic role. Several synchronization and cell cycle manipulation attempts on cells 
with altered levels of RNF8 led to rapid induction of cell death. U2OS cells knocked-down 
for RNF8 by siRNA failed to synchronize in mitosis and initiated apoptosis. Similarly, in 
RNF8 over-expression studies, no cells were found in mitosis (data not shown). These 
observations, together with my novel evidence of RNF8 recruitment to diverse mitotic 
structures and the previously described function of RNF8 in mitotic-exit control (Tuttle et 
al., 2007; Plans et al., 2008), suggest that RNF8 plays important roles in the regulation of 
mitosis entry as well as exit.  
 
Time-course analyses revealed that RNF8 accumulation to IRIF was resumed in late 
mitosis, yet 53BP1 foci were not detected in these cells (Figure 22). Accordingly, a GFP-
tagged construct where the MDC1 twin BRCT domains, required for direct binding to the 
γH2AX phospho-site, were fused to RNF8 was transformed in U2OS and forced tethering 
of RNF8 to γH2AX after DNA damage. Despite GFP-RNF8MDC1[BRCT] hybrid protein being 
recruited to sites of DSBs, 53BP1 remained excluded from mitotic IRIF (data not shown). 
Therefore, a multi-layered control exists to prevent activation of secondary DDR responses 
to IRIF during mitosis. RNF8-mediated transition, comprising alteration in the chromatin 
status, may be unfeasible in the context of highly compacted mitotic chromosomes and 
may be blocked on several levels until cells have completed karyokinesis and entered G1. 
 
Altogether, the data and observation presented suggest that lack of RNF8 recruitment in 
mitosis is likely to be due to a combination of post-translational modifications (Figure 21A 
and 20D), as well as sequestration of RNF8 to mitotic structures (Figure 20A). 
GFP-RNF8                  γH2AX                                    MERGED with  DAPI
  
GFP-RNF8                  53BP1                                    MERGED with  DAPI
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FIGURE 22. RNF8 foci formation at late mitotic stages does not lead to 53BP1 recruitment to DSBs
A
B
10 μm
RNF8 binding to IRIF is dierentially regulated in early, mid and late stages of mitosis. GFP-RNF8 asynchronously growing U2OS 
cells were stained for γH2AX and treated with 5 Gy of IR. RNF8 is largely excluded from mitotic chromatin in early and mid mitosis. 
In late mitotic stages, RNF8 starts to form IRIF, co-localizing with γH2AX foci (A). Productive association of RNF8 with IRIF in late 
mitosis does not lead to accumulation of mitotic 53BP1 to DSBs (B). RNF8 co-localizes strongly with centrosomes at all stages, as 
detected by 1 or 2 large, bright RNF8 dots (A and B).
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RNF168                     γH2AX          MERGED with DAPI
RNF168                               γH2AX                                  MERGED
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FIGURE 23. RNF168 is excluded from mitotic chromatin and IRIF until late mitosis
10 μm
Asynchronously growing U2OS stable cell lines expressing GFP-RNF168 were stained for γH2AX. RNF168 is excluded from mitotic 
chromatin and does not co-localize with γH2AX foci following irradiation (A) or phelomycin-treatement (A and B). An insert of 
panel A, outlined by the blue square, is enlarged in panel B to show that RNF168 forms ne dots, corresponding to the mitotic 
kinetochores, but does not co-localize with γH2AX (B). RNF168 recruitment to IRIF is resumed in late mitosis, following the 
anaphase to telophase transition (C), with similar kinetics to RNF8 indicating their close succession to DSBs.
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3.3.XII RNF168 is not recruited to DNA damage foci in mitosis, but localizes 
to kinetochores 
 
The RING finger E3 ubiquitin ligase RNF168 associates with damaged chromatin via two 
UIMs that bind RNF8-mediated polyubiquitin chains on H2A. In turn, RNF168 binds the 
E2 ligase UBC13 and catalyzes the formation of K63-linked conjugates on H2A and 
H2AX. The epistatic recruitment of RNF168, downstream of RNF8, synergizes to locally 
enrich the ubiquitylation level to a threshold capable of inducing dynamic structural 
changes to the chromatin and propagating the DDR signal to downstream factors. 
 
Consistent with the exclusion of RNF8 from IRIF during mitosis, I found that GFP-
RNF168, stably expressed in U2OS, was not recruited to DSB and did not co-localize with 
mitotic chromatin (Figure 23A). Although RNF168 was mostly excluded from mitotic 
chromatin, further examination revealed that GFP-RNF168 associated with kinetochores in 
mitosis, yet the fine punctuated RNF168 staining at kinetochores did not co-localize with 
γH2AX DNA damage foci  (Figure 23B). Unlike RNF8, however, no obvious staining was 
observed at centrosome or at the midbody in late mitosis. 
 
RNF8 (Figure 22A) and RNF168 (Figure 23C) share similar localization kinetics in their 
resumption of recruitment to IRIF in late mitosis. Indeed, these factors are recruited to 
DNA damage foci and co-localize with γH2AX only once mitotic cells pass the metaphase-
to-anaphase transition and enter telophase. Presumably, the pre-emptive recruitment of 
RNF8 and RNF168 to DSB sites serves to prepare the chromatin for conformational re-
arrangements anticipatory to 53BP1 binding once the nuclear envelope reforms and the cell 
enters G1. In addition, the ability of RNF8 and RNF168 to bind to DSBs within the 
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compacted mitotic chromatin in late mitosis infers that chromatin compaction is unlikely to 
play a major role in the exclusion of these factors in earlier mitotic stages. 
 
3.3.XIII The DDR mediator BRCA1 is also excluded from mitotic IRIF  
 
RNF8 and RNF168-dependent ubiquitin-mediated conformational changes allow for 
recruitment of the third E3 ligase, BRCA1. In mitosis, exclusion of RNF8 and RNF168 
from IRIF causes failed association of BRCA1 to IRIF. Indeed, both live cell imaging 
using U2OS stably expressing GFP-BRCA1 and immunofluorescence of the endogenous 
protein with BRCA1 antibody revealed that BRCA1 was undetectable in mitotic γH2AX 
foci (Figure 24A and data not shown). As previously reported, I found BRCA1 localization 
at centrosomes in mitosis (Figure 24B), where it actively plays a role in centrosome 
duplication (Hsu and White, 1998). In accord with RNF8, RNF168 and 53BP1, protein 
levels of BRCA1 also showed no marked changes throughout the cell cycle (data not 
shown). 
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FIGURE 24. BRCA1 is excluded from mitotic chromatin and fails to localize to 
sites of DSB during mitosis 
 
 
 
Immunofluorescence analysis co-staining cells for BRCA1 and γH2AX shows that BRCA1 does not 
co-localize with DAPI-stained mitotic chromosomes and is not recruited to γH2AX-marked DNA 
damage foci. White arrows point to mitotic cells (A). BRCA1 forms two bright spots at either side of 
mitotic cells, indicating accumulation of BRCA1 to the centrosomes (red arrows; B). 
 
Different phosphorylation statuses exist for BRCA1 during the cell cycle, which have been 
implicated in its sub-cellular compartmentalization (Okada and Ouchi, 2003). Like many 
other proteins, BRCA1 had altered gel migration properties during M-phase, in line with 
its mitotic hyper-phosphorylation (data not shown;(Poon, 2007). Perhaps surprisingly, a 
sub-pool of mitotic BRCA1 in its hypo-phosphorylated form preferentially associates with 
γ-tubulin and localized to centrosomes (Hsu and White, 1998). It is possible to envisage a 
scenario whereby mitotic cells impart a dual regulation on DDR proteins. Firstly, the 
truncation of the DNA damage signalling cascade at the level of RNF8 prevents 
recruitment of downstream factors, and this is further controlled by several inhibitory 
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mechanisms. Also, mitotic-specific hyper-phosphorylation, by nuclear exclusion of 
phosphatases or activation of mitosis-specific kinases (Poon, 2007), may impair protein 
activities within the DDR network; only DDR factors required for physiological mitosis 
are sequestered into specific mitotic structures and are post-translationally regulated to be 
maintained active in a compartment-dependent manner.  
 
Collectively, these data show that E3 ubiquitin ligases RNF8, RNF168 and BRCA1 are not 
recruited and DDR-mediated ubiquitylation does not take place at DSB sites in mitosis; 
this truncation of the DDR is likely to be regulated on multiple levels, both by alterations 
of the DSB compartment, through PTMs and sequestration of individual proteins during 
mitosis.  
 
3.3.XIV Absence of a DNA damage checkpoint in mitosis correlates with failed 
activation of checkpoint kinases 
 
Several lines of evidence support the idea of a lack of the DNA damage checkpoint in 
mitosis (Rieder and Cole, 1998; Mikhailov et al., 2002). To investigate the consequences 
of DSB induction on the progression through mitosis, I synchronized cells and released 
them into mitosis in the presence or absence of the DSB-causing agent, phleomycin. The 
progression of mitotic cells into G1 is not delayed by DSBs as observed in both HeLa and 
U2OS cells (Figure 25 and 27), supporting the idea that the presence of DSBs per se does 
not lead to cell cycle arrest in mitosis.  
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FIGURE 25. Presence of DSBs does not trigger a DNA damage checkpoint delay 
in the progression through mitosis and re-entry into G1  
 
 
 
Mitotic cells were synchronized by thymidine-nocodazole arrest and harvested by shake-off, treated as 
indicated and 30 minutes later released into fresh medium. Samples were collected for FACS analyses 
after 30 minutes and 2 hours post-release. Damaged and undamaged cells display the same kinetics in 
progressing through and exiting mitosis, and re-entering into the following G1, indicating lack of 
significant DNA damage-induced delay in mitotic exit of HeLa cells. 
 
To investigate the reasons for the absence of a mitotic DNA damage checkpoint, we 
examined the molecular mechanisms of checkpoint activation. Indeed, phosphorylation of 
downstream ATM substrates, including checkpoint effector kinases, occurred to a lesser 
extent in mitotic cells than in interphase cells in response to DSB induction. Mitotic 
samples displayed a reduced level of phosphorylation of Chk2 on T68 (Figure 26 and 28) 
and Chk1 on serine 345 in response to DNA damage, compared to interphase cells (Figure 
26). Smc1 phosphorylation on serine 966, a classical ATM target, is also abolished in 
mitosis (Figure 26), in spite of the presence of damage-activated ATM 
autophosphorylation on S1981 and γH2AX-containing IRIF. Interestingly, in line with the 
lack of 53BP1 recruitment, ATM-mediated 53BP1 serine 25 phosphorylation was not 
induced by DNA damage in mitotic cells (Figure 26). These data strongly suggest that the 
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absence of DNA damage-induced delay and attenuation of checkpoint signalling during 
mitosis may be related phenomena. 
 
FIGURE 26. The absence of DNA damage checkpoint in mitosis correlates with 
impaired activation of Chk1, Chk2 and other canonical ATM targets  
 
 
 Content not visible due to copyright limitations 
 
Diminished phosphorylation of ATM targets in IR-treated (2 Gy) mitotic cells (M) as compared to 
asynchronous cells (AS). M-phase cells were obtained from thymidine-nocodazole synchronization. 
Phosphorylation of ATM-target sites on 53BP1 (S25), SMC1 (S966), Chk2 (T68) and Chk1 (S345) is 
monitored by western blotting and was found impaired in mitotic cells.  
 
3.3.XV Mitotic cells mark sites of DSBs prior to full DDR activation in G1  
 
Next, I wanted to monitor the behaviour of cells damaged in mitosis as they progressed 
into the following cycle of cell division. To see whether DSBs carried over from mitosis 
are able to trigger full DDR activation in G1, mitotic cells were collected from a pre-
synchronized culture, treated with IR, released from nocodazole block and then analyzed at 
different time-points for cell cycle distribution, presence of 53BP1 in IRIF and Chk2 
phosphorylation.  
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FIGURE 27. Exclusion of 53BP1 from mitotic IRIF precedes its association and checkpoint activation in G1
10μm
Untreated or irradiated (2 Gy IR) mitotic cells were released from nocodazole-block, collected at the indicated times and moni-
tored for cell cycle progression by FACS and 53BP1 recruitment to IRIF by immunouorescence of endogenous 53BP1, co-stained 
with γH2AX and DAPI. 
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 Cells damaged in M-phase progressed into G1 with kinetics similar to that of untreated 
cells for up to 5 hours after release from nocodazole (Figure 27). Irradiated cells exhibited 
slower entry and/or progression through S-phase, as well as a delay in G2 (Figure 27; see 
10-24 hour time-points). Similar to the findings with EGFP-53BP1 in live-cell imaging 
experiments, endogenous 53BP1 started forming foci 1-2 hours after G1 entry (Figure 27). 
Furthermore, few IRIF were still detectable 24 hours after irradiation, indicative of 
ongoing DSB repair.  
 
Parallel examination of IR-induced Chk2 phosphorylation on T68 revealed that this 
modification was reduced in M-phase in comparison with asynchronous cells (Figure 28 
and 26). Nevertheless, once cells progressed into G1, T68 became highly phosphorylated 
(Figure 28), supporting the notion that an attenuated DDR during mitosis is then fully 
activated in the following interphase. Six hours after irradiation, Chk2 phospho-signal 
starts attenuating, becoming very low at 24 hours, indicating repair of the DNA insults and 
resumption of cell cycle progression. 
 
FIGURE 28. Proficient phosphorylation of Chk2 T68 upon re-entry into G1  
 
 
 
Cells were treated as in Figure 28. Immunoblot analysis of Chk2 T68 phosphorylation in cells 
released into G1 after IR treatment (2 Gy) in mitosis shows full Chk2 activation when mitotic cells 
bearing DSBs exit mitosis and enter the following G1 (1, 2 and 4 h time-points).  
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Collectively, these data indicate that, upon entry into G1, DSBs carried through from 
mitosis elicit a full DDR activation and trigger the DNA damage checkpoint, allowing time 
to repair the DNA lesion in the following cell cycle. 
 
3.3.XVI Biological significance of the ‘primary’ DDR in mitosis 
 
 
Having established that mitotic cells respond to DSB with induction of a primary DDR, 
comprising ATM, γH2AX, MDC1 and MRN, but exclude events downstream of RNF8, 
and checkpoint activation, I next asked whether activation of early DDR events in mitosis 
is a biologically important phenomenon. To assess the potential physiological significance 
of DSB marking in mitosis, together with Rimma Belotserkovskaya, I performed 
clonogenic survival assays on asynchronous and mitotic cells that had been irradiated 
either in the absence or presence of ATM and DNA-PK inhibitors. In agreement with 
earlier studies (Stobbe et al., 2002), mitotic cells displayed much higher radio-sensitivity 
compared to asynchronous cells (Figure 29). Furthermore, acute PIKK inhibition, at a dose 
sufficient to ablate γH2AX IRIF formation, further enhanced the killing of mitotic and 
asynchronous cells (Figure 29). As cells were extensively washed following DSB 
induction to remove the inhibitors, this result was unlikely to reflect residual PIKK 
inhibition still taking place because the effect of PIKK inhibition on γH2AX was readily 
reversible within 1 hour (Figure 30). This indicates that, although mitotic cells are 
intrinsically radio-sensitive, inhibition of primary responses to DSB in mitosis induces 
further radio-sensitivity. 
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FIGURE 29. Primary DDR in mitosis is biologically important for cell survival 
 
 
 
Radio-sensitivity of asynchronous and mitotic cells pre-treated with DMSO or a combination of ATM 
and DNA-PK inhibitors for 1 hour and then exposed to various doses of IR, as indicated. ATM and 
DNA-PK inhibitors are used to abolish the primary DDR in mitotic cells. 30 minutes after irradiation, 
the inhibitors were removed by extensive washing and cells were plated in fresh medium. Error bars 
represent standard deviations of the means from six independent experiments. P values were 
calculated at the standard 0.05 threshold. For both asynchronous and mitotic cells, radiation has a 
statistically significant increase in the killing effect of PIKK inhibitors treated cells versus DMSO-
treated cells. In asynchronous cells, p = 0.00015. In the mitotic cells, p = 0.041.  
 
To assess how PIKK inhibition during mitosis could lead to radio-sensitization, I quantified 
γH2AX foci at various time-points after release from inhibitor treatment and nocodazole 
block. Notably, after 1 hour, similar numbers of foci were present in cells that had been 
mock- or PIKK-inhibitor-treated (Figure 30A), indicating that similar amounts of damage 
were generated, and that the majority of DSBs generated in mitosis were not repaired before 
G1 entry. Lack of ongoing DSB repair in mitosis is also supported by the difference in 
PIKK-inhibitor-mediated radio-sensitization between asynchronous and mitotic cells: the 
effect of the PIKK inhibitors on mitotic cells is ~3-fold lower than on asynchronous cells 
(Figure 29). I did, however, observe significant differences in IRIF numbers between mock- 
and inhibitor-treated cells at 2, 4 and 24 hours time-points. The inhibitor-treated cells showed 
2-fold more residual foci after 24 hours (Figure 30A and 30B), suggesting that a subset of 
lesions, perhaps more complex DSBs, requires the ‘primary’ DDR in mitosis in order to be 
efficiently repaired in the next cell cycle and to promote cell survival.  
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Collectively, these data suggest that activation of early DDR steps in mitosis, including the 
marking of such sites by H2AX phosphorylation, MDC1 and MRN recruitment is a 
biologically important response and contributes to preserving genomic integrity, possibly 
by facilitating recognition of breaks and their repair in the following cell cycle. 
 
Taken together, the data presented in this study support a model in which mitotic cells 
treated with DSB-inducing agents prioritize timely passage through mitosis over activation 
of a full DDR. The latter is likely to involve substantial changes in chromatin structure 
proximal to DSB sites that would presumably not be feasible in the context of highly 
condensed mitotic chromosomes and might otherwise perturb mitotic progression. 
Nevertheless, the mitotic cells activate a primary DDR, which is important for cell 
survival. 
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FIGURE 30. Primary DDR in mitosis promotes DSB repair in the following cell cycle
Transient inhibition of ATM and DNA-PK activity in mitosis is reversed upon removal of the inhibitors. U2OS cells were treated as in Figure 29 and 
exposed to 2 Gy of IR. Cells were co-stained for γH2AX and 53BP1 (A). Counting of γH2AX foci number per cell was performed using Volocity software 
and the average number of foci was reported in table and graph formats (B). Error bars represent standard errors calculated from the following 
formula: SE = SD/√n, where SD is the standard deviation of the means, and n is the number of cells counted treated as independent variables. Note 
that the average number of foci counted per cell at 2 hours post-release is less than that at 1 hour due to impairment focus visualization caused by 
the irregular morphology of cells in early G1, prior to full reattachment and attening, that aects foci imaging and counting.
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3.4 Discussion 
3.4.I Analysis of DNA damage responses in mitosis: exclusion of secondary 
DDR factors from IRIF 
 
The study of DNA damage signalling undertaken during my PhD has revealed a 
differential mode of responding to life-threatening lesions such as DSBs between 
interphase and mitotic cells. I have outlined the signalling cascade than unfolds in a DSB-
dependent manner in mitotic cells by monitoring the behaviour of all known components 
of the DDR signalling cascade. Importantly, this study specifically focussed on DNA 
damage induced while cells were in mitosis. Considering that 2 Gy of IR causes about 50-
60 DSBs, damage induced in G2 would prevent mitotic entry via activation of the G2/M 
checkpoint. Also, samples were fixed within 30 minutes after DNA damage induction to 
avoid loss of mitotic cells through mitotic exit, indicating that the immunofluorescence 
analyses show mitotic cells that have been damaged while already in mitosis. 
 
The observation that DDR mediators 53BP1 and BRCA1 fail to be recruited to damage 
foci following treatments with IR and phleomycin during mitosis suggests that multiple 
factors impact on the recruitment of downstream players in the DDR cascade. Several 
aspects involved in the effective recruitment of DDR factors, like RNF8, may play a role in 
mitosis to prevent their binding. The pronounced compaction of chromatin during mitosis 
may represent a physical barrier to the recruitment of factors to damaged loci. Epigenetic 
modifications, specific to the mitosis phase, may alter the DDR compartment, delaying or 
preventing the remodelling of chromatin required for certain factors, including 53BP1, to 
bind to DNA. The modification of chromatin flanking the break sites by PTMs is 
particularly intricate during mitosis. For instance, in H3 pS10 immunoblots, I have 
observed a high molecular weight band appearing only in mitotically-arrested samples, 
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suggesting that phosphorylated H3 is further modified by ubiquitylation and possibly 
SUMOylation in a mitosis-specific manner. In addition, the decrease in ubiquitylated H2A-
type histone is actively promoted upon entry into mitosis and does not correlate with a 
general loss of ubiquitylation, in line with my findings that conjugated ubiquitin levels do 
not change during the cell cycle.  
 
In addition, modifications applied to the protein may directly hinder binding of factors. 
Numerous DDR proteins are hyper-phosphorylated during mitosis, which may affect their 
binding ability directly or indirectly. Another possibility of regulation may include mitosis-
specific nuclear localization of DDR factors. Although difficult to analyse experimentally, 
it is possible that sequestration of proteins into mitotic structures jeopardizes their 
recruitment to damaged chromatin. 53BP1 is loaded to the kinetochore during prophase, 
where it co-localizes with CENP-E. In addition, I have shown for the first time that 
RNF168 also localizes at kinetochores and RNF8 not only co-localizes with the midbody 
in late mitosis, but is also recruited to centrosomes and kinetochores during unperturbed 
mitosis. It would be interesting to investigate the mitotic role that these proteins play at 
these structures. Especially, the observation that RNF8, RNF168 and 53BP1 localize to 
kinetochores in mitosis raises the possibility that their recruitment follows a similar 
epistatic relationship with analogous molecular dynamics as localization of DDR factors at 
DNA damage sites in interphase. Because kinetochores are subjected to tensional forces 
from the spindle microtubules, it is possible to envisage a scenario whereby genomic 
surveillance mechanisms are constitutively active to monitor these fragile sites and to 
promote rapid mending of spontaneously-arising DNA break. On the other hand, mitotic 
structures that harbour only RNF8 accumulation, like centrosomes and the midbody, may 
have different binding requirements, serve different functions and simultaneously work to 
sequester the protein from sites of DNA damage in mitosis. The results presented 
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emphasize that, whereas in interphase cells DDR factors play a major role in the responses 
to DNA double strand breaks, in unchallenged conditions these same DDR factors may 
have a role in monitoring and enabling physiological processes like mitosis. Both roles 
may be pivotal in maintaining genome stability. 
 
Despite our best effort to solve the puzzle of the failed binding of RNF8 FHA to the 
MDC1 phospho-epitope, this still remains one of the major unanswered questions of this 
study. The data collected suggest that a combination of mitosis-specific protein 
modifications and sequestration, controls the recruitment of DDR factors, like RNF8, to 
mitotic IRIF. It would be interesting to investigate the mitotic recruitment of E2 ubiquitin-
conjugating enzymes, like Ubc13, that work in partnership with E3 ligases to promote 
local accumulation of ubiquitin conjugates and may also be required to stabilize RNF8 
binding and endorse its focal recruitment. In addition, SUMOylation has recently been 
shown to be another post-translational modification to control recruitment of DDR factors 
to IRIF and amplification of the DNA damage signalling. Despite occurring downstream of 
RNF8, SUMO modifications are required for the productive association of ubiquitin, 
RNF168, 53BP1 and BRCA1 to sites of damage (Galanty et al., 2009; Morris et al., 2009). 
Therefore, it would be interesting to explore how SUMOylation is regulated in the context 
of mitotic cells. 
 
In addition, the understanding of molecular dynamics within the compacted chromatin 
status of mitosis may relate to other nuclear compartments, such as in heterochromatic 
regions. Penny Jeggo’s laboratory has shown that repair of DSB in heterochromatin is 
heavily reliant on ATM-mediated regulation of KAP1 that enables transient relaxation of 
chromatin and promotes DSB repair (Goodarzi et al., 2009). However, mitotic cells 
regulate HP1 chromatin binding via Aurora B-dependent phosphorylation of H3 pS10; 
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similarly to HP1, KAP1 is released from mitotic chromatin, suggesting that mitotic 
chromatin is considerably different from heterochromatic regions. It would also be 
interesting to investigate how the DDR in mitosis relates to responses to DSBs on the 
inactive X chromosome. Not much is known about DDR in this context, yet BRCA1 has 
been found to associate with the inactive X chromosome during S-phase (Chadwick and 
Lane, 2005), indicating that rather than compacted chromatin per se, it is the epigenetic 
marks typical of these different chromatic statuses that affect DDR factors’ recruitment. 
 
3.4.II Modulation of DNA damage checkpoint during mitosis 
 
Treatment with DSB-causing agents in mitosis leads to activation of ATM, γH2AX focal 
accumulation and increased phosphorylation of certain ATM targets, such as KAP1 and 
MDC1. However, the phosphorylation of typical ATM targets, Chk1, Chk2, Smc1, 53BP1 
and possibly others, is impaired in damaged mitotic cells. Attenuation of certain ATM-
mediated phosphorylations in mitosis is in agreement with a recent report by van Vugt et 
al., (2010) which shows that Plk1 targets 53BP1 and Chk2 for inhibitory phosphorylation, 
initiating a negative feedback network to inactivate the ATM-Chk2 branch of the DNA 
damage checkpoint in mitosis. In addition, here I show that substrates like Chk1 and Smc1 
are also not phosphorylated after DNA damage in mitosis. Therefore, this suggests that 
some ATM substrates require a higher level of regulation to be retained in their 
phosphorylation status. The parallels between failed recruitment of 53BP1 to IRIF and lack 
of Chk2 T68 phosphorylation following DSB induction in mitosis might reflect the 
previously described inter-dependencies between 53BP1 and Chk2 in DDR activation 
(Wang et al., 2002). Truncation of mitotic DDR at the level of RNF8, and absence of DDR 
mediators BRCA1 and 53BP1, may compromise a positive feedback loop that acts to 
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enhance mitotic signalling and convey it to downstream transducer kinases like Chk1 and 
Chk2, for activation of the DNA damage checkpoint (Diagram 8). Therefore, the 
peculiarities of the DDR in mitosis, outlined by this and other studies, may be exploited as 
a model to understand more complex feedback mechanisms of regulation of the DNA 
damage signalling at different levels of the cascade.  
 
DIAGRAM 8. Mitotic data support the existence of a positive feedback loop 
between recruitment of DDR mediators and checkpoint activation 
 
 
 
A model describing that the unfolding of a full DDR cascade following DSB induction requires 
recruitment of mediators, including 53BP1 and BRCA1, to sites of DNA damage, in order to trigger 
proficient phosphorylation-dependent activation of Chk1 and Chk2 and stimulate a plethora of DNA 
damage induced responses. In mitosis, the absence of a putative positive feedback loop mediated by 
cross-talk between mediator and checkpoint kinases may impact on the subsequent activation of 
checkpoint signalling.   
 
The study presented in this thesis experimentally demonstrates that the cell has devised 
several mechanisms to restrict secondary DDR activation in mitosis, by inhibiting 
ubiquitylation-dependent chromatin remodelling, downstream mediators recruitment and 
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Chk1 and Chk2-mediated activation of the DNA damage checkpoint. Thus, I suggest that 
activation of the secondary DDR and the DNA damage checkpoint do not occur in mitosis 
as deleterious to the cell in several ways. In the complex scenario of mitosis, where the 
nuclear envelope has broken down and the chromatin is irreversibly compacted, chromatin-
remodelling events brought about by the secondary DDR cascade might result in local 
dismantling of mitotic chromosomes and may interfere with the process of karyokinesis. 
Furthermore, DSB-induced activation of the checkpoint may delay progression through 
mitosis, leading to mis-coordination of accurately timed mitotic events, potentially 
inducing mitotic catastrophe. Taking into consideration the DNA damage hyper-sensitivity 
of mitotic cells, both the brevity of mitosis and prioritizing the progression through mitosis 
in such a short time over activation of a full DDR cascade may represent evolutionarily 
selected traits.  
 
3.4.III Biological significance of the primary DDR in mitosis: marking and 
tethering  
 
Although secondary aspects of the DDR are not present in mitosis, mitotic cells do not 
ignore life-threatening lesions like DSB as was previously postulated. Mitotic cells mark 
the site of damage, using γH2AX, MDC1 and MRN. Significantly, the data from this study 
shows that the primary DDR in mitosis is important for cell survival. I hypothesise that the 
effect of the primary DDR in mitosis is two-folds. Firstly, γH2AX mediates a robust 
marking of the sites of DSB in mitosis. The marking may facilitate the identification of 
damaged sites in G1 and, thus, accelerate recruitment of repair factors and prompt a more 
rapid DDR activation. Moreover, the recruitment of MRN to mitotic DSBs could be 
instrumental in holding the broken DNA ends together until G1 and this might be mediated 
by the DNA end tethering activity of Mre11 (Williams et al., 2008). Simpler lesions might 
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be held together by the compacted chromatin structure, typical of mitotic chromosomes, 
while more complex lesions could benefit from the MRN-dependent DNA bridging 
activity, facilitating the repair process in the ensuing cell cycle. In line with this 
hypothesis, I show that a subset of DSBs remains unrepaired 24 hours after DNA damage 
when primary DDR activation is prevented in mitotic cells. These are likely to represent 
more complex lesions that would have benefited from the marking and end tethering 
immediately after DNA damage formation. The persistence of these DSBs can lead to 
increased mortality as cell progress through subsequent cell cycles. Thus, while secondary 
DDR responses are inhibited as presumably incompatible with the spatio-temporal set-up 
of mitosis, primary responses act in mitosis to favour DNA damage recognition and repair 
in the following cell cycle, representing a pivotal feature in maintaining genomic integrity 
and promoting cell survival.  
 
3.4.IV Absence of DNA damage repair in mitosis  
 
The data presented in this study also infer that no repair occurs in mitotic cells. I found that 
one hour after the removal of the ATM/DNA-PK inhibitors, mock- and inhibitor-treated 
cells exhibited similar numbers of IRIF, which suggests that the majority of DSBs 
generated in mitosis are not fully repaired before the cell enters G1 phase. However, it was 
recently reported that DSBs are repaired in M-phase as well as interphase with similar 
kinetics (Kato et al., 2008). In the study presented by Kato et al., DSB repair was measured 
by pulse-field gel electrophoresis, which requires very high doses of damage (10-100 Gy). 
The fact that DSB repair was similar in mitotic and G1 cells could be explained by such 
high doses of radiation causing major perturbations in the chromatin organization of the 
cells as well as overall cellular metabolism. It is also possible that, upon irradiation with 
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these high doses, mitotic cells lose some of their unique qualities and persistent activation 
of the SAC may lead to atypical induction of DNA repair; indeed, a large amount of DNA 
damage is more likely to impact on the process of cell division itself, by impairing spindle 
attachment or causing loss of large portions of chromosomes, inducing prolonged 
activation of the SAC to act as a barrier to retain genomic protection during mitosis. 
Whatever the case, mitotic cells subjected to damage treatment of such magnitudes 
certainly do not progress into G1 and largely undergo cell death, as implied by the survival 
data showed in Figure 29. Therefore, it is very difficult to compare the data presented here 
to the previously published report by Kato et al. Notably, however, the IRIF dynamics as 
assessed by Kato et al., when they used 100-fold lower dose of IR, are similar to the one 
reported in this study: IRIF formed in mitosis persist into the following G1. Furthermore, 
close examination of the survival data presented in Figure 29 demonstrates that the PIKK 
inhibitors affect the radio-sensitivity of asynchronous cells much more strongly than that of 
mitotic cells. Even though further sensitisation of the mitotic cells by the PIKK inhibitors 
is statistically significant, when compared pair-wise, the differences at 0.5, 1 and 2 Gy are 
less than 2-fold and 4-fold at 4 Gy. At the same time, the difference is increasing 
progressively for the asynchronous cells, which have active DSB repair, and is more than 
12-fold at 4 Gy. Taken together, these results suggest that the inhibition of DSB repair is 
not the major component contributing to cell killing upon transient inhibition of ATM and 
DNA-PK in mitotic cells. Instead, γH2AX marking and MRN-dependent end tethering of 
the break until G1 may be sufficient to enable chromosome segregation and exit from 
mitosis, without perturbing cell division with invasive repair and chromatin remodelling 
apparatuses.  
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3.4.V Different kinetics of DDR activation: breathing chromatin versus 
mitotic chromosomes 
 
Although the physical chromatin conformation of mitotic chromosomes per se does not 
obviously impact on local recruitment of factors to the DSB compartments, chromatin 
compaction renders cells intrinsically sensitive to DNA damage. Therefore, compacted 
chromatin may not cause local barriers to the damaged DNA but may globally affect the 
signalling cascade following DNA damage. Conversely, it is tempting to speculate that 
chromatin plasticity facilitates genomic surveillance. For instance, chromatin relaxation by 
expressing reduced levels of the linker histone H1 correlated to a hyper-responsiveness to 
DSB and resistance to DNA damaging agents (Murga et al., 2007). Similarly, 
transcriptional up-regulation of chromatin remodellers in pluripotent stem cells (Gaspar-
Maia et al., 2009) increases plasticity of chromatin, which may correlate with stem cells’ 
faster dynamics in their responses to DNA damage and repair of the DNA lesion (Maynard 
et al., 2008). Based on these data and those presented in this study, a model can be drawn 
where human cells in interphase, which have mixed chromatic environments of 
euchromatin and heterochromatin, display standard DDR signalling cascade and repair 
kinetics. Pluripotent stem cells, and other cells whose chromatin is in a more open 
conformation, show a more dynamic response to DSB, with increased signalling and repair 
capabilities. Mitotic cells, on the other hand, where chromatin is highly compacted, are 
characterized by an impaired DDR and strong radio-sensitivity. Although the exact causes 
of the phenotypic effect of different chromatin arrangements are still unclear, a correlation 
is starting to emerge between chromatin status and intensity of the DDR. Moreover, the 
status of chromatin directly impacts on propagation of the DNA damage signal and on the 
physical mending of the DNA insult. Attenuated DDR in mitosis is especially relevant in 
view of DSBs triggering DDR-dependent global relaxation process. A global relaxation 
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may facilitate responses to DNA breaks by enabling faster access of DDR factor to the 
DSB site to facilitate genomic surveillance; in mitosis, however, global relaxation may 
have disastrous consequences and human cells may have evolved to prioritize mitosis over 
full DDR activation and repair, and compacted chromatin may play a direct or indirect role 
in exerting this regulation. 
 
The peculiarities of the DDR in mitosis, outlined by this and other studies, may be 
exploited as a model system to understand more complex feedback mechanisms of 
regulation of the DNA damage signalling at different levels of the cascade. Therefore, this 
study not only demonstrates how mitotic cells respond to DNA damage, but it also offers 
novel insight into the minute regulation of the DNA damage signalling cascade that are 
highly relevant in understanding DNA damage responses in all cell cycle phases. 
 
3.5 Conclusions and future prospective  
 
The impact of DNA damage in mitosis is a phenomenon that has been largely overlooked 
in mammalian cells. In particular, no molecular data existed on the consequence of DSB 
induction in mitosis when this project started.  
 
The aim of this study was to analyze how mitotic cells respond to an extremely cytotoxic 
form of DNA damage, DSBs. The notion that mitotic cells do not have a DNA damage 
checkpoint and do not arrest in response to irradiation had led to the assumption that no 
DDR was elicited by DSB during mitosis. However, I started the project with a simple 
observation. γH2AX foci formed in mitosis, implying that mitotic cells did not simply 
ignore DNA lesions including DSBs and that certain responses to DNA damage were 
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elicited in mitosis. On the other hand, the observation that the DDR mediator 53BP1 was 
not recruited to DSB in mitotic cells prompted further analysis to dissect the differential 
regulation of DNA damage responses between mitosis and interphase.  
 
Herein, I showed that that mitotic cells treated with DSB-inducing agents exhibit apical 
aspects of the DDR, but not downstream DDR components, such as RNF8, RNF168, 
53BP1 and BRCA1 and lack of a DNA damage checkpoint. RNF8 represents a critical cut-
off point in the DNA damage signalling cascade. Importantly, however, RNF8, RNF168 
and 53BP1 become associated with IRIF after mitotic cells bearing DNA damage enter G1, 
when the full DDR activation occurs. Moreover, activation of primary DDR in mitosis is 
important for cell viability, possibly facilitating foci repair in the following cell cycle 
(Giunta et al., 2010). 
 
The data presented by this study on the signalling mechanisms following induction of 
DNA damage in mitosis may be useful to gain a better understanding of the action of anti-
mitotic agents on cancer cells. Hyper-sensitivity of mitotic cells and the understanding of 
the molecular mechanisms by which mitotic cells deal with DNA insults may impact on 
the creation of novel therapeutics against hyper-proliferating cancer cells.    
 
Although this study provides a comprehensive analysis of the signalling responses elicited 
by DSB in mitosis and offers a first assessment of how mitotic cells deal with DSBs, 
numerous questions remain unanswered. A key challenge for the future will be to 
understand how exactly RNF8 is regulated in mitosis and what is the main mechanism to 
prevent its recruitment to IRIF. Understanding these aspects of mitotic regulation of RNF8 
would help to gain more insight into the DDR cascade in interphase cells as well. In 
addition to RNF8, understanding how the DNA damage checkpoint is modulated in mitosis 
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would be of major interest. In this regard, confirming the existence of an essential cross-
talk between mediators and checkpoint kinases would be extremely exciting and would 
provide a complex platform of regulation in a non-linear cascade. Outside of the responses 
to DNA damage under challenged conditions, more studies are required to understand the 
physiological role of DDR factors in mitotic structures. Especially, RNF8, RNF168 and 
53BP1 recruitment to the kinetochores begs further investigations. Answering these and 
many more questions regarding mitotic DDR and the role of DDR factors in unperturbed 
mitosis would represent substantial progress toward gaining a better understanding of the 
signalling cascade initiated by DSBs and the process and regulation of mitosis; 
furthermore, it may allow us to gain a better understanding of the action of 
chemotherapeutic drugs on cancer cells and may be exploited to improve 
chemotherapeutics in a near future. 
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4 ANALYSIS OF THE GINS COMPLEX SUBUNIT PSF1  
4.1 Summary  
The connection between DNA damage responses and the mechanisms of arrest of DNA 
replication is still largely unclear. The GINS complex is an evolutionarily conserved 
component of the DNA replication machinery that has been suggested to coordinate DNA 
unwinding at the leading strand with priming of DNA synthesis at the lagging strand. In 
addition to its essential roles for DNA replication, I speculated that GINS may be an ideal 
candidate for transferring the DNA damage signal to the replication apparatus, thereby 
mediating DNA replication arrest and/or preventing firing of new replication origins.  
 
Here, I show the identification of a conserved ‘SQ’ (serine-glutamine) site at the carboxyl 
end of two subunits of the GINS complex, Psf1 and Psf2, that conforms to the target 
consensus for the key DNA damage activated kinases ATM, ATR and DNA-PK. In S. 
cerevisiae, a single amino acid mutation in Psf1, switching the conserved serine to a 
glutamic acid (S187E), is lethal, indicating that the site is crucial for the protein function.  
In human cells, Psf1 C-terminus interacts in vitro with the UV-DDB, a heterodimeric 
complex involved in diverse cellular processes such as repair and ubiquitylation. 
Moreover, I show that the human PSF1 gene product is involved in maintaining GINS 
complex stability and plays a role in DNA replication and cell cycle progression.  
 
Altogether, the data presented in this chapter provide novel experimental support for a role 
of the Psf1 C-terminus consensus motif in modulating GINS complex activity in human 
and yeast cells. 
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4.2 Introduction 
4.2.I The GINS complex is an evolutionarily conserved component of the 
replisome 
 
GINS is a heterotetrameric protein complex found in all eukaryotic cells. The four distinct 
subunits of the GINS complex are Sld5 (Synthetically Lethal with Dbp11-1 five), Psf1, 
Psf2, and Psf3 (Partners of Sld5 1, 2 and 3;(Takayama et al., 2003). Sld5 was initially 
identified in a synthetic lethal screen to map genetic interactions using a Dpb11 thermo-
sensitive allele in S. cerevisiae (Kamimura et al., 1998). It is noteworthy that Dpb11 itself 
had been hitherto uncovered in a genetic screen where it suppressed mutations in two 
essential DNA polymerase ε subunits and was found to be required for both DNA 
synthesis and intra-S-phase checkpoint activation (Araki et al., 1995). Subsequent to its 
identification in the 1990s, Sld5 remained unstudied until 2003, when its analysis led to the 
discovery of the other GINS subunits and thus of the whole GINS complex (which stands 
for ‘go’ ‘ichi’ ‘ni’ ‘san’: 5, 1, 2, 3 in Japanese;(Kubota et al., 2003; Takayama et al., 2003).  
 
The GINS complex is structurally and functionally conserved throughout evolution. From 
archaea, yeast and frog, through to human, the GINS complex displays a quaternary 
structural arrangement and has been shown to hold an ancient fundamental role in DNA 
replication (Kubota et al., 2003; Takayama et al., 2003; Marinsek et al., 2006). The four 
paralogous GINS subunits are phylogenetically related in all eukaryotes. In archaea, the 
GINS core tetramer contains two homodimers of Gins23 and Gins51, which are distantly 
related to the eukaryotic GINS in terms of sequence homology. Duplication of the 
ancestral archeo-genes gave origin to the conserved heterotetramer found in all eukaryotes 
(Makarova et al., 2005; Marinsek et al., 2006). The complete depletion of one of the GINS 
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polypeptides causes lethality to eukaryotic cells, due to GINS pivotal function in DNA 
synthesis and cell cycle progression. In 2005, Ueno et al. showed the requirement for the 
GINS subunit Psf1 in early mouse embryogenesis. PSF1 knock-out mice died in utero due 
to the absence of cell proliferation (Ueno et al., 2005), recognizing GINS essential role in 
genome duplication and GINS disruption being incompatible with life.  
 
GINS function in DNA replication initiation and DNA unwinding has been characterized 
in Drosophila, Xenopus and, extensively, in budding and fission yeast. The GINS 
heterotetramer is part of the CMG complex, a candidate eukaryotic DNA replication 
helicase. The CMG complex comprises Cdc45, the ring-shaped MCM hexamer and the 
four GINS proteins (Moyer et al., 2006). In Drosophila and Xenopus, the CMG is present 
at sites of DNA unwinding during replication and it displays intrinsic DNA helicase 
activity in vitro (Moyer et al., 2006; Pacek et al., 2006). The MCM2-7 double hexamer 
represents the core of the CMG macromolecular ‘unwindosome’ machinery. Cdc45 and the 
GINS complex, on the other hand, have auxiliary functions as helicase cofactors, 
enhancing MCM2-7 unwinding activity (chapter 1.2.II). It remains unclear whether Cdc45 
and GINS supporting role is fundamental for MCM-mediated DNA unwinding. In the 
context of DNA unwinding, GINS may function as a structural co-factor that facilitates 
interactions with DNA, base pair separation and translocation speed (Aparicio et al., 2006). 
In addition to the auxiliary role in DNA unwinding, budding yeast GINS has been shown 
to be an accessory factor for DNA polymerase ε in vitro (Seki et al., 2006b), possibly 
coordinating DNA unwinding and polymerization during DNA synthesis. Moreover, 
genetic studies in S. cerevisiae have mapped the sequential incorporation of replication 
factors, including GINS, at the nascent fork (Diagram 9). In G1, the MCM-containing pre-
replication complex (pre-RC) does not include the GINS complex, which becomes 
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associated upon the CDK/Cdc7-dependent transition from pre-RC to pre-IC (pre-initiation 
complex), also requiring Sld3 and Cut5. Association of GINS to the pre-IC is needed to 
stabilize Cdc45 in the active replisome and to promote fork progression during S-phase 
(Kanemaki and Labib, 2006); see Diagram 9 and chapters 1.2.II and 1.2.III for details).   
 
DIAGRAM 9. Ordered assembly of the replisome for initiation of replication in 
S. cerevisiae 
 
 
 
A model for the sequential assembly of factors to the replication fork in budding yeast. The origins of 
replication sites are bound by ORC. In G1, Cdt1 and Cdc6 serve to enable the loading of the MCM2-7 
ring to pre-RC. CDK-dependent phosphorylation of Sld2 and Sld3 and interaction with Dpb11 create 
a molecular bridge to facilitate loading of cdc45 and GINS to the pre-IC. Sld3 is then removed from 
the pre-IC and a plethora of other factors associate with the replication fork during the transition from 
G1 to S-phase to enable initiation and elongation of replication. 
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Investigations in fission yeast revealed that GINS are required for the chromatin 
association to the replication origin of the Dpb11 homologue Cut5, as well as Cdc45 and 
the DNA polymerase ε (Yabuuchi et al., 2006); yet, DNA polymerase α is successfully 
recruited to chromatin when GINS is inactivated (Pai et al., 2009). Nevertheless, GINS 
may interact with DNA polymerase α during replication, directly or indirectly by binding 
to the Pol α-interacting factors Ctf4 in budding yeast (my own result and(Gambus et al., 
2009) and may be required for the activity of the DNA polymerase α-primase complex. 
The archaeal GINS associates with DNA primase and stimulates its activity in vitro. Thus, 
GINS interactions with factors at the replication fork may be necessary for coupling MCM 
progression with priming events (Marinsek et al., 2006). This hypothesis, yet to be 
verified, would reconciles the two fundamental roles of the GINS complex in replication: 
DNA unwinding and DNA synthesis. However, Xenopus egg extracts treated with the 
DNA polymerase inhibitor aphidicolin displayed enrichment of GINS, Cdc45 and MCM2-
7 to paused replication sites, but not of the DNA polymerases, suggesting that the helicase 
complex is physically uncoupled from the replication apparatus (Pacek et al., 2006). 
Furthermore, GINS interacts with Drc1, Mrc1 (homologue of human Claspin), Tof1 and 
several other replication factors, suggesting that complex functional interfaces regulate 
GINS during DNA synthesis and other S-phase-specific activities for the GINS complex 
are likely to exist.  
 
In 2006, when this PhD project started, the investigation of GINS physiological role in 
mammalian cells had yet to be addressed; new data from the Italian group of Dr. Pisani in 
2007 confirmed the interactions between the human GINS and DNA polymerase α-
primase complex (De Falco et al., 2007). The human GINS complex was then shown to 
bind to Cdc45 and the Mcm2-7 complex, where Cdc45 bridges the replicative helicase 
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with the processive DNA polymerases δ and ε (Bauerschmidt et al., 2007), strengthening 
the idea that GINS may coordinate unwinding and DNA synthesis. Similarly to budding 
yeast, the assembly of human CMG helicase requires Ctf4, RecQL4 and Mcm10 proteins 
(Im et al., 2009). These findings outline a strong degree of conservation in the molecular 
mechanisms of the replication initiation and elongation in eukaryotes, of which GINS is a 
central nexus.   
 
DIAGRAM 10. The GINS complex activities at the replication fork during DNA 
synthesis 
 
 
Content not visible due to copyright limitations 
 
The eukaryotic GINS heterotetramer is composed of Sld5 (in blue), Psf1 (in green), Psf2 (pink) and 
Psf3 (yellow; Psf2 and Psf3 are placed behind the Sld5-Psf1 dimer). GINS have been directly 
associated with DNA pol ε, pol α-DNA primase, as well as being part of the CMG helicase complex, 
with the MCM2-7 ring and Cdc45, suggesting roles in DNA unwinding and DNA synthesis. 
                                                                              Image modified from(Chang et al., 2007) 
 
 
 
  
 159 
4.2.II Structural organization of the GINS complex in the context of the 
DNA replication fork 
 
Several structural conformations of the GINS complex have been suggested by electron 
microscopy images and gel filtration data to support the functional link with Mcm2-7, 
Cdc45 and DNA polymerases ε and α-primase. Initially, GINS was thought to be a ring-
shaped molecule (Kubota et al., 2003) that acted as a molecular link between Cdc45 and 
the MCM ring, where both complexes formed rings that, juxtaposed, made a central 
channel for ss and dsDNA to pass through (Moyer et al., 2006). Furthermore, the idea of 
GINS shaped as a closed ring encircling the DNA prompted the theory of it functioning in 
a similar fashion to the trimeric polymerase-accessory-ring PCNA, as a ‘sliding clamp’ for 
DNA polymerase ε, promoting initiation of DNA duplication (Aparicio et al., 2006). 
 
In 2007, analysis of the crystallized human GINS complex described it as a globular ellipse 
with a small central channel (Chang et al., 2007; Choi et al., 2007; Kamada et al., 2007). 
The complex has a pseudo two-fold axis of symmetry, where Sld5-Psf1 dimer sits ‘on top’ 
of the Psf2-Psf3 dimer, constituting the heterotetramer. Each GINS subunit comprises two 
distinct protein domains; an A-domain made largely of α-helices, and a smaller B-domain 
composed of β-sheet – located at the C-terminus of Sld5 and Psf1 (Diagram 11). 
Structurally, Sld5 and Psf2 resemble Psf1 and Psf3, respectively, indicating that they 
evolved from one common ancient ancestor.  
 
Resolution of the crystal structure of the human GINS complex (Chang et al., 2007; Choi 
et al., 2007; Kamada et al., 2007) added yet more controversy to the molecular 
organization and mode of DNA interaction of the complex. Kamada et al. and Choi et al. 
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showed that GINS central cleft is too small for either ss or dsDNA to pass through it 
(Diagram 11;(Choi et al., 2007; Kamada et al., 2007). However, Chang and colleagues 
supported the idea that a short, 16-residues peptide on the flexible Psf3 N-terminus can 
move to enlarge the central channel by 80% and regulate accessibility of the DNA (Chang 
et al., 2007).  
 
DIAGRAM 11. The molecular structure of the human GINS complex 
 
 
Content not visible due to copyright limitations 
 
The GINS complex is arranged in a pseudo-two-fold symmetry between the Sld5-Psf1 and Psf2-Psf3 
dimers. The pseudo-symmetry extends at the structural level of individual subunits, showing that the 
morphology of Sld5 and Psf2 resemble those of Psf1 and Psf3, respectively. Each subunit is made of 
two types of structural domains, A and B, and a linker region connects them. The C-terminus of Psf1 
is truncated in the crystal structure (dotted circle). The right panel shows GINS central cleft (zoom). 
Due to the cleft’s dimension, GINS is unlikely to make contact to the DNA via this central channel.  
Images modified from(Kamada et al., 2007) 
 
Another study, using single-particle electron microscopy and three-dimensional 
reconstruction analyses, suggested that GINS complex shows a ‘horseshoe’ shape and is 
arranged as an open ring that can accommodate ss and dsDNA. The GINS complex 
partially encircles and directly binds to DNA, with higher affinity for ssDNA.  Based on 
these observations, the authors speculate a possible role for the GINS complex as ‘strand 
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displacement unit’ during MCM-dependent DNA unwinding (see chapter 1.2.II and 
diagram 1;(Boskovic et al., 2007).    
 
4.2.III Functional relevance of Psf1 carboxyl terminal domain in mediating 
initiation of replication 
 
Despite discrepancies in the structural information provided by the crystallized human 
GINS complex, both Kamada et al. (2007) and Chang et al. (2007) uncovered areas 
undetectable by electron density maps and difficult to crystallize, representing highly 
flexible, unstructured regions in the GINS complex. These disordered regions are located 
on the C-terminal domains of Sld5 (residue 65-71), Psf3 (194-216) and the very C-
terminus of Psf1 (from residue S145 to end) and are likely to be important functional and 
protein-binding interfaces (Chang et al., 2007). Whereas the Psf1 carboxyl tail is 
dispensable for the stability of the GINS complex, the Sld5 C-terminus is pivotal for the 
core complex assembly. Psf1 B domain is a structurally distinct region, anchored to the rest 
of the complex via a linker region (Diagram 11). Truncation of the Psf1 B-domain at the 
carboxyl end of the protein results in the assembly of a stable core complex, which is, 
however, non-functional. No initiation of replication was detected in Xenopus extracts 
were Psf1 full-length protein was replaced by its truncated counterpart (Kamada et al., 
2007). Thus, Psf1 C-terminal end is the functional interface of the entire complex, 
mediating chromatin binding and DNA replication activities. The exposed position of the 
Psf1 C-terminal end is meaningful as it provides a docking site for interactions with other 
proteins involved in DNA replication and beyond. Therefore, the B domains on Sld5 and 
Psf1 are essential for the GINS complex and function both to stabilise the interfaces 
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between the layers of the complex and to form higher-order protein complexes with 
additional factors, respectively. 
 
In conclusion, several studies in the last decade have enriched our knowledge about the 
GINS complex across and beyond the animal kingdom (for review, see(MacNeill, 2010). 
Yet, significant uncertainties remain as to the exact structural conformation, mode of 
action and coordination dynamics between the various functional interfaces of the GINS 
complex.   
 
4.2.IV Alternative roles for the GINS complex: do all roads come from Rome? 
 
In addition to the evolutionarily conserved functions of the GINS complex in DNA 
replication, several additional roles have been recently described, that may represent novel 
functions of the complex, or may be indirect consequences of GINS essential role in DNA 
replication. 
 
The identification of the GINS subunit Psf2 as a multi-copy suppressor of the mutated 
fission yeast protein Bir1, the human homologue of Survivin, inferred a role for the GINS 
complex in chromosome segregation. Bir1 is a conserved chromosomal passenger factor, 
whose suppression leads to aberrant cell division and cytokinesis. Loss of Psf2 in the 
fission yeast S. pombe caused failed localization of Bir1 to elongating spindles and resulted 
in chromosomes mis-segregation. The same study reported a dramatic chromosome mis-
segregation phenotype when PSF2 was knocked-down by siRNA in human HeLa cancer 
cells, which resulted in aneuploidy and growth arrest. Psf2 may play a conserved role in 
promoting high-fidelity chromosome segregation and mitotic division; however, this may 
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be an indirect effect of GINS role during S-phase, possibly through regulation of 
centromere replication (Huang et al., 2005a). In support of a direct role for the GINS 
complex in mitosis, I have observed recruitment of the GINS subunit Psf1 to the mitotic 
structure of the midbody in late anaphase and telophase (Figure 41). In addition, GINS 
levels are maintained constant across the cell cycle, inferring for additional roles outside of 
S-phase. Nonetheless, a recent study investigated the putative mitotic role of GINS in 
human dermal fibroblasts (HDF) and found absence of gross chromosomal abnormalities 
and mitotic defects in Psf1/Psf2-depleted cells. The authors point to defects in the 
progression through S-phase and in delayed mitotic entry as the underlying cause of 
chromosome aberrations in GINS down-regulated cells (Barkley et al., 2009). In addition, 
siPFS1/2-induced S-phase delay caused replicative stress, including formation of DNA 
damage – as monitored by γH2AX foci formation – and activation of the ATM/Chk2-
dependent checkpoint – indicated by robust Chk2 T68 phosphorylation – in the absence of 
genetoxins. Interestingly, the ATR/Chk1 branch fails to be activated in Psf1/2-depleted 
HDF (Barkley et al., 2009), suggesting that the key role of GINS in maintaining replicative 
helicase activity is necessary for generating RPA-coated ssDNA and initiating the intra-S-
phase checkpoint by Chk1.  
 
Given accurate replication and repair of DNA is crucial for maintaining genomic stability 
and ensure faithful genome duplication, DDR activation has been shown to be an hallmark 
of pre-malignant tissues (reviewed in(Halazonetis et al., 2008), indicating the presence of 
mutational damage which may lead to malignant transformation. Therefore, Psf1/2 down-
regulation leads to a precarious scenario of genomic instability, characterized by DDR 
activation, possibly leading to subsequent chromosome mis-segregation. Conversely, 
GINS role in promoting cell proliferation represents the other face of the same coin. In 
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fact, up-regulation of GINS subunit drives cancer cell proliferation. Psf3 was shown to be 
over-expressed in colon cancer cells and its depletion results in cancer cell growth arrest, 
rendering Psf3 suitable as a biomarker for diagnosing progression of colon cancer, as well 
as a target for novel cancer therapeutics (Nagahama et al., 2010). More examples of GINS 
over-expression in malignancy include elevated levels of Psf2 in intrahepatic 
cholangiocarcinoma tissues (Obama et al., 2005), Psf1 and Sld5 in aggressive melanoma 
(Hayashi et al., 2006) and also Psf1 in MCF7 human breast carcinoma cells, where PSF1 
was identified as an estrogen target (Ryu et al., 2007). These findings suggest a scenario 
where GINS down-regulation leads to genomic instability and contributes to pre-
malignancy. A later role of GINS up-regulation in malignancy serves to promote cancer 
cell hyper-proliferation and further mutagenic transformations. Accordingly, GINS mRNA 
levels are tightly regulated in human and mouse tissues, with the highest expression 
observed in the embryo, given GINS is essential for embryogenesis. Studies in Xenopus 
showed that Psf2 is specifically required for eyes and brain early development (Walter et 
al., 2008). GINS expression is lowered in adult tissues, made exceptions for the areas 
where the stem cell system is active, like bone marrow and testis. In the testis, 
transcriptional up-regulation of PSF1 is essential for spermatogenesis (Han et al., 2009). 
Psf1 was also shown to be required for maintenance of immature haematopoietic SC and 
bone marrow regeneration (Ueno et al., 2009). 
 
Therefore, maintenance of physiological levels of the GINS complex is pivotal for 
propagation of life, as both the under and over-expression statuses have equally deleterious 
consequences on human cells. Similarly to GINS, MCM had previously been shown to 
mark cell replicative potential (Musahl et al., 1998; Madine et al., 2000; Stoeber et al., 
2001) and display dysregulated expression in a range of neoplastic conditions. MCM has 
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been shown to be a marker of dysplasia (Todorov et al., 1998; Freeman et al., 1999) and its 
over-expression correlates with increasing tumour grade and poor prognosis (Gonzalez et 
al., 2005). Thus, MCM is currently being exploited as a diagnostic and prognostic cancer 
biomarker (reviewed in(Coleman and Laskey, 2009). Whether pre-RC components, like 
the MCM, Cdc6 or ORC complexes, have direct oncogenic potential is still under debate 
(Lau et al., 2007), yet other pre-RC and pre-IC proteins, including GINS, may be exploited 
to monitor changes in cellular replicative capabilities. 
 
In a physiological scenario, GINS is essential to drive embryogenesis by ensuring 
sustained cell division, modulate tissue differentiation and promoting proliferation-
dependent maintenance of the stem cells pool. Instead, in the aberrant environment of the 
cancer cell, GINS may contribute to hyper-proliferation, facilitating the propagation of the 
tumour. Therefore, the balance between endorsing physiological cell division and 
preventing uncontrolled cell growth by tight regulation of replication must be maintained 
to sustain life.   
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4.3 Results 
4.4 Analysis of the GINS subunit Psf1 in human cells  
4.4.I Psf1 and Psf2 subunits of the GINS complex contain an evolutionarily 
conserved DNA damage related motif at the C-terminus 
 
The GINS complex functions at the interface between two essential processes of 
replication: DNA synthesis and DNA unwinding. The functional activity of GINS in 
coordinating these events places it under the spot light as a key factor to ensure accuracy of 
the replicative process and to preserve replication fork integrity. Therefore, GINS complex 
may be an important target to modulate DNA replication in the presence of genotoxic 
alterations and function to maintain genomic stability. 
 
To identify novel proteins containing ‘SQ’ (serine-glutamine) sites, which conform to the 
consensus target site for phosphorylation by the key DNA damage activated kinases ATM, 
ATR and DNA-PK, I performed in silico searches for this motif. Phosphorylation of these 
motifs may play a functional role in controlling cellular responses to DNA insults. With 
the help of Mike Gilchrist, the Gurdon institute bioinformatician, I performed a Blast 
search against the human genome for the closest homologue to the (S/T)QxF/Y motif 
located at the C-terminal end of proteins. One of the hits of the blast search was the SQEY-
COOH consensus motif in human H2AX (Table 6), a main target site of PIKK kinases, 
validating the screen. The first hit of the bioinformatics search was the SQDF-COOH site 
in the GINS subunit, Psf2 (Table 6), also located at the very carboxyl end of the protein, 
similarly to H2AX.  
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TABLE 6. In silico search for C-terminal consensus (S/T)QXF peptide motifs 
across the human genome  
 
Motif Proteins 
SQDF* DNA replication complex GINS protein Psf2 
SQDF* Protein ARV1 (hARV1) 
SQEY* Histone H2A.x (H2A/x) 
SQGY* Synaptogyrin-1 
SQKF* Centaurin-beta 2 (Cnt-b2) 
SQPY* Melanoma-associated antigen B5 (MAGE-B5 antigen) 
SQRY* Keratin 6L 
TQIY* UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 
TQQF* CDK5 and ABL1 enzyme substrate 2 (interactor with CDK3 2) 
TQTY* Clorf113 protein (Fragment). 
 
Blast search for human proteins containing sites homologue to the (S/T)QXF motif at the very C-
terminus (* = COOH). The 10 resulting protein hits are shown, along with the site’s sequence  
 
Strikingly, Psf1, another subunit of the GINS complex, also contains an evolutionarily 
conserved ATM consensus motif within its C-terminus, present in eukaryotes from yeast to 
human (Figure 31).  ATM sits at the apex of the DDR cascade and, upon induction of 
DNA damage, it phosphorylates a plethora of substrates, mediating a range of cellular 
responses (Shiloh, 2003). The consensus motifs on Psf1 and Psf2 carboxyl termini may 
also be targeted for phosphorylation by ATM and may serve as a means to control 
replication fork elongation and/or unwinding in the presence of DNA lesions.  
 
 
 
 
 
 
 
 168 
FIGURE 31. Multispecies alignment of Psf1 and Psf2 proteins sequences 
 
 
 
 
Psf1 (A) and Psf2 (B) sequence alignment in different eukaryotic species: human, Xenopus, zebrafish, 
chicken, Drosophila, budding and fission yeasts. Human Psf1 and Psf2 share high sequence identity 
with their counterparts in different species with the highest conservation at the C-terminus, including 
the ‘SQXF’ consensus site. 
 
4.4.II A candidate approach to test the BRCT phospho-peptide binding 
hypothesis  
 
The evolutionarily conserved SQXF motifs on Psf1 and Psf2 (in human, SQHF and SQDF, 
respectively) resemble phospho-epitopes acting as docking sites for binding to selected 
BRCT-containing substrates, similarly to the phosphorylated S139 of γH2AX, within a 
consensus SQ C-terminal motif, that recruits the twin BRCTs of MDC1. The BRCT 
phospho-binding modules are present in several DDR proteins such as MDC1, 53BP1, 
BRCA1 and TopBP1, mediating signal transduction events of the DDR cascade. In 
addition, Psf1 and Psf2 SQ sites both share a conserved phenylalanine amino acid in the +3 
position (3 residues C-terminal with respect to the phospho-serine). BRCA1 BRCTs have 
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been shown to bind with high affinity phospho-serine peptide targets that contain a 
phenylalanine residue in +3 position (Manke et al., 2003; Yu et al., 2003). The crystal 
structure of the interacting interface revealed that, along with the phospho-serine, the +3 
phenylalanine is a key binding pocket for the BRCT hydrophobic groove (Clapperton et 
al., 2004; Williams et al., 2004). The conservation of the interacting residues suggests that 
BRCT proteins recruitment to phospho-epitopes is an evolutionary conserved mechanism 
in the signalling of DNA damage.  
 
Because the human BRCT-containing DNA damage mediator TopBP1 (topoisomerase II 
binding protein 1) is homologue to Dpb11 in S. cerevisiae and Cut5 in S. pombe, that have 
been genetically and physically associated with the GINS complex, I wanted to test 
whether these motifs on Psf1 and Psf2 may represent binding interfaces for TopBP1 
recruitment to the replication fork. Furthermore, to address if phosphorylation may 
regulate these putative interactions, similarly to recruitment of other BRCT-containing 
DDR factors by DNA damage-dependent phosphorylation, I used synthetic biotinylated 
peptides for the phosphorylated and unphosphorylated forms of Psf1 and Psf2 SQXF 
motifs (Table 7). A candidate approach was undertaken to assess if the binding of potential 
interactors was either positively or negatively regulated by phosphorylation. In addition, in 
the Psf1 peptide, the amino acid in the +3 position was modified from a phenylalanine to 
an alanine (F176A), still in the presence of the phosphorylated serine in Psf1, to assess the 
binding potential of candidate BRCT domain-containing proteins through their BRCT 
binding interface. 
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TABLE 7. Synthetic peptides of Psf1 and Psf2 used for pull-downs experiments 
 
Name  Synthetic peptide 
Psf1 SQHF Biotin-SGS-GTSCVLLKKNSQHFLPR-NH2 
Psf1 pSQHF Biotin-SGS-GTSCVLLKKN(pS)QHFLPR-NH2 
Psf1 pSQHA Biotin-SGS-GTSVLLKKN(pS)QHALPR- NH2 
Psf2 SQDF Biotin-SGS-YKLRTNLQPLESTQSQDF-COOH 
Psf2 pSQDF Biotin-SGS-YKLRTNLQPLESTQ(pS)QDF-COOH 
 
Human Psf1 (164-179) and hPsf2 (168-185) peptides in their unphosphorylated and phosphorylated 
forms (Psf1 pS173 and Psf2 pS182) are shown, where the consensus motif is underscored. An 
additional phospho-peptide was used for Psf1 with a mutation of the F176 to alanine, shown in bold.  
 
Pull-downs from HNE showed that RPA, MRE11, BRCA1, 53BP1, TopBP1, MCPH1 and 
MCM7 failed to bind to any of the peptides tested in either their phospho- or 
unphosphorylated-forms (Figure 32).  
 
FIGURE 32. Peptide pull-down experiments and WB for selected candidates 
 
 
 
Psf1 and Psf2 C-termini are used to fish for BRCT-containing DDR proteins: 53BP1 (214 kDa), 
BRCA1 (220 kDa), MCPH1 (110 kDa) and TopBP1 (180 kDa). Binding of MCM7 (81 kDa), MRE11 
(80) and RPA (p70, 70 kDa subunit) was also tested. MDC1 (Figure 33) but not MRE11 bound to 
phosphorylated H2AX peptide, as only direct interactions would be retained under the conditions 
used.  
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In addition, experiments using antibodies raised against human GINS subunits Psf1, Psf2, 
Psf3 and Sld5 did not show in vivo binding to 53BP1, MCPH1 or TopBP1 in co-
immunoprecipitation (co-IP) experiments (data not shown), suggesting that they do not 
interact with the GINS complex under the experimental conditions tested. 
 
4.4.III Mass spectrometry screen for substrates binding to the Psf1 C-terminus 
 
Peptide pull-down experiments were also used to perform a screen to identify novel 
binding partners of Psf1 and Psf2. Psf2 did not show any specific interactions. Psf1 
peptides, however, gave a specific band pattern on silver-strained gels, suggesting binding 
of interacting proteins. In addition, a differential pattern was observed using 
unphosphorylated, phosphorylated or F176A mutant Psf1 peptides, indicating that regulatory 
mechanisms of recruitment may exist between Psf1 and its binding partners (Figure 33).  
 
FIGURE 33. Silver stained gel and selection of bands for identification by MS  
 
 
 
Pull-downs in HNE were performed using the indicated peptides. The silver stained gel shown 
represents one examples of the 6 silver gels used for the identification of novel binding partners for 
Psf1 C-terminus. Only bands found in silver gels from all experiments were considered for further 
analysis. In addition, bands that changed in their levels or were only found interacting with a specific 
form of the peptide were selected. γH2AX was used as a positive control, showing an obvious band 
running above the 200 kDa marker, likely to correspond to MDC1.  
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Psf1 bands from silver gels were sent for protein identification by tandem mass 
spectrometry (MS/MS). Seven silver stained bands were identified as proteins binding to 
Psf1 peptides (Table 8). 
 
TABLE 8. Psf1 peptides-binding proteins identified by mass spectrometry   
 
Serial 
# 
Protein name Gi # Identified 
peptide 
Coverage 
(%) 
1  put. Beta-actin [Mus musculus] 49868 8 30 
2  acetyl-CoA carboxylase 1 
Isoform 2 
Isoform 1 [Homo sapiens] 
33112885 
38679967 
38679960 
17 11 
3 PREDICTED: similar to Prostate, 
ovary, testis expressed protein on 
chromosome 2 [Homo sapiens] 
113413194 1 1 
4 acetyl-CoA carboxylase 1  
Isoform 2 
Isoform 1 [Homo sapiens] 
33112885 
38679967 
38679960 
13 9 
5 Xeroderma Pigmentosum Group E 
Complementing protein; DNA damage 
binding protein 1 (Damage-specific 
DNA binding protein 1, DDB p127) 
[Homo sapiens] 
2632123 
 
2 5 
6 major vault protein [Homo sapiens] 19913410 6 12 
7 (a) lacritin precursor [Homo sapiens] 15187164 1 9 
7 (b) nasopharyngeal carcinoma-associated 
proline rich 4 [Homo sapiens] 
22208536 1 11 
7 (c) proline rich 4 [Homo sapiens] 6005802 1 10 
 
Proteins identified by MS/MS. Interestingly, band 5 was identified as DDB1, a 127 kDa protein that 
corresponded to a silver stained band of the expected size. Two peptides for DDB1 were identified by 
mass spec analysis: IGRPSETGIIGIIDPEC(+57)R and IEVQDTSGGTTALRPSASTQALSSSVSSSK 
which had strong homology for DDB1.  
 
4.4.IV UV-DDB protein complex binds to Psf1 C-terminus in vitro 
 
DDB1 was identified by MS/MS in the screen for proteins interacting with Psf1 SQXF C-
terminal motif. DDB1 is a 127 kDa subunit of the DNA damage binding complex UV-
DDB, involved in the repair of UV radiation photoproducts by nucleotide excision repair 
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(NER). To verify that DDB1 was a bona fide binding partner of Psf1, I analyzed their 
interactions by western blotting. The pull-downs recapitulated the interaction between Psf1 
and DDB1, which occurred constitutively with the unphosphorylated peptide; furthermore, 
the interaction was strengthened by phosphorylation of Psf1 S173 and further increased 
when F176 was mutated to alanine (Figure 34).  
 
FIGURE 34. Psf1 C-terminus peptides bind to DDB1 and the interaction is 
stabilized by phosphorylation 
 
 
Peptide pull-downs from 1 mg of HNE were carried out as in Figures 32-33. The samples were 
analyzed by western blotting using a goat polyclonal antibody against hDDB1 (1128-1140 synthetic 
peptide DLIKVVEELTRIH, ab9194; Table 1).  
 
To confirm interactions between full length Psf1 and DDB1, I cloned, expressed and 
purified recombinant GST-Psf1 protein from E. coli. Expression of recombinant protein in 
bacteria was optimized by overnight incubation with 0.1 mM IPTG at 16°C (Figure 35A, 
panel 1). Although most Psf1 was insoluble (Figure 35A, panel 2), a small amount of full 
length GST-Psf1 from the supernatant was bound to the beads (Figure 35A, panel 3) and 
was able to pull-down DDB1, as well as the smaller 48 kDa subunit, DDB2, from HNE 
(Figure 35B). In addition to pulling down the UV-DDB complex, the other GINS subunits 
were also retrieved when using full-length GST-Psf1 (Figure 35B). This suggests that 
binding of Psf1 to DDB1 did not hinder interactions with other GINS subunits and GINS 
complex formation. In addition, the fact that Psf1 C-terminus peptide did not pull-down 
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other GINS subunits, whereas full-length Psf1 did, infers that the binding interface for Psf1 
to assemble into the GINS complex lies outside of the C-terminus of the protein. These 
observations are in agreement with data from the human GINS crystal structure, which 
indicates that the Psf1 C-terminus is dispensable for GINS complex formation and 
stability, but is an essential functional interface for binding to other factors (Kamada et al., 
2007).  
 
FIGURE 35. Full-length GST-Psf1 expression, purification and pull-downs 
 
 
 
 
GST-Psf1 recombinant protein was expressed in a pGEX-6P-3 vector in E. coli using 0.1 mM IPTG 
overnight at 16°C (A). A band corresponding to Psf1 was observed at ~49 kDa (Psf1 = 23 kDa + GST 
= ~26 kDa; black arrows) only in IPTG-induced lanes (panel 1). After lysis, the soluble (supernatant) 
and the insoluble (bacterial pellet) fractions were analysed, showing Psf1 is mostly insoluble (panel 2). 
The supernatant contained a small amount of Psf1 that was conjugated to GSH-sepharose beads and 
run at ~49 kDa, as expected (top arrow; Panel 3). Full length GST-Psf1 bound to the beads was used 
for pull-down experiments from 1 mg of HNE. Psf1 was pulled-down as shown by Coomassie stained 
gel (Panel 4; A). Western blotting of GST, DDB1, DDB2, Sld5, Mcm7 and Rad50 is shown in B.  
 
To address the regulation of DDB1 and DDB2 binding to Psf1, I mutated S173 to alanine 
(A), which cannot be phosphorylated, or to glutamic acid (E), which may represent a 
phospho-mimicking mutant. Importantly, both mutants behaved like wild-type Psf1 in 
binding other GINS subunits (Figure 35), indicating that site-specific mutagenesis of S173 
in Psf1 does not disrupt GINS complex formation and stability. This was expected due to 
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the truncation of Psf1 C-terminus (aa 140-196) not affecting complex stability (Kamada et 
al., 2007). No differences were observed in the ability of DDB1 to bind Psf1 when the 
serine was mutated to alanine or glutamic acid, indicating that the binding interface 
between Psf1 and DDB1 may be outside of the SQ site and is not phosphorylation-
dependent. The pull-down experiments showing decreased DDB1 binding using F176A 
mutant peptides (Figure 34) suggest that the binding may be modulated by the conserved 
phenylalanine residue (F176), which is exposed on the peripheral surface of the complex. 
Indeed, Kamada et al. (2007) identified this conserved hydrophobic residue as functionally 
important for Psf1 association with target proteins (see discussion chapter  4.6.I for 
details).  
 
4.4.V Phosphorylation of human Psf1 after DNA damage  
 
 
While my investigations were ongoing, Steve Elledge and colleagues performed a large-
scale proteomic screen that revealed the C-terminal SQ site of human Psf2 to be 
phosphorylated by ATM/ATR in response to DNA damage (Matsuoka et al., 2007). This 
prompted me to investigate whether the consensus SQ site on Psf1 was also 
phosphorylated by the PIKK kinases in response to DNA damaging agents or possibly to 
replicative stress.  
 
Initially, I used a similar experimental technique as described in the Matsuoka screen; Psf1 
was immunoprecipitated by irradiated or untreated U2OS cell extracts and phosphorylation 
was assessed by using a phospho-antibody that generally recognizes substrates 
phosphorylated by ATM and/or ATR on S/TQ sites. However, IP experiments using Psf1 
were greatly hindered by the proximity of Psf1 with the IgG light chain that runs at about 
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25 kDa on western blot. The use of TrueBlotTM antibodies that preferentially detect the 
native disulfide form of the IgG reduced but did not clear the signal from the denatured 
IgG light chain, making it difficult to assess the presence of phospho-bands.  
 
To address whether Psf1 was phosphorylated in vitro, I performed pull-downs using GST-
Psf1 recombinant protein incubated in HNE in the presence or absence of ATP. A small 
electrophoretic mobility shift was observed on SDS-PAGE when Psf1 was incubated with 
ATP and when Psf1 S173E mutant was used, even before addition of ATP (Figure 36A), 
suggesting that the protein may be post-translationally modified by phosphorylation. I 
repeated the GST pull-down experiments using radiolabelled [γ32P]-ATP. 
Autoradiography showed very faint signals corresponding to GST-Psf1 (Figure 36B). 
However, the signal persisted when the alanine mutant was used for the pull-down and in 
the presence of 20 µM wortmannin (Figure 36B), a dose inhibiting ATM and DNA-PK 
(Izzard et al., 1999), suggesting that Psf1 may be phosphorylated in a PIKK-independent 
manner on sites other than S173.  
 
In addition, I used the electrophoretic mobility shift assay to monitor the presence of a 
phosphorylation-dependent change in Psf1 protein mobility in vivo following incubation 
with increasing doses of camptothecin (CPT). CPT is a cytotoxic alkaloid that binds to and 
inhibits DNA topoisomerase I causing DNA breaks. The toxicity of CPT treatment is 
mostly observed during S-phase, when ongoing replication converts single-strand breaks 
into double-strand breaks upon collision of the fork. At high dose of CPT, a smear was 
observed in the antibody staining against Psf1, indicative of phosphorylation. Furthermore, 
a similar shift was observed following UV (Figure 36C).   
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 FIGURE 36. Addressing Psf1 phosphorylation in vitro and in vivo 
 
 
 
 
Empty vector (GST), Psf1-GST wild-type and mutant forms (S173A and S173E) were incubated in 
HNE in the presence or absence of 95 µM ATP (A). GST pull-down experiments were repeated with 
Psf1 WT and S173A mutant (‘A’) using radiolabelled [γ32P]-ATP (0.37 MBq/tube; 10 µCi/µl per 
reaction). Reactions were analysed by SDS-PAGE followed by western blotting (left) and 
autoradiography (right). A very faint signal was observed corresponding to GST-Psf1 (~51 kDa, as 
Psf1 ~23 kDa and the GST tag is ~28 kDa) in the autoradiograph. Signals other than Psf1 were 
detected by autoradiography between 100 and 150 kDa, possibly representing phosphorylated Psf1 
binding partners, including the 127 kDa protein, DDB1, and at 36 kDa, possibly representing Psf1 
degradation products (B). Electrophoretic mobility shift assay show a phosphorylation-dependent 
change in Psf1 protein mobility in vivo (lane 6; C) following incubation with the indicated dose of 
CPT for 1 hour. Treatment with 10 J/m2 of UV for 1 hour shows a similar phospho-shift (C).  
 
An antibody was raised against the phosphorylated form of Psf1 S173 to assess whether 
this site is phosphorylated in vivo. However, the pS173 antibody was found to be non-
specific, detecting the Psf1 mutant with an unphosphorylatable form of the site (S173A; 
Figure 37). Therefore, this antibody could not be used to unequivocally address the 
outstanding question of whether Psf1 is phosphorylated on S173 within the conserved C-
terminal consensus ATM phosphorylation motif.   
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FIGURE 37. Psf1 Phospho-S173 rabbit polyclonal antibody tests 
 
 
 
 
A phospho-specific antibody was raised against human Psf1 pS173. Spot test was used to test the 
antibody at a concentration of 1:1000 in 2.5% BSA/TBS-T solution using Psf1 and pPsf1 Ab Peptides, 
used to immunize the rabbit, and Psf1 synthetic peptides as from Table 7. Interestingly, mutation of 
F176A reduces phospho-antibody recognition (A). Cellular fractionation (B) or Laemmli extracts (C) 
of U2OS cells transfected with Psf1-HA, S173A and S173E mutants. Most Psf1 is found in the 
chromatin bound fraction (B). pPsf1 S173 antibody recognizes Psf1 alanine mutant (B and C).  
 
Interestingly, Psf1 S173A and S173E mutants expressed and bound to chromatin similarly 
to the wild-type protein (Figure 37B) and expression of Psf1 mutants did not affect the 
stability of Psf1 (Figure 37C) and other GINS subunits (data not shown), suggesting that 
C-terminus motif mutants behave similarly to Psf1 in terms of DNA binding dynamics.  
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Psf1 levels, for both endogenous and HA-tagged transiently transfected proteins, are 
unchanged after irradiation and treatment with UV, indicating that DNA damage does not 
cause failed stabilization or proteosomal degradation of Psf1 proteins, or transcriptional 
inhibition of the PSF1 gene. In addition, even after IR, a shift was observed in IR-treated 
samples where HA-Psf1 was immunoprecipitated, and the mobility shift was reduced using 
HA-Psf1 S173A mutant, suggesting that S173 may be phosphorylated following irradiation 
of human cells (Figure 38). 
 
FIGURE 38. Level of endogenous and transiently-transfected Psf1 proteins is 
unchanged after DNA damage 
 
 
 
Psf1 protein levels are unchanged after treatment with DNA damaging agents, IR (10 Gy) and UV (10 J/m2). 
Endogenous (endo) and transiently transfected HA-tagged Psf1 in U2OS were monitored using rabbit Psf1 
polyclonal antibody. IP was performed using monoclonal antibody against HA-tag. HA-Psf1 wild-type, but 
not HA-Psf1 A (S173A) mutant, shows a smear after irradiation (marked by asterisk).     
 
4.4.VI Analysis of Psf1 subunit of the GINS complex in the cell cycle 
 
The role of the GINS complex in human cells was largely elusive when this project started. 
Consequently, I set to investigate the physiological function of Psf1 and how it is 
modulated in response to DNA damage in human cells.  
 
To address the affect of PSF1 down-regulation on cell cycle progression, I used small 
interfering RNA (siRNA)-mediated knock-down (KD) of PSF1 in U2OS human cancer 
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cells. siRNAs against PSF1 open reading frame (ORF; siPSF1 # 1) and against the 3’ un-
translated region (3’-UTR; siPSF1 # 2) were tested, with the latter showing the highest 
level of down-regulation (Figure 39A). siPSF1#2 cells were harvested for FACS analysis 
48 hours post-transfection and compared with siLuciferase cells. As expected, Psf1 
depletion showed an increase in S-phase cells, indicative of slower replication. Moreover, 
fewer cells were found in G2/M, suggesting that Psf1 depletion activates replication arrest 
possibly through the induction of intra-S-phase checkpoints (Figure 39B and 39C). These 
data are in agreement with a recent report that shows that siPFS1/PSF2 lead to 
accumulation in S-phase of primary cells (Barkley et al., 2009). Data in HeLa cells, where 
entry into mitosis followed by mitotic catastrophe was observed following siPFS2 (Huang 
et al., 2005a), can be reconciled by the fact that, unlike U2OS, HeLa cells lacking 
functional p53 cannot support proficient intra-S-phase checkpoint arrest (Zhu et al., 2004). 
In line with GINS subunits being essential for cell viability, siPSF1 increased the sub-G1 
population from 0.58% in siLuciferase to 1.32% (Figure 39B and 39C), probably 
indicating cell debris due to apoptotic death or necrosis. In addition, siPSF1 cells showed 
about 30% confluency on the dish, against 50-60% for siLuciferase, at 24 hours post-
transfection (data not shown). The decrease in confluency in siPSF1 cells is caused by an 
increased cell death and, not mutually exclusive, a slower proliferation rate. It is 
noteworthy that no more than ~70% protein depletion was observed using siPSF1 (Figure 
39A), suggesting that reduction of Psf1 below a certain threshold is incompatible with cell 
survival. Indeed, the level of Psf1 down-regulation may affect the choice between cell 
death and cell cycle delay, as a critical level of Psf1 may be sufficient to enable cell 
survival in spite of slower replication events. 
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FIGURE 39. Psf1 down-regulation affects progression through S-phase  
 
 
 
Psf1 depletion by siRNA against the ORF (siPsf1 #1) or the 3’-UTR (siPsf1 #2) in U2OS. WB shows 
good depletion using siPsf1 #2 and no changes in MCM7 levels (A). FACS analysis of siPsf1 (#2) and 
siLuciferase (siLuc) before and after UV irradiation (5 J/m2; B). A graphical representation of the 
number of cells in sub-G1 (cell debris), G1, S and G2/M for each treatment are shown in panel C.  
 
To monitor how cells knocked-down for Psf1 behaved in the presence of DNA damaging 
agents, I compared cell cycle progression of siPFS1 or siLuciferase cells treated with 5 
J/m2 of UV. Treatment with UV on its own caused S-phase delay, similarly to siPFS1 
alone. This suggests that 5 J/m2 of UV light cause enough photoproducts to slow down 
replication fork progression similarly to depletion of Psf1. Yet, UV treatment caused more 
cells to accumulate in G2 and less to re-enter G1, suggesting that UV also causes 
checkpoint activation at the G1/S and G2/M boundaries (Figure 39B and 39C); thus, UV 
impacts on all cell cycle stages, whereas Psf1 specifically acts in S-phase. These data are in 
agreement with the epistatic requirements for replication initiation. Loss of MCM, an 
essential component of the pre-RC complex, arrests cells in G1 and prevents entry into S-
phase. On the other hand, reduction of the GINS complex, loaded upon the G1/S transition 
onto the pre-IC complex, does support entry into S-phase but hamper replication fork 
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elongation and replisome activity. Interestingly, combination of siPFS1 and UV gave a 
decrease in G1 compared to siPFS1 alone, inferring that UV robustly activates the G2/M in 
a Psf1-independent manner. Moreover, S-phase index was also slightly increased (Figure 
39B and 39C), indicating that the residual DNA synthesis in siPFS1 is further slowed 
down by the presence of UV-induced photoproducts.  
 
I also monitored how siPsf1 might affect the level of DDR and replication proteins, in the 
presence or absence of UV. ATM, ATR, MCM7, DDB1, DDB2 and p53 levels were 
unchanged (Figure 39A, 40 and data not shown). However, the levels of other GINS 
subunits, including Psf2 and Sld5, were decreased accordingly to Psf1 down-regulation 
(Figure 40), indicating that full length Psf1 is essential for the stability of the complex. 
Thus, reduction in one GINS subunit triggers destabilization and proteosomal degradation 
of the whole complex or leads to inhibition of GINS transcription. 
 
FIGURE 40. Down-regulation of PSF1 by siRNA causes reduction in protein 
level of other GINS subunits  
 
 
 
Protein levels of DDB1 are unchanged. Treatment with 5 J/m2 of UV does not affect the endogenous 
proteins level of Psf1, Psf2, Sld5 and DDB1.  
 
Next, I wanted to investigate the localization of the GINS complex in U2OS cells using 
antibodies raised against human Psf1 (Figure 41).  
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FIGURE 41. Localization of human Psf1 is altered by DNA damage following irradiation
Immunouorescence analysis of Psf1 in human U2OS cancer cells.  Psf1, stained in green, was co-stained  with  MCM7,  
part of  the  MCM  ring,  or RPA,  staining single stranded DNA regions. Psf1 pan nuclear patter, which co-localize with MCM 
and RPA, and is altered following irradiation with 5 Gy of IR, when the pan-nuclear staining diminish. Psf1 speckles are 
largely excluded from MCM staining. After pre-extraction, Psf1 speckles persisted, indicating staining of chromatin-bound 
proteins. Psf1 also localizes to the mid-body in late mitosis.
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Immunofluorescence analyses revealed that Psf1 has a diffused nuclear pattern, with few 
brighter discretely-staining regions. Psf1 nuclear aggregates were retained following CSK 
pre-extraction (Figure 41), suggesting that these nuclear aggregates contain chromatin-
bound Psf1. However, these Psf1 nuclear aggregates do not effectively co-localize with the 
MCM7 subunit of the MCM helicase, or RPA-marked ssDNA at the replication fork. Thus, 
Psf1 nuclear aggregates may represent regions other than the replication origins or active 
replisomes. Strikingly, irradiation caused an alteration in Psf1 staining, with a decrease in 
pan-nuclear fluorescent intensity, yet persistence of brightly-stained regions (Figure 41). 
This suggests that Psf1 may be degraded, although no evidence for this was found by 
western blotting (Figure 38), or, more likely, may be re-localized after IR. MCM and RPA 
staining remain unperturbed by the presence of DNA damage. This change in Psf1 nuclear 
pattern occurs selectively following irradiation, as treatment with UV rays did not cause 
obvious changes in Psf1 staining. In addition, Psf1 staining was reproducibly observed on 
the spindle midzone in the mitotic structure of the midbody during late mitosis, suggesting 
that the GINS complex may indeed play a role in cytokinesis and in promoting mitotic exit.  
 
Collectively, these data show that Psf1 is required for S-phase progression and, ultimately, 
for cell proliferation and viability. Reduction in Psf1 causes a reduction in the level of 
other GINS subunits, leading to delayed replication, suggesting that the role of GINS in 
replication is conserved in higher eukaryotes. Finally, GINS staining was found to be 
altered following irradiation of human cancer cells, suggesting that perturbation of cellular 
metabolism following DNA damage impacts on Psf1 localization and, possibly, 
interactions with other replisome components.  
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4.5 A C-terminal motif of Psf1 is essential for the GINS complex activity in 
Saccharomyces cerevisiae 
4.5.I Analysis of the conserved SQ motif at the C-terminus of Psf1 
 
 
To further investigate the role of the Psf1 C-terminus conserved SQXF motif, I adopted the 
budding yeast S. cerevisiae as model organism. The SQ site of Psf1 C-terminus is present 
in S. cerevisiae (Figure 31A) and is highly conserved in fungi (Figure 42).  
 
FIGURE 42. Conservation of fungal Psf1 carboxyl terminus and SQFF motif 
 
 
 
ClustalW alignments of S. cerevisiae Psf1 protein sequences with those of other fungi from the 
Saccharomyces Genome Database (SGD) website (http://www.yeastgenome.org). The alignment 
shows a striking conservation of the C-terminus (147 to end, enlarged panel on the right), 
corresponding to the GINS functional interface identified by Kamada et al., 2007. The SQXF motif is 
highly conserved and corresponds to a SQFF motif in fungi (red box), where the serine is S187. 
 
4.5.II Analysis of S. cerevisiae psf1 null and ‘SQ’ motif mutant strains  
 
 
I constructed a diploid W303 wild-type (W303A, RAD5) strain heterozygous for PSF1 
gene deletion. After sporulation and dissection, haploid spores lacking the chromosomal 
copy of PSF1 gene could not germinate (Figure 43A). Thus, as previously shown and 
similarly to mammalian cells, deletion of PSF1 in budding yeast is lethal. Lethality caused 
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by deletion of PSF1 was reversed by expressing a plasmid copy of PSF1 cDNA prior to 
sporulation, which allowed haploid spores to grow normally (Figure 43B). 
   
FIGURE 43. Yeast psf1 deletion mutant is unviable and lethality is rescued by a 
plasmid copy of PSF1 cDNA  
 
 
 
Psf1Δ haploid strain is dead, as only spores containing a chromosomal copy of PSF1 survived and 
grew on plate (A). Lethality is rescued by expression of PSF1-3HA plasmid; only yeast containing 
either a chromosomal copy or a plasmid copy of PSF1 survived and grew similarly on plate (B).  
 
To examine the function of the Psf1 SQ motif, I employed a method called the plasmid 
shuffle technique (see Methods 2.11.V and Figure 44B). I performed site-directed 
mutagenesis to obtain a single amino acid substitution of Psf1 serine 187 to a phospho-
deficient alanine (Psf1S187A) or to a phospho-mimicking glutamic acid (Psf1S187E). Haploid 
psf1Δ strains expressing URA3 plasmids containing wild-type PSF1 were transformed with 
HIS3 plasmids expressing psf1-S187A, psf1-S187E or PSF1. When plated on 5-FOA, 
expression of either PSF1-HIS3 or psf1-S187A-HIS3, but not PSF1-URA3 containing 
strain, conferred growth on 5-FOA-containing medium and rescued the lethality of PSF1 
chromosomal deletion (Figure 44C). psf1-S187E was lethal (Figure 44C), indicating that 
the phospho-mimicking mutant of psf1 is unable to rescue the PSF1 null lethality. 
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FIGURE 44. Yeast psf1Δ  strain complementation experiments with psf1-S187A 
and psf1-S187E and analysis by plasmid shuffle technique 
 
 
 
Psf1Δ expressing Psf1S187A, but not Psf1S187E protein, displayed four surviving tetrad following micro-
dissections of diploid psf1Δ cells (A). The plasmid shuffle technique was used where diploid psf1Δ 
heterozygous strain (1) is transformed with a URA3 plasmid expressing PSF1 (2). Diploid yeasts were 
sporulated and haploid spores were microdissected and selected for spores that contained the PSF1-
URA3 vector and lacked the chromosomal copy of PSF1 (3). These haploid yeasts were transformed 
with HIS3 selectable marker plasmids encoding for wild-type Psf1, Psf1S187A or Psf1S187E (4), and were 
then plated on 5-FOA-containing medium to kill URA3-containing strains (C).   
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4.5.III Analysis of the psf1-S187A mutant   
 
Next, I went on to characterize functional aspects of psf1 deletion mutant expressing 
Psf1S187A protein under challenged conditions. psf1-S187A strain grew like wild-type yeast 
on YPAD and showed no overt sensitivity in response to a range of genotoxic agents, 
including IR, UV, MMS, HU, the UV-mimetic drug 4NQO and phleomycin (Figure 45), 
suggesting that the site is not involved in responses to DNA damage, yet it may be a 
pivotal site for DNA replication, given psf1-S187E lethality.  
 
FIGURE 45. Spot test for psf1-S187A colony formation upon treatment with 
DNA damaging agents 
 
 
 
 
psf1-S187A is not sensitive to DNA damage. W303 (WT), mec1Δ and psf1Δ strain expressing WT 
Psf1 (psf1Δ Psf1) or Psf1 S187A mutant (psf1Δ Psf1-A) were grown overnight, diluted to an OD600nm 
of 0.5 before dilutions (10-fold) were spotted on YPAD alone or on YPAD containing the indicated 
drug.  
 
4.5.IV Analysis of psf1-S187A and psf1-S187E mutants in a psf1-1 strain 
 
To characterize the role of the C-terminus S187 site, I used a psf1-1 thermosensitive 
mutant strain, isolated by Hiro Araki and colleagues (Takayama et al., 2003). Plasmids 
containing HIS3 selectable marker expressing psf1-S187A, psf1-S187E, wild-type PSF1 or 
an empty vector were introduced into psf1-1 and grown in THULL synthetic medium to 
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select for the HIS3 marker. At 37°C, the restrictive temperature, both psf1-1 expressing 
empty vector and psf1-S187E cells were dead, due to complete depletion of endogenous 
Psf1 at this temperature. All other strains grew similarly under these conditions (Figure 
46A and 46D). This finding corroborates previous data using the plasmid shuffle method, 
indicating that S187E single amino acid mutation in Psf1 is lethal. Interestingly, at the 
permissive temperature of 23°C, only psf1-1 expressing Psf1S187E protein showed a mild 
growth defect (Figure 46C and 46D). At the semi-permissive temperature of 30°C, when 
levels of endogenous Psf1 are partially reduced, psf1-1 cells transformed with the empty 
vector showed a mild growth defect, whereas those transformed with psf1-S187E showed 
considerable growth impairment (Figure 46D), suggesting this mutant may behave as a 
dominant negative. Importantly, wild-type Psf1, Psf1S187A and Psf1S187E proteins were 
expressed to the same level in the psf1-1 strain (Figure 46C). This indicates that the 
phospho-mimicking mutation does not destabilize Psf1 and that lethality caused by 
Psf1S187E expression is not due to protein’s absence or lowered expression levels. In 
addition, Psf1S187E mutant protein is unlikely to cause a problem in the GINS complex’s 
assembly and stability, as several lines of evidence have reported that truncation of the last 
50 amino acids in the C-terminus of Xenopus and yeast Psf1 leads to formation of a stable, 
yet inactive, GINS complex (Chang et al., 2007; Kamada et al., 2007).   
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FIGURE 46. Lethality of Psf1S187E in the psf1-1 mutant strain   
 
 
 
Psf1-1 expressing empty vector (-), PSF1, psf1-S187A or psf1-S187E were plated on selection 
medium lacking histidine (-THULL) for 3 days. At 23°C, colonies grew on plate for all strains. At 
restrictive temperature (37°C), psf1-1 expressing empty vector or Psf1-E mutant (S187E) showed very 
little growth (A). TCA preps for western blotting of HA-tagged Psf1, Psf1S187A or Psf1 S187E proteins 
expressed from a single-copy plasmid. MCM2 was used as loading control. Asterisks indicate cross-
reacting band. The third panel from the top is a higher-exposure of the second panel (B). Psf1-1 
strains were grown to saturation into 10 ml selection medium, diluted to an OD600nm of 0.06 and grown 
to an OD600nm of 0.3 at 23°C. Cultures were then re-diluted to an OD600nm of 0.06 and the absorbance 
measured every hour for five hours (C). The indicated strains were grown overnight, diluted to an 
OD600nm of 0.5 before 10-fold dilutions were spotted on selection medium and grown at the indicated 
temperature for 3 days (D). 
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I then repeated the sensitivity assay using psf1-1 mutant strains to assess Psf1S187E 
functional relevance in the presence of genotoxic agents. At permissive temperature, 
Psf1S187E showed overt sensitivity to phleomycin and HU (Figure 47), suggesting that this 
mutant may disrupt Psf1 regulation under challenged conditions. At 30°C, psf1-S187E, but 
not psf1-1, was sensitive to irradiation, to a similar extent as rad9Δ strain. As Rad9 
controls activation of DNA damage checkpoints in S. cerevisiae (Weinert and Hartwell, 
1988), rad9 null mutant is hyper-sensitive to DNA-damaging agents (Weinert and 
Hartwell, 1990) and was used as a positive control in this experiment. In addition, both 
psf1-1 and psf1-S187E resulted sensitive to phleomycin and HU, with Psf1S187E displaying 
additional sensitivity compared to the psf1-1 strain (Figure 47). These data suggest that the 
growth defect phenotype caused by reduced levels of wild-type Psf1 protein at semi-
permissive temperature is exacerbated upon exposure to DNA breaks and replication stress 
induced by phleomycin and HU, respectively. In addition, the Psf1S187E mutant protein 
works in an antagonistic manner to the residual expression of endogenous Psf1 and shows 
additional sensitivity upon exposure to phleomycin, HU and also IR. At the restrictive 
temperature, death of the psf1-1 strain is fully rescued by plasmid expression of wild-type 
Psf1 and Psf1S187A mutant proteins (Figure 47). Strikingly, and in accord with my previous 
data obtained with the plasmid shuffle system, the Psf1S187A mutant protein behaves like a 
wild-type protein, displaying no sensitivity to DNA damaging agents (Figure 47). 
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FIGURE 47. Psf1-S187E displays hyper-sensitivity to specific DNA damaging 
agents, whereas psf1-S187A behaves like a wild-type strain 
  
 
 
  
Psf1-S187E is sensitive to irradiation, phleomycin and HU treatments. The indicated strains were 
grown overnight, diluted to an OD600nm of 0.5 before dilutions (10-fold) were spotted on selection 
medium containing the indicated drugs and grown at the indicated temperature for 3 days. 
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To gain additional insight into the molecular activity of Psf1 mutant proteins, I monitored 
their ability to progress into S-phase in the presence of the DSB-inducing agent 
phleomycin at 30°C. FACS of cells released from α-factor G1 arrest was used to monitor 
entry and progression through S-phase and advancement into the cell cycle for up to 200 
minutes post-release. In addition, immunoblot monitored activation of Rad53 by the 
appearance of a phospho-dependent upper band upon treatment with DNA damage. Rad53 
was shifted in all samples pre-treated with phleomycin, indicating that lowering of Psf1 
wild-type levels, or expression of mutant Psf1S187A and Psf1S187E proteins per se did not 
induce a Rad53-dependent checkpoint activation. Similar levels of Rad53 activation were 
observed across all damaged samples, indicating that activation of Rad53 is proficient in 
these yeast strains. This observation is supported by FACS data, where all strains remained 
arrested upon release from α-factor into 5 µg/ml phleomycin, indicating robust activation 
of the DNA damage checkpoint. FACS profiles of asynchronous cells at semi-permissive 
temperature, however, showed that expression of Psf1S187E caused cells to accumulate in S-
phase in the absence of DNA damage, inferring a role for this site in replication.  
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FIGURE 48. Proficient Rad53 phosphorylation and activation of the G1/S 
checkpoint in psf1 mutant strains 
 
 
 
Psf1-1 strains containing PSF1, psf1-S187A, psf1-S187E or empty vector were grown logarithmically 
into selection medium at the permissive temperature of 23°C and arrested into α-factor for 2 hours. 
Once yeast cells were synchronized in G1, the temperature was shifted to 30°C (semi-permissive) and 
kept into α -factor for an additional hour. Half of the cultures were then treated with phleomycin (5 
µg/ml) for 1 hour, in the presence of α-factor. α-factor and phleomycin were then washed out and cells 
were allowed to progress into S-phase at 30°C. Samples were collected for FACS and immunoblot 
analyses for up to 3 hours. Both failed progression into S-phase by FACS and continued Rad53 
phosphorylation show that the G1/S checkpoint is induced and maintained in the timeframe analysed 
in all strains.  
 
Next, I attempted to verify Psf1 and mutant proteins’ ability to bind to the MCM helicase. 
To this end, I took advantage of protocols for yeast lysates provided by Karim Labib’s 
laboratory, including the yeast ‘spaghetti’ or popcorn technique using liquid nitrogen 
(Gambus et al., 2006) and benzonase extracts (Gambus et al., 2009) and performed IP 
experiments using asynchronous as well as synchronous S-phase population. Although all 
Psf1 constructs expressed equally and the HA-tagged proteins were IP-ed to the same 
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level, no interaction with MCM2 subunit of the MCM ring was observed. The reverse IP, 
using antibodies against MCM2 to IP for Psf1, also showed no detectable binding (Figure 
49). I cannot exclude that the N-terminal HA-tag may interfere with binding to MCM, 
hindering the interactions.  
 
FIGURE 49. HA-Psf1 does not co-IP MCM2 subunit of the MCM complex  
 
 
 
 
W303 strain expressing wild-type Psf1, Psf1S187A (Psf1-A) and Psf1S187E (Psf1-E) proteins were 
synchronized in G1, released into fresh medium for 20 minutes to synchronize them in S-phase and 
harvested. Cell extracts were used for co-IP experiments using HA or scMCM2 antibodies. The 
asterisk marks the light chains of the IgG due to antibody cross-reaction. 
  
4.5.V Psf1-S187E is a dominant negative mutant in budding yeast 
 
The observations collected using psf1-1 mutant strain suggest that psf1-S187E may behave 
as a dominant negative mutant of Psf1. To test this hypothesis, I used W303 wild-type 
strains expressing PSF1, psf1-S187A, psf1-S187E and compared their growth curves and 
cell cycle progression from G1 arrest. As expected, expression of Psf1S187E mutant protein 
showed a slower growth phenotype under unperturbed conditions and is further slowed-
down by addition of HU, despite the presence of endogenous Psf1 (Figure 50A and 50B). 
This infers that Psf1S187E protein is a dominant negative mutant. In addition, psf1-S187E 
mutant strain displayed a mild defect in progressing into S-phase 15 minutes after α-factor 
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release, a delay in S-phase and in progressing into G2/M in the presence of HU (Figure 
50C; 150 minutes time-point), indicating that problems caused by this mutant in S-phase 
are exacerbated under conditions of replicative stress possibly due to the presence of 
unreplicated DNA. 
 
FIGURE 50. Psf1-S187E is a dominant negative mutant of yeast PSF1 
 
 
 
WT W303 stains, containing PSF1, psf1-S187A, psf1-S187E or empty vectors were grown 
logarithmically into selection medium and arrested into α -factor for 2 hours. Once yeast cells were 
synchronized in G1, they were released from the α -factor block into fresh medium or medium 
containing HU (100 mM). Samples were collected for growth curve assays (A and B) and FACS (C) 
for ~3 hours. Growth curves show that expression of psf1-S187E in W303 cause a delay in cell growth 
(green line; A) and this is further reduced in the presence of HU (grey line; B), suggesting that 
Psf1S187E is a dominant negative mutant of Psf1. 
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4.5.VI A multicopy suppressor screening of psf1-S187E lethality 
 
To gain more insight into the functional significance of the lethality of the psf1-S187E 
mutant strain, I screened a genomic library for multicopy suppressor genes. The LEU2-
based library was transformed in psf1-1 mutant strain expressing Psf1S187E protein. 
Transformants were plated on large YPAD plates and grown at the restrictive temperature 
of 37°C for three days. Plating of 1/100th of yeast transformants selected for LEU2 marker 
gene-containing colonies indicated that about 300,000 transformants could be obtained 
from the screen (Figure 51A). Considering that S. cerevisiae genome contains a total of 
about 6,000 genes, the genomic library was made up of numerous copies for each gene.  
 
150 colonies grew at 37°C, they were picked and re-plated in medium to select for the 
presence of HIS3 and LEU2 genes and grown at 37°C overnight (Figure 51B). Genomic 
DNA was obtained from each colony and transformed in bacteria to isolate the plasmids 
containing library DNA. Sequence analysis revealed that the colonies contained PSF1, 
validating the screen. However, no additional genes were identified. Considering that PSF3 
was identified by screening for a multicopy suppressor of psf1-1, it is evident that over-
expression of other GINS subunits is not sufficient to suppress the dominant negative 
phenotype of psf1-S187E mutant and the only suppressor of this mutant is PSF1 gene 
itself. These data further emphasize the central and unique role for this Psf1 C-terminus 
motif in replication and cell viability. 
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FIGURE 51. Screen for suppressors of psf1-S187E mutant lethality at 37°C 
  
 
 
A LEU2-based multicopy suppressor genomic DNA library was transformed in psf1-1 mutant strain 
expressing Psf1S187E protein. . 1/100th of yeast transformants were plated on LEU2- selection medium 
at 37°C (A). 150 colonies formed at 37°C and were re-plated in HIS3 and LEU2 selection medium and 
grown at 37°C overnight (B). Sequencing of plasmid DNA from colonies revealed presence of PSF1 
gene. 
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4.5.VII Phosphorylation of Psf1 SQXF motif in S. cerevisiae 
 
To assess whether S187 site in S. cerevisiae Psf1 was a bona fide phosphorylation site in 
vivo, I performed large-scale purification of TAP-tagged Psf1 following three hours 
incubation with 100 mM HU, to increase the S-phase population (Gao et al., 1995). 
Purified Psf1 was eluted, run by SDS-PAGE and identified by coomassie staining. Psf1 
was subjected to phospho-peptide mapping using liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) at the University at Albany mass spectrometry facility. Under 
non-stringent conditions, Psf1 protein sequence was fully covered and 16 phosphorylation 
sites of the 20 potential serine/threonine phospho-sites were found to be phosphorylated 
(Figure 52). 
 
FIGURE 52. Yeast Psf1 phosphorylation sites upon incubation with HU 
 
 
Phospho-peptide mapping by LC-MS/MS identified 16 potential in vivo phosphorylation sites in Psf1. 
Amongst the 16 sites, the C-terminal conserved S187 (in bold) within the SQXF motif was 
phosphorylated.  
 
The ion score is a -10*Log(P), where P is the probability that the observed match is a 
random event. Individual ions scores ≤ 3 indicate identity or extensive homology with the 
suggested modification (p<0.05). S187 phosphorylation emerged with an ions score of 3. 
Other phospho-sites with a significant ion score were T139 (ion score 5) and T51 (ion 
score 4). However, these sites are just above or on the threshold of the 95% confidence 
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interval, suggesting that there may be a margin of error as to whether the detected 
phosphorylation occurs in vivo. In addition, no phosphorylation sites were identified by 
phospho-peptide mapping under stringent conditions.  
 
4.5.VIII Identification of Psf1 interacting partners in budding yeast 
 
At the beginning of this study, scarce data existed on Psf1 binding partners in budding 
yeast. To identify novel binding partners of Psf1 in S-phase, I performed affinity capture-
MS interaction studies using TAP-tagged Psf1 purified from yeast extracts treated with 
HU, similarly to the phospho-peptide mapping analysis. Interaction partners were 
identified by MS/MS. Psf1, Sld5 and Psf3 were all found to associate with purified Psf1, 
suggesting that TAP-tagged Psf1 is proficiently incorporated in the GINS complex (Table 
9 and Figure 53). As for the IP experiments (Figure 49), no MCM binding was detected 
under these conditions. However, novel binding partners of full-length Psf1 were 
identified: Rps3, Rpl9a, L19, Rps7b, Ctf4 and Stm1 (Table 9 and Figure 53).  
 
TABLE 9. Proteins interacting with full length Psf1  
 
Serial 
# 
Protein name Gi # Identified 
peptide 
Coverage 
(%) 
1 (a) Sld5 [Saccharomyces cerevisiae] 6320697 14 54 
1 (b) Stm1 [Saccharomyces cerevisiae] 6323179 5 23 
2 (a) Psf1 [Saccharomyces cerevisiae] 6320216 11 48 
2 (b) Rps3 [Saccharomyces cerevisiae] 6324151 9 44 
3 Ctf4 [Saccharomyces cerevisiae] 6325393 5 7 
4 Ctf4 [Saccharomyces cerevisiae] 6325393 9 13 
5 (a) Rpl9a / Rpl19b [Saccharomyces 
cerevisiae] 
6321291/ 
6319444 
3 20 
5 (b) Ribosomal protein L19 [S. cerevisiae] 602897 2 11 
5 (c) Rps7b [Saccharomyces cerevisiae] 6324233 1 8 
5 (d) Psf3 / orf6 [Saccharomyces cerevisiae] 37362690/ 
886950 
1 11 
6 Ctf4 [Saccharomyces cerevisiae] 6325393 1 3 
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FIGURE 53. Factors interacting with full-length Psf1 upon incubation with HU 
in S. cerevisiae 
 
 
 
 
TAP-Psf1 yeasts were cultured in 100 mM HU for 2 hours. Purified Psf1 was pulled-down and 
samples from the various elution steps were visualized on silver stained-gel. The indicated bands 
(asterisk) were cut and sent for MS/MS to identify Psf1 binding partners (numbered): GINS complex 
subunits Psf2, Sld5 and Psf3, and Psf1 itself, Stm1, Ctf4 and numerous ribosomal proteins were 
identified.  
 
 
Collectively, the data shown in this chapter provide a preliminary assessment of Psf1 C-
terminal SQXF motif in human and yeast cells. My observations suggest that the conserved 
serine site is important for replication in budding yeast, and may also be regulated in 
presence of replicative stress and DNA damage. 
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4.6 Discussion and conclusion 
4.6.I Conserved SQXF motif on human Psf1 binds to the UV-DDB complex 
 
In this study, I analyzed a possible role for Psf1 in the DDR. The functional activity of 
GINS in coordinating DNA synthesis and unwinding makes it an appealing target to 
modulate replication in the presence of genotoxic alterations. Indeed, I have found that 
Psf1 and Psf2 GINS subunits contain an evolutionarily conserved SQXF motif at the 
carboxyl end, which conforms to the consensus target site for PIKK-dependent 
phosphorylation following DNA damage.  
 
Interaction analyses of Psf1 C-terminus domain revealed binding to DDB1 in vitro. 
Binding to DDB1 and DDB2 (UV-DDB complex) were also confirmed using full-length 
recombinant Psf1. The interaction data showed no difference in the ability of DDB1 and 
DDB2 to bind Psf1when the serine was mutated to an alanine or to a glutamic acid, 
indicating that the binding interface between Psf1 and UV-DDB may be outside of the SQ 
site and it may not be regulated by phosphorylation events. However, the pull-down data 
using synthetic peptides showed robust interactions when S173 was phosphorylated and 
the phenylalanine amino acid in the +3 position was mutated (F176A), suggesting that not 
only the SQ site, but also the surrounding amino acids, represented a binding interface and 
affect stability of interactions with DDB1. Indeed, Kamada et al. (2007) suggested that the 
binding interface of Psf1 C-terminus might reside in the conserved phenylalanine residue 
(F176), which is exposed on the peripheral surface of the complex (Diagram 12). Mutation 
of Psf1 F176 to alanine resulted in a substantially lower replication activity compared to 
the wild-type complex (Kamada et al., 2007). In light of my observations, where mutation 
of this same residue in the Psf1 phospho-S173, F176A peptide caused stronger association 
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of Psf1 to DDB1, this conserved hydrophobic residue on Psf1 C-terminus may be 
negatively regulating binding to DDB1, suggesting that DDB1 may reduce replication 
activity.  
 
DIAGRAM 12. Highly conserved, exposed phenylalanine 176 on Psf1 may 
regulate interaction with DDB1  
 
Structural model of the C-terminus (B-domain) of Psf1. The B-domain is outlined as a grey area in the 
GINS complex structure and is enlarged as a grey globular α-carbon trace with transparent molecular 
surface. Yellow regions are predicted internal hydrophobic and pink regions are exposed aromatic 
residues, including Phe176 (red arrow). 
Image modified from Kamada et al., 2007 
 
The DNA damage binding UV-DDB complex – comprising DDB1 and DDB2 – is 
involved in repair of UV radiation photoproducts by nucleotide excision repair (NER) and 
is found mutated in the Xeroderma pigmentosum group E. Xeroderma pigmentosum is an 
autosomal recessive genetic disease characterized by hyper-sensitivity to UV light due to 
inability to perform NER. In addition to the DDB dimer, DDB1 and DDB2 are found 
associated with Cullin4 and ROC1 in an ubiquitin ligase complex activated in response to 
DNA damage (Groisman et al., 2003; Wang et al., 2006). The role of DDB1-CUL4A-
ROC1 ubiquitin ligase in regulating the replication-licensing factor Cdt1 in response to 
DNA damage directly links DDB1 to controlling replication (Higa et al., 2003; Hu et al., 
2004). DDB1 was shown to directly bind to Cdt1 enabling its proteosomal degradation 
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following UV damage in S-phase. Recent data shows that PCNA is an essential cofactor in 
this process (Hu et al., 2004). GINS was recently shown to co-localize with PCNA on 
extended chromatin fibres (Cohen et al., 2009) and had been previously suggested to 
function in a similar fashion to the trimeric polymerase-accessory-ring PCNA, as a ‘sliding 
clamp’ for DNA polymerase ε (Aparicio et al., 2006), thus GINS binding to UV-DDB may 
follow a similar mechanism of action. It is tempting to speculate that Psf1 phosphorylation 
following DNA damage promotes DDB1 binding leading to replication inhibition; F176 
antagonize the binding, to promote resumption of DNA synthesis. Based on my data, 
which do not show reduction in Psf1 levels after treatment with diverse DNA damaging 
agents, it is unlikely that DDB1 targets the GINS complex for proteosomal-mediated 
degradation. However, similarly to PCNA, GINS may serve to bridge the ubiquitin ligase 
to substrates such as Cdt1, yet no direct interaction between Psf1 and Cdt1 was found by 
co-IP in human cells (data not shown). It would also be interesting to investigate the 
potential interactions between Psf1 and Cullin4A and Roc1, but commercially available 
antibodies against these proteins have proven to be non-specific and gave very high back-
ground signal (data not shown). 
 
DDB2 role in connection with DDB1-CUL4A is unclear.  DDB2 is likely to be a substrate 
of the DDB1-CUL4A ligase (Nag et al., 2001), as treatment with UV induces its 
degradation and loss of DDB2 did not affect the catalyses of poly-ubiquitylation and 
proteosomal degradation of other substrates (Hu et al., 2004). On the other hand, DDB2 
may associate with a subset of ubiquitin ligases, mediating substrate specificity and 
differential responses (Groisman et al., 2003). My data showing Psf1 binding to both 
DDB1 and DDB2 would be consistent with and favour the latter hypothesis.    
To understand these interactions is especially interesting in light of findings showing that 
the C-terminal domain of Psf1 (aa 140-196) is the most exposed part of the complex and 
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“is crucial for chromatin binding and replication activity”. Thus,“the core GINS complex 
ensures a stable platform for the C-terminal domain of Psf1 to act as a key interaction 
interface for other proteins in the replication-initiation process” (Kamada et al., 2007). 
However, the exact significance of Psf1 interaction with DDB1 and DDB2 remains to be 
established. In all Psf1 pull-downs, I noticed that only a small percentage of DDB1 total 
input was pulled-down, suggesting that interactions between these factors may be very 
transient or present in only a small subset of cells due to cell cycle regulations. To this end, 
I did not observe interactions between these proteins in immunoprecipitation experiments. 
Perhaps, the interaction is limited to a short time window during the cell cycle in vivo, and 
in vitro pull-downs bypass this regulation.  
 
No data currently exist with regard to post-translational modifications that regulate Psf1 
activity and interactions. Despite extensive efforts to demonstrate phosphorylation of the 
SQ motif at Psf1 C-terminus, this point remains to be addressed. Psf1, however, displayed 
a mobility shift following treatment with DNA damaging agents in vivo, indicative of 
phosphorylation. Given the striking conservation of this motif and the location within the 
functional interface of the GINS complex, it would be extremely interesting to establish 
whether this evolutionarily conserved site is post-translationally modified.  
 
4.6.II Physiological roles for Psf1 in cell cycle progression in human cells 
 
The role of the mammalian GINS complex had yet to be addressed at the beginning of this 
study. Additionally to investigations of Psf1 C-terminus, I identified a role for human Psf1 
in enabling cell cycle progression through S-phase, in turn affecting cell proliferation and 
viability. During the course of this study, two other groups also reported similar analysis of 
the human GINS complex, including analogous cell cycle phenotypes following down-
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regulation of GINS subunits (Aparicio et al., 2009; Barkley et al., 2009). Barkley and 
colleagues (2009) also showed activation of the checkpoint kinase Chk2 by ATM-
dependent phosphorylation on T68 and increase in γH2AX signal and foci after siPsf1/2 
(Barkley et al., 2009). This observation may explain the delay in S-phase progression of 
siPFS1 cells, possibly due to triggering of the intra-S-phase checkpoint.  
 
After observing a cell cycle progression defect in Psf1 down-regulated cells, the next 
logical step was to examine whether the level of other GINS complex subunits and other 
replication fork-associated factors was affected by Psf1 depletion. Down-regulation of 
PSF1 resulted in lowered expression of the other GINS complex subunits, likely as a result 
of transcriptional repression and/or proteolytic degradation of existing GINS complexes. It 
has been proposed that proliferation inhibition leads to a decrease in protein levels of DNA 
replication factors Cdc6, MCM and Cdc45 (Aparicio et al., 2009). Interestingly, I observed 
no obvious changes in the levels of other proteins, including human MCM ring subunit 
MCM7. My observations favour the hypothesis that the GINS complex stabilization is 
promoted by the presence of optimal levels of all subunits to prevent proteolytic 
degradation, rather than a global regulation of the replication-associated transcriptional 
program. 
 
Immunofluorescence analysis of Psf1 revealing a change in nuclear patterning was after IR 
but not UV. UV radiation induces the formation of DNA photoproducts that links adjacent 
pyrimidines, including cyclobutane pyrimidine dimers (Lober and Kittler, 1977) and 
pyrimidine-pyrimidone (6-4) products (Mizukoshi et al., 2001), that block polymerase 
progression, causing accumulation of ssDNA and checkpoint activation. IR, on the other 
hand, is a potent DNA damaging agent that causes single strand breaks and base damage 
on multiple sites by creation of oxygen radicals (Friedberg et al., 2006), often leading to 
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collapsed forks. A global change in Psf1 staining might be due to the replication fork 
collapsing at several sites across the genome, rather than a transient stalling of the fork that 
meets UV photoproducts. It would be interesting to further investigate the underlying 
reason for this IR-dependent re-localization of Psf1 and how this may be regulated by post-
translational modifications or other mechanisms.  
 
In line with recent reports suggesting additional role for the GINS complex outside of S-
phase, I have observed localization of Psf1 on the spindle midbody during mitosis. In Psf3 
mutants, where the recruitment of Cut5 and Sld3 to origins is disrupted, a fraction of cells 
enter mitosis prior to completion of duplication of the genome (Yabuuchi et al., 2006), 
indicating that GINS may be involved in preventing unscheduled cytokinesis and to ensure 
faithful completion of replication. Furthermore, a more direct role for GINS in mediating 
accurate chromosome segregation has been postulated by Huang and colleagues (2005), 
where yeast Psf2 suppresses phenotypic defects in chromosome segregation and spindle 
attachment caused by bir1/cut17 mutation and siPSF2 in human cells causes gross 
chromosomal aberrations (Huang et al., 2005a). Although a direct role for GINS in mitosis 
is yet to be confirmed, the replication licensing factor Cdc6 has been widely associated in 
controlling mitosis and was shown to be involved in monitoring entry into mitosis, 
possibly as a signal of ongoing replication, through a Chk1-dependent checkpoint 
mechanism (Clay-Farrace et al., 2003). Further investigation would be required to assess 
whether GINS plays a similar role in coordinating replication activities with cell cycle 
progression through S-phase and into mitosis by regulation of DNA damage checkpoints 
and other means. 
  
Taken together, the data presented in this chapter show that, in human cells, PSF1 gene 
product is involved in maintaining GINS complex stability and plays a role in DNA 
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replication and cell cycle progression. Moreover, the data showing Psf1 binding to DDB1 
via its C-terminus motif might suggest a mechanism to regulate DNA replication in 
response to DNA damage. However, further studies are required to address many questions 
that remain unanswered, to gain additional information on the role of human GINS during 
cell cycle progression and possible regulations following DNA damage. 
 
4.6.III Psf1 serine 187 is important for cell viability in S. cerevisiae 
 
The function of Psf1 has been extensively studied in budding yeast (reviewed in(MacNeill, 
2010). Here, I show that mutational dysregulation of the conserved S187 at the carboxyl 
end of Psf1 to a glutamic acid (S187E) affects yeast viability. Mutation of S187 to an 
alanine resulted in a wild-type-like protein, which grows and tolerates genotoxic agents 
similarly to the wild-type strain. I uncovered that psf1-S187E mutant is not a functionally 
null allele, but an antimorphic allele enconding for a protein that behaves as a dominant 
negative in yeast cells. The antimorphic effect of Psf1S187E is especially obvious under 
challenged conditions, in the presence of the genotoxic agents HU, phleomycin and IR. 
Hydroxyurea (HU) depletes the dNTPs pool (Krakoff et al., 1968). Because at any given 
time in S-phase there are only enough dNTPs to replicate a fraction of the genome, 
treatment with hydroxyurea results in stalling of the polymerases, but continued 
advancement of the helicase leading to the accumulation of ssDNA and hence activation of 
the replication checkpoint. Therefore, Psf1S187E compromises the cellular metabolism 
during HU-mediated replication stress and fork stalling, as expected given Psf1 essential 
role during DNA synthesis. In addition, Psf1S187E displays additional sensitivity to IR and 
phleomycin, an IR-mimetic antibiotic that, similarly to IR, causes SSBs and DSBs (Povirk, 
1996). These findings suggest that Psf1 is regulated following DSB and this essential 
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regulation is lost when the S187 site is mutated to a negatively charged glutamic acid. 
GINS role in the DDR has been supported by interactions with checkpoint factors like 
Mrc1 and Tof1, where GINS may serve to link these proteins to the MCM helicase, DNA 
polymerase and DNA primase (Moyer et al., 2006). In addition, human Psf2 is 
phosphorylated by ATM/ATR on two SQ/TQ consensus sites at the very carboxyl end of 
the protein (Matsuoka et al., 2007). However, at present, is not known what are the effects 
of these phosphorylations on GINS activity and how these relate to the DDR.  
 
Given the S187 site was found phosphorylated in the phospho-peptide mapping analysis by 
mass spectrometry, it is tempting to speculate that the behaviours of the phospho-
mimicking Psf1S187E and the unphosphorylatable Psf1S187A mutants reflect changes in post-
translational modifications, such as phosphorylation, on this site in vivo. Psf1 essential role 
in replication may be maintained when the site is unphosphorylated and inhibition of 
replication may be modulated by alternative mechanisms under perturbed circumstance 
and at termination sites. When Psf1 becomes phosphorylated at the C-terminus S187 site 
(or constitutively phosphorylated, as in Psf1S187E), its activity in the context of replication 
is impaired, leading to cell death. How Psf1 constitutive inactivation by phosphorylation 
affects DNA damage sensitivity remains unclear. Although Psf1 wild-type and mutant 
proteins were expressed to a similar level, indicating that mutations do not affect protein 
stability, I was unable to verify whether the binding of MCM or other GINS subunits was 
affected by these mutations. It is possible that the residual level of endogenous Psf1 at 
semi-permissive temperature in psf1-1 may be sufficient to retrain a functional activity of 
the complex; on the other hand, Psf1S187E may not get incorporated into the GINS complex, 
phenocopying a psf1Δ background strain. Although I cannot formally exclude the 
possibility that S187E mutation alters the stoichiometry of the GINS complex, 
crystallography data argue against this point (Chang et al., 2007; Kamada et al., 2007). 
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Collectively these data point to a role for Psf1 conserved C-terminal serine in replication 
and regulation after DNA damage, yet the exact functional consequences of S187 
mutational changes remain to be established.  
 
4.6.IV Identification of novel Psf1 binding partners in S. cerevisiae 
 
Finally, I identified novel binding partners of S. cerevisiae Psf1 after treatment with HU. 
Because of the stringent experimental conditions used in this experiment, these factors are 
likely to be directly associated with Psf1. Ctf4, a chromatin-associated protein required for 
sister chromatids cohesion in budding and fission yeast (Hanna et al., 2001; Williams and 
McIntosh, 2002) was found to bind to Psf1. Ctf4 was also shown to interact with DNA 
polymerase alpha (Pol 1), serving as an accessory factor (Formosa and Nittis, 1999) and 
associates with the replisome and with the CMG helicase (Gambus et al., 2006). Ctf4 has 
been recently shown to bind directly to GINS and this interaction persists in the presence 
of up to 900 mM salt (Gambus et al., 2009). These data and my own result indicate that 
Ctf4 binds Psf1 with high affinity, perhaps stronger than binding between GINS and the 
MCM ring, whose interaction may be bridged by Cdc45. 
 
In addition, Psf1 interacts with several ribosome-associated proteins, including Rps3, 
Rpl9a, L19 and Rps7b. Due to their abundance, ribosomal factors were previously 
regarded as non-specific contaminants and discarded from genetic and physical 
interactome screens in S. cerevisiae (Krogan et al., 2006). However, the recurrence of 
certain ribosomes-associated factors in these screens is now shaping into a more obvious 
functional significance in the global landscape of these interactions (Nevan Krogan, 
personal communication). Indeed, a very recent genome-scale genetic map reported 
interaction between PSF1 and RPL16A (Costanzo et al., 2010), indicating that GINS may 
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play a role in linking DNA replication with ribosome biogenesis. The nucleolar protein 
Yph1, required for 60S ribosomal subunit biogenesis, was also found to bind ORC and 
MCM and to be required for S-phase progression (Du and Stillman, 2002). In addition, S. 
pombe homologue of the budding yeast nucleolar complex NOC3, that is involved in 
origin recognition and is loaded to pre-RC complexes (Zhang et al., 2002), was recently 
shown to be essential for cell division and ribosome biogenesis, although it does not seem 
to play a role in replication (Houchens et al., 2008). Stm1, another Psf1-binding factor, is a 
guanine-quadruplex and purine-motif triple-helical-DNA binding protein (Nelson et al., 
2000; Hayashi and Murakami, 2002). Genetically, it interacts with Cdc13 to help preserve 
telomere structure (Hayashi and Murakami, 2002).  Interestingly, recent reports found 
Stm1 to be associated with ribosomes and to regulate ribosomal translation elongation by 
altering association to the eukaryotic elongation factor 3 under nutrient stress (Van Dyke et 
al., 2004; Van Dyke et al., 2006; Van Dyke et al., 2009). This establishes yet another link 
between the GINS complex and ribosome-associated proteins, suggesting that the 
interactions found in this study may have a functional significance in vivo.  
 
Altogether, the data presented provide novel experimental evidences in support of a role 
for the Psf1 C-terminus consensus motif in modulating GINS complex activity and provide 
a starting point to unravel multiple roles of the GINS complex in human and yeast cells. 
 
4.6.V Open questions and future directions 
 
In this chapter, I show that, in human cells, Psf1 is involved in maintaining GINS complex 
stability and plays a role in DNA replication and cell cycle progression. Moreover, the data 
suggests a mechanism for how Psf1 binding to DDB1 via its C-terminus motif may 
regulate DNA replication in response to DNA damage. In S. cerevisiae mutational 
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dysregulation of the conserved C-terminus serine within the SQXF motif of Psf1 leads to 
loss of cell viability, suggesting this site is important for the GINS complex activity. Taken 
together, the results presented here provide a platform for future study of Psf1 carboxyl 
terminus and the GINS complex in the DDR pathways. 
 
However, several questions remain to be addressed. Foremost, deciphering the exact 
molecular functions of the GINS complex at the replication for would be extremely useful 
in furthering our understating of the eukaryotic replication fork and the DNA helicase 
machinery. GINS interactions with MCM and Cdc45, as part of the CMG helicase, as well 
as GINS binding to the DNA polymerases, are evolutionarily conserved in eukaryotes (for 
a comprehensive review, see(MacNeill, 2010). Recent data suggesting that GINS 
preferentially binds to ssDNA (Boskovic et al., 2007) support a model where GINS works 
as a ‘ploughshare’ in the proximity of DNA unwound by the MCM (Takahashi et al., 
2005) and at the intersection with the replication fork, coordinating replicative polymerases 
with the unwinding process. In this regard, more detailed understanding of the GINS 
complex is hindered by our lack of knowledge of the mechanism of the MCM helicase. As 
discussed in chapter 1.2.II, several models have been proposed on how MCM may work as 
a helicase, coordinately with speculative roles for the cofactors GINS and Cdc45. 
However, no definite proof of MCM acting as a helicase during DNA replication has been 
provided as yet. A crystal structure of the CMG unwindosome complex would be helpful 
to clarify a model of activity for this replication machinery and perhaps suggest modes of 
regulating unwinding in the presence of DNA damage.   
 
Moreover, GINS complex is not only a co-factor in DNA unwinding, but also an accessory 
of replicative polymerase ε and the DNA polymerase α-primase complex. Genetic studies 
showed that the processivity and stabilization of these DNA polymerases requires GINS; 
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however, exactly how this is mediated is currently unclear. In addition to GINS roles 
during S-phase, a mitotic role for GINS in maintaining chromosomes integrity during cell 
division has been proposed (Huang et al., 2005a). It would be key to establish whether the 
aberrant mitotic phenotypes observed are caused by GINS functions that are distinct and 
separable from the replication role of GINS during S-phase. As recently alleged, the 
observed mitotic defects may be a consequence of incompletely replicated chromosomes 
undergoing separation (Barkley et al., 2009). Further investigation is required to address 
this point.    
 
GINS functions in vertebrate development and in maintenance of the stem cell pool are just 
beginning to emerge (see chapter 4.2.IV). Psf1 expression is up-regulated in actively 
proliferating tissues and is essential for the initial stages of embryonic development in 
mice (Ueno et al., 2005). It is currently unclear how the role of GINS in promoting 
replication impacts on GINS requirement for physiological development. In addition to the 
role of GINS in normal embryogenesis and tissues preservation, over-expression of GINS 
complex subunits has been recently associated with a wide variety of cancers (Obama et 
al., 2005; Hayashi et al., 2006; Ryu et al., 2007; Nagahama et al., 2010). It remains to be 
determined if GINS aberrant expression directly contributes to malignant transformation. 
Ectopic expression of human MCM has already been widely implicated in induction of 
tumourigenesis (Pruitt et al., 2007; Shima et al., 2007b; Shima et al., 2007a). Importantly, 
MCM is currently being used as a cancer biomarker to stain highly proliferating cells and 
tissues (Coleman and Laskey, 2009). Similarly, GINS expression was recently linked to 
cell proliferation in human cells, where GINS marked more robustly proliferating 
lymphocytes, given a similar pattern to MCM3 protein (Aparicio et al., 2009).  
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Thus, further investigation of GINS in the context of physiological and pathological 
proliferation remains an exciting challenge for future research, with vast medical relevance 
and clinical implications. 
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5 RAD9 CONSENSUS CDK PHOSPHORYLATION SITES 
REGULATE CHK1 ACTIVATION IN BUDDING YEAST  
5.1 Summary  
S. cerevisiae Rad9 is a major checkpoint mediator protein required for Mec1/Tel1-
dependent phosphorylation and activation of Rad53 and Chk1 DNA damage checkpoint 
kinases. Here, I present evidence for the requirement of consensus CDK phospho-sites 
within Rad9 for the effective phosphorylation and activation of Chk1. I found that Rad9, 
which is cell cycle regulated by Cdc28-dependent phosphorylation, contains consensus 
CDK phosphorylation sites within the CAD region at its N-terminus. Mutation of four 
conserved S/TP sites to alanine, but not mutation of these sites individually, confers 
defective Chk1 phosphorylation following treatment with various DNA damaging agents. 
Further investigation suggests that Rad9 regulation via these sites contributes to Chk1 
activation in the intra-S and the M-phase checkpoints.  
 
In addition, identification of conserved CDK sites in a putative CAD region in the human 
and chicken microcephalin proteins suggests that analogous cell cycle regulations mediate 
activation of Chk1 in these systems. I show that scRad9 and hMCPH1 N-termini interact 
with Chk1 in vitro. These data highlight an evolutionarily conserved pattern regulating 
Chk1 binding and activation, possibly through CDK-dependent phosphorylation. Further 
investigations are ongoing to elucidate the mechanisms of Rad9 and MCPH1 binding to 
Chk1 and shed light on a functional relationship between these proteins, which may be 
conserved throughout evolution. To this end, I have produced hybrid constructs swapping 
the Rad9 CAD and N-terminus for those of human and chicken MCPH1, which will be 
used as tools to dissect the evolutionarily conservation of checkpoint activation. 
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5.2 Introduction 
5.2.I Rad9 as the prototypical DNA damage checkpoint adaptor protein  
 
Radiation sensitive 9 (Rad9) is the prototypical DNA damage checkpoint protein in S. 
cerevisiae. The RAD9 gene encodes a protein of 1,309 amino acids with a predicted 
molecular mass of 148 kDa (reviewed in(Toh and Lowndes, 2003). Rad9 contains several 
structural regions with functional relevance for the protein’s activity. At the amino-
terminus is the Chk1 activation domain (CAD;(Blankley and Lydall, 2004) that contains 
several closely-spaced consensus CDK phosphorylation sites. A cluster of 6 (S/T)Q sites 
consensus for Mec1/ATR  and Tel1/ATM phosphorylation are found within the SCD 
(SQ/TQ cluster domain) between amino acids 390 and 457. The carboxyl terminus is 
characterized by a region of interaction with the FHA-domain of Rad53 (Emili, 1998; Sun 
et al., 1998; Vialard et al., 1998), tandem Tudor domains (Lancelot et al., 2007) and twin 
BRCT domains at very end of the protein, for binding to Tel1/Mec1-phosphorylated 
histone H2A (Downs et al., 2000; Hammet et al., 2007) (Diagram 13). The twin BRCTs 
are also required for Rad9 oligomerization in response to DNA damage (Soulier and 
Lowndes, 1999). 
 
DIAGRAM 13. Rad9 protein structural features and domains 
 
Content not visible due to copyright limitations 
 
Rad9 is a large protein with 12 consensus CDK and 14 Mec1/Tel1 phosphorylation sites, indicating 
that Rad9 is regulated in response to DNA damage and during the cell cycle (Vialard et al., 1998). 
Image modified from(Toh and Lowndes, 2003) 
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Despite low sequence conservation, Rad9 shares functional and structural homology with 
S. pombe Crb2, and the mammalian DDR mediator 53BP1. scRad9, spCrb2 and h53BP1 
contain tandem Tudor domains for binding to methylated histones (Huyen et al., 2004; 
Botuyan et al., 2006; Du et al., 2006; Grenon et al., 2007) and twin BRCT motifs at the 
very carboxyl-end. In addition, other twin BRCT-containing DDR mediators MDC1 and 
BRCA1 are also putative Rad9 orthologues in higher eukaryotes. Indeed, like mammalian 
MDC1, Rad9 BRCTs bind to H2A phospho-epitope (Hammet et al., 2007). 
 
Similarly to its aforementioned mammalian counterparts and S. pombe homologue Crb2, 
Rad9 is a DNA damage response factor required for checkpoint responses following DNA 
damage. More than 20 years ago, Weinert and Hartwell identified the RAD9 gene as a 
master regulator of the G2/M cell cycle delay induced upon treatment with IR. In the same 
paper, the term ‘checkpoint’ was coined to describe transient arrests in cell cycle 
progression induced by DNA damage (Weinert and Hartwell, 1988). RAD9 plays a role in 
activation of cell cycle delays induced by DNA damage at the G1/S (Siede et al., 1993; 
Siede et al., 1994), intra-S (Paulovich et al., 1997), as well as G2/M boundaries (Weinert 
and Hartwell, 1989). Given Rad9’s pivotal role in halting cell cycle progression in the 
presence of genotoxic lesions, the rad9 deletion mutant shows high genomic instability and 
hyper-sensitivity to DNA damaging agents (Weinert and Hartwell, 1990).  
 
5.2.II Rad9 mediates activation of the checkpoint kinases 
 
Rad9 functions as an adaptor-like factor to relay the DNA damage signal from the apical 
kinases Mec1 and Tel1 to downstream checkpoint transducer kinases Rad53 (homologue 
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of mammalian Chk2) and Chk1. Upon induction of DNA damage, Mec1 and Tel1 target 
the Rad9 SCD for phosphorylation. Phosphorylated S/TQ sites act redundantly to allow 
docking of Rad53 via its second FHA domain (FHA2). Rad9 is in a large molecular 
complex of about 850 kDa. Conformational changes induced by DNA damage-dependent 
hyper-phosphorylation cause remodelling to a smaller 560 kDa complex. This hyper-
phosphorylated Rad9 is responsible for catalysing in trans auto-phosphorylation and 
activation of Rad53 (Gilbert et al., 2001). Both oligomeric assembly of Rad9 and its 
recruitment and retention to damaged chromatin promote a localized concentration of 
Rad53 to enable its auto-phosphorylation. In addition, Rad9 acts as an adaptor bridge to 
facilitate Mec1 phosphorylation of Rad53 (Sweeney et al., 2005). Efficient 
phosphorylation of Rad53 permits its release from the Rad9 complex (Gilbert et al., 2001). 
Once released, active Rad53 specifically targets substrates required for a variety of cellular 
responses, including checkpoint-induced cell cycle delay to allow for efficient repair of 
DNA lesions.  
 
Although genetic and molecular data have helped to define the association between Rad9 
and Rad53, the mechanistic dynamics of their interactions are still unclear. Three models 
have been proposed that attempt to explain Mec1-Rad9-Rad53 interaction steps (Gilbert et 
al., 2001; Pellicioli and Foiani, 2005; Sweeney et al., 2005), as illustrated below in 
Diagram 14. In the solid-state catalyst model (Diagram 14, panel A) proposed by Lowndes 
and colleagues (2001), Rad9 molecules are hyper-phosphorylated, resulting in the 
recruitment and auto-phosphorylation of Rad53 kinases. Autophosphorylated Rad53 is 
released and activated. In a positive feedback loop, inactive Rad53 molecules get recycled 
into pre-active Rad9-Rad53 complexes (Gilbert et al., 2001). The adaptor-based model 
(panel B) by Durocher’s group (2005), on the other hand, suggest that Rad9, hyper-
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phosphorylated by Mec1 (B, step 1), recruits the inactive form of Rad53 that is 
subsequently phosphorylated by Mec1 (B, step 2), inducing Rad53 autophosphorylation 
(B, step 3), activation and release (Sweeney et al., 2005). Lastly, Pellicioli and Foiani 
(2005) reconcile both previous models in the adaptor-catalyst model (panel C), where 
Mec1 phosphorylation of Rad9 continues to a threshold when hyper-phosphorylated Rad9 
is able to recruit inactive Rad53 (C, step 1), which is in turn phosphorylated by Mec1 (C, 
step 2). Rad53 then undergoes autophosphorylation, which subsequently causes Rad9 
oligomerization, amplifying the recruitment of Rad53 molecules (C, step 3). Active Rad53 
molecules are then released from pre-active Mec1-Rad9-Rad53 complexes (reviewed 
in(Pellicioli and Foiani, 2005).  
 
DIAGRAM 14. Modes of Rad53 activation through the Rad9 adaptor protein 
 
Content not visible due to copyright limitations 
 
The solid-state catalyst (A), adaptor-based (B) and adaptor-catalyst (C) models are shown (see text 
for details). Rad9 (in violet); inactive (red), pre-active (yellow) and active (green) Rad53; Mec1 
(azure) are shown. Black round dots representing phosphorylated residues.   
Image by(Pellicioli and Foiani, 2005) 
 220 
 
5.2.III Rad9’s role in activating Chk1  
 
Rad9 is required for Chk1 activation in response to DNA damage (Sanchez et al., 1999; 
Blankley and Lydall, 2004), yet the molecular mechanisms underlying this interaction are 
largely elusive. Previously, it had been noticed that rad9 yeast mutants lacking the SCD 
cluster were unable to activate Rad53 kinase; however, Chk1 phosphorylation and 
interactions with Mec1 were not disrupted by these mutations (Schwartz et al., 2002), but 
were abolished by rad9 deletion. This indicates that other sites in Rad9 are involved in 
inducing Chk1 activation. Similarly to Rad53, Chk1 phosphorylation depends on both 
Mec1 and Rad9; however, Chk1 modification is independent of Rad53 and vice versa 
(Sanchez et al., 1999). Rad9 interacts with Chk1, as detected by two-hybrid studies 
(Sanchez et al., 1999), and is activated via a Mec1-dependent mechanism analogous to 
Rad53 activation (Sun et al., 1998; Vialard et al., 1998). In 2004, David Lydall’s group 
mapped a 160 amino acid region (from 40 to 200) in Rad9 that is required for Chk1 
activation, named CAD. No Mec1 consensus sites for phosphorylation are found within the 
CAD, but it has been shown to contain consensus CDK phospho-sites (Toh and Lowndes, 
2003; Blankley and Lydall, 2004). As CDK phosphorylates Crb2, fission yeast homologue 
of Rad9 (Esashi and Yanagida, 1999; Caspari et al., 2002) and scRad9 is cell cycle 
regulated, with the phospho-shift becoming apparent not only upon irradiation, but also 
under unperturbed situation, following nocodazole arrest in G2/M (Vialard et al., 1998), it 
is possible that CDK phosphorylation of these consensus motifs promotes Chk1 
recruitment and activation. Once activated, Chk1 is required for CDK inhibition and 
induction of cell cycle delay after DNA damage (Weinert, 1997), possibly suggesting the 
presence of a negative feedback loop in CDK regulation.  
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Chk1 regulates phosphorylation and protein levels of Pds1 to inhibit entry into anaphase 
and prevent mitotic exit. Because Rad53 also works in a redundant manner to control Pds1 
degradation, chk1 null mutants are only mildly sensitive to genotoxic agents. Furthermore, 
Chk1 plays a redundant role in maintaining replication fork stability during S-phase 
(Schollaert et al., 2004) and promotes HR in a mec1-21 hypomorphic mutant, leading to a 
hyper-recombination phenotype and genomic instability (Fasullo and Sun, 2008). CHK1 is 
also required for tolerance mechanisms in the presence of persistent single-stranded DNA 
breaks (Karumbati and Wilson, 2005), possibly being required for the phenomenon of 
adaptation in yeast. Thus, S. cerevisiae Chk1 differs from its mammalian homologue, 
whose activity not only plays a major role in activating intra-S and G2/M DNA damage 
checkpoints, but is also essential under normal physiological conditions to control 
progression through S-phase and mitosis (Chen et al., 2003; Sorensen et al., 2003). This 
emphasizes a diverging specialization of Chk1 protein functions in different organisms, yet 
a general conservation in the nature of the DNA damage checkpoint activation might have 
been preserved throughout evolution. 
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5.3 Results 
5.3.I Rad9 contains consensus CDK phosphorylation sites within its N-
terminal CAD 
 
Although Mec1/Tel1-dependent phosphorylations of Rad9 have been extensively 
investigated, regulation of Rad9 activity by CDK during the cell cycle is still unclear. 
Several lines of evidence suggest that Rad9 is likely to be regulated by CDK-dependent 
phosphorylation (Vialard et al., 1998; Esashi and Yanagida, 1999; Caspari et al., 2002), yet 
direct phosphorylation of Rad9 by CDK is yet to be shown. In budding yeast, only one 
CDK exists, Cdc28, which can bind to nine regulatory cyclin subunits, Cln1-3 and Clb1-6. 
Depending on the cyclin partner, Cdc28 exercises controlled regulation to drive cells 
through the cell cycle (Nasmyth, 1993). As previously shown, I observed that Rad9 is 
constitutively phosphorylated in asynchronous, undamaged yeast cultures, as indicated by 
an electrophoretic mobility shift abolished by treatment with alkaline phosphatase (data not 
shown). In addition, using a cdc28as, a mutant cdc28 sensitive to the ATP analogue 
1NMPP1, I inhibited Cdc28 and saw a small reduction in Rad9 phospho-shift, suggesting 
that Rad9 is a target of CDK phosphorylation in vivo (data not shown). This is in line with 
data demonstrating that mutation of 18 CDK sites to alanines in Rad9 N-terminus leads to 
loss of cell-cycle-dependent constitutive phosphorylation (Bonilla et al., 2008).  
 
To investigate the regulation of Rad9 during the cell cycle, I performed in silico searches 
for minimal consensus sites (S/TP) or full consensus motifs (S/TPXK/R), targeted for 
phosphorylation by CDK. I found 19 S/TP sites in Rad9, 12 SP sites and 7 TP sites, of 
which 5 and 3 match the full CDK consensus motif, respectively, the majority of which 
were localized at the N-terminus. The 18 N-terminal CDK phospho-sites are essential for 
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Rad9 checkpoint function (Bonilla et al., 2008) and may play a functional role in 
regulating Rad9 activation at different stages of the cell cycle. One of the major domains 
present at the N-terminus of Rad9 is the CAD, required for Chk1 activation (Blankley and 
Lydall, 2004). This region contains 6 minimal CDK consensus sites – 2 SP and 4 TP – 
with one full CDK consensus site (T125 TPGK; Figure 54), which may impact on Rad9-
mediated activation of Chk1 in a cell cycle dependent manner.  
 
FIGURE 54. Rad9 consensus CDK sites within the N-terminal CAD region 
 
 
 
 
Rad9 contains a CAD domain at the N-terminus of the protein that spans from amino acid 40 to 200. 
The CAD contains 5 minimal CDK consensus sites (S56, S83, T110, T143, T155) and one full CDK 
consensus motif (T125). CDK sites found within the CAD domain of Rad9 are underlined in black. 
Alignment of S. cerevisiae Rad9 CAD sequence with Rad9 homologues from other fungi and from 
Rad9 fission yeast homologue, Crb2, does not display extensive sequence conservation, yet shows 
conservation of CDK consensus sites S56, S83 (black arrows), T110, T125 and T143 (red arrows), but 
not of T155 in fungi.  
 
5.3.II Site-directed mutagenesis of 5 consensus CDK sites in Rad9 
 
In silico screenings revealed five conserved consensus CDK-phosphorylation motifs in the 
N-terminal CAD region of Rad9: S56 (SPKA), S83 (SPRH), T110 (TPDL), T125 (TPGK) 
and T143 (TPLM). The sites were mutated into unphosphorylatable alanine residues. rad9-
S83A, rad9-T110A, rad9-T125A and rad9-T143A single mutants and rad9-3A (rad9-
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S83A+T110A+T143A), rad9-4A (rad9-S83A+T110A+T125A+T143A) and rad9-5A (rad9-
S56+S83A+T110A+T125A+T143A) combination of multiple sites mutants were 
transformed into rad9Δ W303 strain and their expression was assessed (Figure 55). The N-
terminal HA-tag caused a lower expression of Rad9. Removal of the tag increased 
expression of the Rad9 constructs from plasmid, but not to the levels of endogenous Rad9.  
 
FIGURE 55. Expression of rad9 CDK mutants 
 
 
 
Expression of the Rad9 single CDK (A) and combination CDK mutant (B) constructs in a pRS414 
plasmid was assessed by harvesting logarithmic cultures and performing TCA preparation for SDS-
PAGE analysis. The constructs were transformed in rad9Δ::HIS3, CHK1-FLAG::KanMX6 strains. 
WT W303 strain (WT) was used as comparison for endogenous Rad9 expression (A and B). Chk1 
was tagged with FLAG inserted in the chromosomal locus. Antibodies against FLAG show that Chk1 
is expressed correctly in all the rad9Δ::HIS3, CHK1-FLAG::KanMX6 yeast strains. Note that Chk1 
was not tagged in the WT W3030 strain, used as a negative control (A, lane 1). Removal of the N-
terminal triple HA-tags, as in rad9-T110A (A), and in panel B, increased Rad9 expression. PGK-1 was 
used as loading control (A and B). It is noteworthy that rad9-S83A gives a different pattern on gel, 
running lower than WT Rad9. It is possible that another mutation is present, although this was not 
evident from sequencing. Further analyses carried out using Cdc28 inhibitors showed that rad9-S83A 
was not a hypo-phosphorylated form of Rad9. 
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5.3.III Failed Chk1 phosphorylation and activation in the rad9-4A mutant 
 
Next, I analyzed the effects of mutating these sites, collectively and individually, on Chk1 
phosphorylation and activation. To assess the ability of rad9 mutants to mediate Chk1 
phosphorylation, I used an acute treatment with phleomycin to induce single and double-
stranded DNA breaks in asynchronously growing cells. Single mutants did not display an 
obvious defect in Chk1 phosphorylation shift (Figure 56), nor did the rad9-3A mutant (data 
not shown). However, the rad9-4A showed an overt defect in effective Chk1 
phosphorylation following phleomycin treatment. Reduction of Chk1 phosphorylation 
observed in the rad9-4A mutant was similar to the lack of Chk1 shift seen in rad9 null cells 
(Figure 56). The rad9-5A mutant, including the S56A mutation, did not show further 
reduction in Chk1 phosphorylation (data not shown). Reduction of Chk1 phosphorylation 
observed in the rad9-4A mutant was also reproduced using methane methylsulfonate 
(MMS), another DNA damaging agent (data not shown). This result suggests that S83, 
T110, T125 and T143 consensus sites for CDK phosphorylation in Rad9 CAD act 
redundantly to promote efficient Chk1 phosphorylation and activation.  
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FIGURE 56. Rad9 S83, T110, T125 and T143 are required for Chk1 
phosphorylation 
 
 
 
Logarithmic cultures of the indicated yeast strains were incubated in the presence and absence of 10 
µg/ml of phleomycin for 1 hour and harvested for TCA prep. ‘P >’ indicates phospho-bands with 
decrease electrophoretic mobility for Chk1 (Chk1-P) and Rad53 (Rad53-P). Similarly to rad9Δ, Chk1 
phosphorylation is abolished in rad9-4A compared to rad9 single mutants expressed to similar levels. 
Untagged Rad9 (Rad9-WT) expressed from plasmid has higher expression than HA-tagged Rad9 
(Rad9-3HA-WT), but not as high as endogenous Rad9 (WT). 
   
To understand the exact timing during the cell cycle when Rad9 phosphorylation by CDK 
impacts on Chk1 activation, I synchronized cells in G1 using α-factor and released them 
into the cell cycle, monitoring progression into S-phase (early S, 20 minutes; late S, 40 
minutes time-points), through G2/M and back into G1. I assessed Chk1 phosphorylation by 
WB (Figure 57A), progression through the cell cycle and activation of the DNA damage 
checkpoint by FACS (Figure 57B) following treatment with the radiomimetic drug, 4NQO. 
As expected, Chk1 did not respond to DNA damage in early S-phase (20 minutes time-
point; Figure 56A). In late S-phase (40 minutes), Rad53 and Chk1 became activated by 
treatment with 4NQO in the presence of wild-type Rad9, whereas the rad9-4A strain shows 
a reduction in Chk1 phosphorylation (Figure 57A). Further decrease in Chk1 
phosphorylation was observed at the 120 minutes time-point following α-factor release, 
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when cells are found in G2/M (Figure 57A), indicating that CDK-phosphorylation of the 
four sites in Rad9 CAD is specifically important in regulating activation of Chk1 in the 
mitotic checkpoint, and partially in the intra-S-phase checkpoints in late S-phase. In 
agreement with published data, Rad53 phosphorylation was not affected by the rad9-4A 
mutant (Figure 57A), indicating that the mechanism of regulation by CDK sites in the 
CAD is specific to Chk1 and does not impact on Rad53 activation. 
 
FIGURE 57. Rad9-4A mutant is not proficient in mediating phosphorylation of 
Chk1 during late S-phase and in mitosis 
 
 
 
Logarithmic cultures of the yeast strains were synchronized into G1 using α-factor and released into 
the cell cycle either into fresh medium or medium containing 0.2 µM 4NQO. Samples were collected 
for western blotting analysis at 20, 40 and 120 minutes post-release (A). FACS analysis of samples of 
asynchronous, G1-arrested cells and cells released and collected at 20, 40, 60, 80, 100 and 120 
minutes time-points (B) show that the four CDK sites in Rad9 CAD are required for Chk1 
phosphorylation in late-S-phase and in G2/M and for regulation of the DNA damage checkpoint. 
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Failed phosphorylation of Chk1 in late-S-phase in the rad9-4A mutant caused a mild defect 
in progressing into S-phase at 20 and 40 minutes and from S-phase into G2/M at 80 
minutes. However, rad9-4A mutant did not display an obvious over-riding of the G2/M 
checkpoint (Figure 57B). These data indicate that Rad9-mediated phosphorylation of Chk1 
controlled through the four CDK sites is required for slowing down replication and 
preventing entry into G2/M with unreplicated or damage DNA, yet compensatory 
mechanisms may exist which allow activation of the mitotic checkpoint in the absence of 
active Chk1. These data are in agreement with findings that Rad53 acts in a redundant 
manner to Chk1 activating a parallel pathway to control the anaphase checkpoint (Sanchez 
et al., 1999). 
 
Next, I assessed the phenotypical consequences of mutating the four CDK sites, 
individually or in combination, in response of chronic exposure to a range of genotoxic 
agents by sensitivity assays. In line with my previous findings, single mutants did not show 
sensitivity to DNA damaging agents (Figure 58). The Rad9-4A mutant was mildly 
sensitivity to UV and high doses of 4NQO (Figure 57), but not to the same extent as the 
rad9Δ strain. This was expected, since mutating the four CDK consensus sites does not 
impair the role of Rad9 outside of Chk1 activation, such as Rad53 activation, and chk1Δ is 
only mildly sensitive to DNA damaging agents, due to functional redundancy with Rad53 
in mediating checkpoint activation. 
 
Collectively, these data show that S83, T110, T125 and T143 consensus CDK 
phosphorylation sites in the Rad9 CAD act redundantly to promote Chk1 phosphorylation 
and activation in late-S-phase and in G2/M checkpoints; mutation of these sites leads to 
mild sensitization to certain genotoxins. 
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FIGURE 58. Sensitivity assay of Rad9 CDK mutants 
 
 
 
The indicated strains were grown overnight, diluted to an OD600nm of 0.5 before dilutions (5-fold) 
were spotted on yeast selection medium for tryptophan expression containing the indicated drug. 
Rad9-4A is mildly sensitive to high doses of UV and 4NQO. Rad9-S83A is sensitive to certain 
cytotoxic agents but, due to abnormal expression patter in WB (Figure 55), its phenotype was 
disregarded. This is one representative example of the sensitivity assay; all experiments were repeated 
in triplicates. 
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Throughout this study, I noted that the rad9Δ strains expressing untagged Rad9 from a 
single-copy plasmid showed lower expression compared to endogenous Rad9 in a W303 
WT strain (Figure 55A and 57A). Tagging of Rad9 using HA or FLAG tags, at the amino 
or carboxyl ends, caused further reduction in protein expression (Figure 55A, 56 and data 
not shown). Although abrogation of Chk1 phosphorylation was specifically due to 
combined mutagenesis of all four sites as shown in Figure 56 and 57A, and not to the 
reduced levels of expression, I noticed that the rad9Δ strains expressing Rad9 plasmids had 
a slightly impaired checkpoint activation (data not shown) and sensitivity to cytotoxic 
agents (Figure 58) compared to the WT strain. To confirm the role of Rad9 consensus 
CDK sites in Chk1 activation in the response to DNA damage, I established a collaboration 
with Prof. Noel Lowndes and Dr. Muriel Grenon (National University of Ireland Galway) 
to subclone the CAD mutants into a yeast integrative plasmid (Yip) to perform Yip-
mediated mutagenesis by ‘pop-in pop-out’ HR-guided events for integration into the 
chromosomal RAD9 locus. Integration of my mutants in the endogenous gene’s locus is 
more rigorous and gives more reproducible results than expressing mutated genes from a 
plasmid. Integrated rad9-4A mutant, as well as individual mutants, showed endogenous 
levels of expression from the Rad9 genomic locus; using these strains, we were able to 
show that the combination of all four mutations, but not the individually mutated sites, 
decreased Chk1 phosphorylation, when yeast cells were arrested in nocodazole and treated 
with 400 Gy of IR; moreover, no additive affect was observed using the rad9-5A mutant 
strain (data not shown). This further confirms that mutational dysregulation of these four 
CDK sites in Rad9 CAD affects efficient Chk1 phosphorylation and activation in M-phase 
following a range of DNA damaging agents.  
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In addition, I have made serine/threonine to glutamic acid mutants of the consensus CDK 
sites, individually or in combination. These are currently being integrated and tested for 
rescuing Chk1-associated phenotype. 
  
5.3.IV Physical interactions between Rad9 and Chk1 
 
 
The Rad9-Chk1 interaction has been previously described by yeast two-hybrids (Sanchez 
et al., 1999; Uetz et al., 2000), yet, to date, no other biochemical evidence for a physical 
interaction between Chk1 and Rad9 exists. In addition, attempts by David Lydall’s group 
to detect a direct interaction between Rad9 and Chk1 were unsuccessful, suggesting that 
potential binding may be very transient (Blankley and Lydall, 2004), indirect or cell cycle-
regulated.  
 
I wanted to verify the interaction between the N-terminus of Rad9 and Chk1, and test 
whether mutations of the four CDK sites in the CAD domain improved or hindered the 
binding. To address this, I sub-cloned the very N-terminal region of Rad9 containing the 
four CDK sites (1-166 amino acids), wild-type or mutated, into a pGEX vector and 
expressed the GST fusion fragments in bacteria. Once purified, I compared the capabilities 
of the Rad9-GST N-terminus fragments to bind and pull-down FLAG-Chk1 expressed in a 
rad9Δ strain. I found that a small amount of Chk1 bound to the N-terminus of wild-type 
Rad9. Pre-incubation of Rad9 with activated Cyclin A/CDK2 in an in vitro kinase assay 
slightly increased the binding (Figure 59). No obvious binding was observed in all 
experiments performed with the mutated N-terminus of Rad9 (data not shown). This 
suggests that phosphorylation may play a positive role in mediating the interaction with 
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Chk1, hence explain why I did not observe binding of Rad9-4A and wild-type Rad9 N-
terminal fragments in the absence of phosphorylation-inducing agents.  
 
FIGURE 59. A small amount of Chk1 binds to Rad9 N-terminus in vitro 
 
 
 
Rad9-GST N-terminus fragment on beads was added to human recombinant Cyclin A/CDK2 or to the 
kinase buffer only, and pre-incubated for 15 minutes. Rad9 was then used for GST pull-downs, 
overnight (GST pd ON) or for 2 hours (right) at 4°C. 10 mg of yeast extracts from rad9Δ, CHK1-
FLAG strain was used for each pull-down. Rad9 N-terminus binds a minute fraction of Chk1 upon 
incubation with CDK. 
 
5.3.V Microcephalin is a novel candidate homologue of budding yeast Rad9 
 
The absence of a clear homologue for S. cerevisiae Rad9 in mammalian cells suggests that 
the multitude of roles exercised by Rad9 have been separated into different, more 
specialized proteins during evolution. Indeed, although budding yeast Rad9, fission yeast 
Crb2 and metazoan 53BP1 share conserved structural homologies and display analogous 
modes of recruitment to sites of DNA damage, 53BP1 has limited checkpoint function, 
whereas Crb2 and Rad9 play a major role in checkpoint activation (Ward et al., 2006). 
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MCPH1 (microcephalin) is a human gene encoding a protein characterized by three BRCT 
domains, one at the N-terminus (BRCT1) and two twin BRCTs located at the C-terminus 
(BRCT2 and BRCT3; Figure 60). Mutations in this gene cause primary microcephaly, an 
autosomal recessive genetic disorder characterized by reduced brain size and mental 
retardation (Jackson et al., 2002). In addition to roles in determining human brain size 
during neurogenesis (reviewed in(Woods et al., 2005), microcephalin localizes to γH2AX 
DNA damage foci and functions in the execution of the intra-S and G2/M checkpoints. To 
this end, MCPH1 is required for stabilization of BRCA1 and Chk1, increasing their 
proteins levels, and for phosphorylation of Nbs1 (Xu et al., 2004; Lin et al., 2005). Thus, 
microcephalin is an important proximal factor in the DDR, whose inhibition leads to 
chromosomal abnormalities, indicating it may act as a tumour suppressor gene (Rai et al., 
2006). In another study, microcephalin was found to physically interact with Chk1 and to 
control Cdc25A phosphatase turnover for activation of the ATR-branch of the checkpoint 
(Alderton et al., 2006). In addition, MCPH1 plays a physiological role in regulating mitotic 
entry by promoting the association of Chk1 with centrosomes, thus restraining the 
activation of centrosomal cyclin B–CDK1 and preventing unscheduled entry into mitosis 
(Tibelius et al., 2009).  
 
Given MCPH1 is required for Chk1-dependent activation of the DNA damage checkpoint 
and physically binds to Chk1, I wanted to investigate whether hMCPH1 interactions with 
Chk1 were mediated by the protein’s N-terminus and regulated by phosphorylation in a 
similar manner to scRad9. Interestingly, MCPH1 contains a putative CAD region located 
at the N-terminus of the protein – localized between amino acids ~103 and 250 – which 
shares conserved CDK phospho-sites with scRad9 CAD (Figure 60A; Richard Chahwan, 
personal communication). To verify the interaction between MCPH1 CAD domain and 
human Chk1, I sub-cloned hMCPH1 N-terminus (1-252 aa) into a pGEX vector and 
expressed the GST-fragment in E. coli. MCPH1 N-terminus robustly interacted with 
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purified Chk1 in vitro, both in the presence and absence of ATP (Figure 60B), suggesting 
that binding between MCPH1 and Chk1 occurs though the N-terminus of the protein, 
possibly via the novel CAD region, independently of phosphorylation. However, I cannot 
exclude that in vivo interactions may be regulated by phosphorylation. 
 
FIGURE 60. Identification of a novel CAD region in human MCPH1, which 
shares conserved CDK sites with scRad9 and binds to human Chk1 
 
 
 
Cross-species Mcph1-Rad9 alignments show presence of 3 conserved consensus CDK phospho-sites 
within the CAD domains. In scRad9: T110 TPDL; T125 TPGK; and T143 TPLM showed homology 
with hMCPH1 sites: T120 TPED; T162 TPTI; and S190 SPTS, respectively (A; image by Richard 
Chahwan). Human MCPH1 N-terminus avidly binds to purified Chk1 in vitro. GST alone, MCPH1-
GST or Rad9-GST N-terminus fragments were incubated with 1 µg of purified human Chk1 (10% 
input, i). 5 mM ATP was added to the reaction with GST alone, MCPH1-GST and Rad9-GST and 
with the input. Also, MCPH1-GST was pre-incubated with ATP (+*), washed and then added to 
purified Chk1 for binding in the absence of ATP. Ponceau stained membrane prior to WB shows the 
expression of the recombinant constructs: GST only (~ 26 kDa), GST-MCPH1 (252 aa = ~28 kDa + 
GST = ~55 kDa) and GST-Rad9 (166 aa = ~18 kDa + GST = ~44 kDa) N-terminus fragments. 
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Next, I wanted to test the ability of S. cerevisiae Rad9 N-terminus fragment to bind 
purified human Chk1, suggesting a possible evolutionarily conserved mechanism. Binding 
of Rad9 to human Chk1 was increased above background upon incubation with ATP 
(Figure 60B). This finding is in agreement with the previous data using CyclinA-CDK2, 
suggesting that phosphorylation events on Rad9 N-terminus promote interactions between 
Rad9 and Chk1. 
 
To investigate the functional relevance of the MCPH1 N-terminus and CAD domain 
interaction in the activation of Chk1, in collaboration with Muriel Grenon, I designed a 
strategy to make hybrids constructs where scRad9 N-terminus or CAD were swapped for 
human or chicken MCPH1 N-terminus and CAD, respectively (Figure 61). I performed 
fusion-PCR to produce the scRad9-hMCPH1N-terminus1-203 and scRad9-ggMCPH1N-terminus1-
199 constructs and these were verified by DNA sequencing (see hybrids for N-terminal 
region in Figure 61). The constructs can be utilized to rescue defects caused by rad9-4A 
mutant and verify the existence of a conserved role for hMCPH1 and scRad9 in mediating 
Chk1 phosphorylation and activating intra-S and M-phase checkpoints. Chicken Mcph1 
was cloned and analyzed by Ciaran Morrison’s group (Galway), which found that cMcph1 
localized to centrosomes through the N-terminal BRCT1, and was recruited to IRIF via its 
C-terminal twin BRCTs, playing a role in the DDR (Jeffers et al., 2008), similarly to 
hMCPH1. Thus, testing the ability of both human and chicken MCPH1 to rescue my Rad9 
CDK mutants could yield interesting results and help in defining evolutionarily convergent 
and divergent roles for these proteins.  
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FIGURE 61. Strategy for the design of Rad9-h/ggMCPH1 hybrid constructs 
 
 
Content not visible due to copyright limitations 
 
Sequence homology and experimental data were used to predict the spanning of the CAD in Rad9 and 
in human and chicken MCPH1. Two types of constructs were designed: Rad9 N-terminus swap, 
where the first 174 amino acids of scRad9 are substituted for hMCPH1 N-terminus (1-203 aa) or 
ggMcph1 N-terminus (1-199 aa; panels 1.1 and 2.1). In Rad9 CAD swap, scRad9 CAD (107-174 aa) 
was swapped for hMCPH1 putative CAD (94-203 aa) or ggMcph1 putative CAD (93-199 aa; panels 
1.2 and 2.2 – Image by Muriel Grenon). 
 
The constructs I have made are currently being tested in Noel Lowndes’s lab for 
interaction with scChk1 by yeast two-hybrid and they will be used to map functional 
conservation of the Rad9/MCPH1-Chk1 branch of the DNA damage checkpoint in the near 
future. 
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The findings shown in this study demonstrate that S. cerevisiae Rad9 contains consensus 
sites for CDK phosphorylation within the CAD region at the N-terminus. Combined 
mutation of these conserved S/TP sites to alanine (S83A, T110A, T125A and T143A), 
confers a defect in Chk1 phosphorylation following treatment with a variety of DNA 
damaging agents. These sites contribute to Chk1 activation in the context of both the intra-
S and M-phase checkpoints in budding yeast. Identification of conserved CDK sites in a 
putative CAD region in human and chicken microcephalin proteins suggests that analogous 
cell cycle regulation of these proteins may control phosphorylation, activation, localization 
and/or interaction with Chk1 in these systems. Indeed, I have shown that phosphorylation 
by Cyclin A/CDK2 enables the scRad9 N-terminus to bind Chk1 in vitro; moreover, 
human MCPH1 N-terminus is also capable of binding purified Chk1. Although it is unclear 
whether the interactions between hMCPH1 and Chk1 are positively or negatively regulated 
by phosphorylation, these data highlight a pattern of evolutionary conservation in the 
mechanisms of Chk1 regulation and binding through the N-terminus of yeast Rad9 and 
human MCPH1. Further investigations are ongoing to elucidate additive effects of other 
CDK sites in Rad9 CAD, understand the mechanisms of Rad9 and MCPH1 binding to 
Chk1 and shed light on a functional relationship between these proteins, which may be 
conserved throughout evolution.  
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5.4 Discussion and conclusion  
S. cerevisiae Rad9 is a major cell-cycle-regulated adaptor protein required for Mec1/Tel1-
dependent phosphorylation and activation of Rad53 and Chk1-branches of the DNA 
damage checkpoint. The study presented in this thesis produces evidence for the 
requirement of specific consensus CDK phospho-sites within Rad9 CAD region for Chk1 
phosphorylation and activation. The data shown in this study infers that Rad9 is regulated 
by CDK phosphorylation, which, in turn, affects its ability to phosphorylate Chk1 and 
activate Chk1-mediated cell cycle delays in response to DNA damage. 
 
5.4.I Functional activity for Rad9 consensus CDK sites in Chk1 activation 
 
Identification of a functional role for 4 consensus CDK sites (S83, T110, T143 and T155) 
within the CAD region of Rad9 in mediating Chk1 phosphorylation suggests that CDK 
activity influences the activation and choice of checkpoint pathways. Indeed, mutation of 
these sites to alanine caused disruption in Chk1 activation, yet Rad53 phosphorylation was 
unperturbed. These data are in agreement with previous reports showing that Rad53 
binding to Rad9 and subsequent activation is mediated by Tel1/Mec1-induced 
phosphorylation of Rad9 SCD, a region containing several clustered S/TQ sites (Emili, 
1998; Usui et al., 2001; Schwartz et al., 2002) and is independent of Chk1 activation. The 
impact of putative CDK phosphorylations on Rad9 regulating activation of Chk1 is 
especially interesting considering that Rad9 is differentially phosphorylated in a cell cycle-
dependent manner: Rad9 is hypo-phosphorylated in G1, when Chk1 is inert to DNA 
damage, and becomes hyper-phosphorylated in S and G2/M, when Chk1 responds to DNA 
damage. In support of this hypothesis, I found that Chk1 was not activated by 
phosphorylation upon treatment with 4NQO when cells are synchronized at early stages of 
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S-phase. However, Chk1 becomes selectively active in mid-to-late S-phase to monitor 
replication, and in mitosis for activation of the checkpoint branch that halt mitotic 
progression into anaphase. Furthermore, proficient activation of Chk1 in both these context 
require the presence of intact Rad9 CDK sites. Thus, existence of CDK sites on Rad9 to 
regulate Chk1 activation emphasizes a strong requirement for cell cycle control over 
induction of this branch of the DNA damage checkpoint in a timely manner. 
 
Due to the low sensitivity of the chk1 null strain to DNA damaging agents, the functional 
relevance of the Chk1 checkpoint in yeast is questionable. It is likely that redundancy with 
the Rad53-branch masks phenotypical defects of chk1Δ strain. Indeed, it has been shown 
that Rad53 and Chk1 work in parallel pathways, regulating Cdc5 and Pds1 respectively, 
both converging to inhibit mitotic exit and metaphase-to-anaphase transition after DNA 
damage (Sanchez et al., 1999). However, the mild sensitivity of the rad4-4A strain to high 
doses of UV and 4NQO suggests that Chk1 functions do not entirely overlap with Rad53. 
UV radiation and the UV-mimetic 4NQO induces several types of adducts and DNA 
“photoproducts”, that would block progression of the polymerase (Friedberg, 1996; 
DePamphilis et al., 2006), causing accumulation of ssDNA and checkpoint activation. In 
the context of late S-phase, Chk1 may play a more predominant role than Rad53 in slowing 
down replication in the presence of genotoxic agents. On the other hand, an independent 
Chk1-induced checkpoint control may exist that regulate termination of replication.  
Although I favour the former explanation, I currently have no evidence to exclude the 
latter. Thus, it would be interesting to understand the extent of the cross-talk between these 
two checkpoint kinases and how this changes in different cell cycle phases. In this regard, 
it’s tempting to speculate that CDK activity controls not only the choice between repair 
pathways in budding yeast (Huertas et al., 2008), but also the mode of checkpoint 
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activation, possibly coordinating the selection of the DNA repair mechanism with 
activation of the appropriate cell cycle delay machinery.  
 
It is noteworthy that expression of RAD9 from a single-copy plasmid resulted in lower-
than-endogenous protein levels. This may be due to differences between the chromatin 
structures in regulating RAD9 gene expression from the plasmid versus the endogenous 
genomic locus. In addition, tagging of Rad9 using HA or FLAG tags at the N-terminus 
resulted in a further decrease in protein levels indicating that the tags destabilized the 
protein. To circumvent these problems, rad9 mutants were integrated in the chromosomal 
locus. Integrated rad9-4A confirmed defects in Chk1 phosphorylation. However, mutation 
of 9 consensus CDK sites located in Rad9 N-terminus completely abolished the Chk1 shift, 
inferring that another important or several less important sites may also be required for 
proficient Chk1 activation. Identification of the minimal requirements for Chk1 activation 
is therefore an interesting line of further enquiry. My data also show that single mutants do 
not display overt defects in Chk1 phosphorylation; thus, these sites act redundantly and in 
a concerted manner to efficiently mediate Chk1 phosphorylation by Mec1/Tel1 and 
checkpoint activation in late-S and G2/M. 
 
5.4.II Phosphorylation of Rad9 by CDK enables interaction with Chk1 
 
To date, evidence for a physical interaction between Rad9 and Chk1 has been very scarce. 
By yeast-two-hybrid, Rad9 and Chk1 interact (Sanchez et al., 1999); however, other 
attempts to demonstrate direct physical interactions failed (Blankley and Lydall, 2004). 
Attempts to IP Chk1, or a kinase-dead versions of the protein, using wild-type or Rad94A 
mutant, as well as reverse IPs, were unsuccessful, indicating that interactions may be very 
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transient. Here, I show that, using the Rad9 N-terminus fragment, a small amount of Chk1 
was pulled-down. Interestingly, binding was observed upon pre-incubation with 
CyclinA/CDK2 complex. These data show that a fraction of Chk1 does interact with Rad9 
and the binding occurs between Chk1 and the N-terminal region of Rad9, possibly 
following phosphorylation by CDK. Thus, phosphorylation of Rad9, but not Chk1, by 
CDK is required for the two proteins to interact, corroborating the idea that CDK 
regulation of Rad9 N-terminus controls binding and activation of Chk1 in a cell cycle-
dependent manner. It would be interesting to analyze how cell cycle regulations affect this 
interaction and the spatio-temporal settings for Rad9-Chk1 binding in vivo. 
 
5.4.III MCPH1, a new homologue of S. cerevisiae Rad9 in higher eukaryotes 
 
Although the domain organization of mammalian Chk1 and its yeast orthologues is 
evolutionarily conserved (Stracker et al., 2009), the functional aspects of Chk1 have 
diverged during evolution. In budding yeast, the functional overlap with Rad53 renders this 
factor dispensable for cell viability and unnecessary for DNA damage checkpoints 
activation. By contrast, mammalian Chk1 not only plays a major role in intra-S and G2/M-
checkpoints, but is also essential for cell viability, due to an as yet undefined role during 
unperturbed mitosis (Wilsker et al., 2008). Despite differences in Chk1 roles between 
mammals and lower eukaryotes, the molecular mechanisms of Chk1 activation may be 
preserved during evolution. Here, I show that the BRCT-containing mammalian DDR 
mediator protein MCPH1 contains a CAD-like region at the N-terminus, similar to scRad9 
CAD, including three conserved consensus CDK phosphorylation sites. In addition, 
hMCPH1 has been previously shown to regulate the Chk1-branch of the DNA damage 
checkpoint pathway. Indeed, I show that hMCPH1 N-terminus binds to purified Chk1 in 
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vitro, suggesting that interactions between MCPH1 and Chk1 in human may be analogous 
to those in budding yeast. Because MCPH1 BRCT1 at the very N-terminus was shown to 
be required for Chk1 localization to the centrosome, I used the full N-terminal region for 
my experiments, as both the CAD and the first BRCT domain may be required for binding 
to Chk1. These preliminary observations suggest that MCPH1 is a novel homologue of 
scRad9 in higher eukaryotes.  
 
5.4.IV Open questions and future directions 
 
Further investigations are needed to establish the minimal consensus for Rad9 and MCPH1 
binding and activation of Chk1, to address how this may be regulated by CDK-dependent 
phosphorylation and how this regulation impacts on Chk1 pivotal roles in mammalian 
cells. Addressing these questions is particularly relevant in light of the essential role of 
Chk1 in mammals, considering MCPH1 may be an important mediator of Chk1 activation. 
Although these hypotheses have yet to be tested, I have produced powerful tools to verify 
how the functional relationship between Rad9/MCPH1 and Chk1 has evolved during 
evolution. I have made hybrid constructs swapping Rad9 MCPH1 CAD or N-terminus 
with the respective human or chicken homologue regions. These constructs will be utilized 
for rescue experiments of rad9-4A mutant and to verify the existence of an evolutionarily 
conserved or divergent role for human and chicken MCPH1 and scRad9 in mediating Chk1 
phosphorylation and subsequent activation of the checkpoint. Also, these studies may help 
in uncoupling Chk1 essential cell cycle role and Chk1 role in the DDR.  
 
The study presented in this thesis provides a starting platform for subsequent investigations 
into a novel homologue of Rad9 in higher eukaryotes, MCPH1. Especially interesting is 
the identification of conserved sites consensus for CDK phosphorylation on human MCPH1 
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within a novel CAD-like region. Both budding yeast Rad9 and human MCPH1 bind to 
Chk1, strengthening the speculation that an evolutionarily conserved mechanism exists in 
mediating Chk1-dependent checkpoint activation. Several questions remain to be 
addressed as to how CDK regulates both scRad9 and MCPH1 impacting on checkpoint 
activation and, possibly, on other, essential roles of mammalian Chk1. Also, further studies 
might provide novel molecular evidence as to the clinical relevance of MCPH1 in brain 
development in human. Chk1 role in monitoring physiological cell proliferation and 
mitotic division may be a missing link in explaining the microcephaly phenotype and 
reduced body size consequent to MCPH1 mutations. Hence, more studies will be required 
to untangle the diverse contributions of adaptor-like proteins throughout evolution in 
regulating the checkpoint effector kinase Chk1, and in preserving genomic integrity and 
physiological homeostasis. 
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6 GENERAL DISCUSSION 
Selective evolutionary pressure has been shaping molecular phenomena for millions of 
years. Biological systems have acquired a multilayered complexity to ensure an elevated 
level of proficiency in their cellular responses. Fundamental cellular events that guarantee 
the propagation of life include the faithful duplication of the genetic information, a 
proficient cell division program and surveillance mechanisms to maintain genomic 
integrity. These events must synergistically coordinate their efforts to allow cell growth 
while retaining high-fidelity segregation of the genetic material to the progeny. Aberrations 
in different aspects of these pivotal processes have widespread impacts on the genesis of a 
variety of human pathologies, including neoplasia.  
  
The work presented in this thesis aims to explore interactions between cell cycle 
mechanisms and preservation of genome integrity. The molecular interface shared by these 
processes is characterized by direct cross-talk, as well as by positive and negative feedback 
loops that indirectly influence cellular responses in these contexts. While responses to 
DNA damage act to delay cell cycle progression by enforcing activation of so-called 
checkpoints, the DDR itself is subject to cell cycle regulation (Branzei and Foiani, 2008; 
Pardo et al., 2009). For instance, some DDR factors are only readily available at certain 
cell cycle stages, while the function of others is modulated by phosphorylation events 
mediated by cell cycle kinases (e.g. CDKs). In addition, the sub-cellular localization of 
certain DDR factors changes during the cell cycle and/or upon induction of DNA damage, 
affecting their activity. This communication between the cell cycle machinery and the 
DDR apparatus is fine-tuned depending on myriad variables, including the nature of the 
DNA lesion, the chromatin status of the genomic locus, availability of sister chromatids, 
and the phase of the cell cycle. These affect the choice of the repair pathways, the 
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activation of different checkpoint cascades and the selection of factors required to 
orchestrate these responses.  
 
During my PhD, I have shown that DNA damage responses are heavily influenced by cell 
cycle regulations and that the DNA damage cascade unfolds in a different manner 
depending on the cell cycle phase when the cells suffers genotoxic insults. Specifically, I 
have found that the DDR in mitosis differs remarkably from that in interphase stages. This 
work has revealed that human cells have evolved a mechanism that prioritizes timely 
passage through mitosis over a complete activation of all the steps in the DNA damage 
signalling cascade. Once committed to mitosis, cells containing DNA DSBs do not perturb 
progression through mitosis, to achieve the timely accomplishment of chromosome 
segregation and cytokinesis, as they fail to activate a DNA damage checkpoint and 
corresponding effector kinases Chk1 and Chk2 while in mitosis.  
 
Although the observation that mitotic cells do not delay cell cycle progression in the 
presence of DSBs is not novel, my studies have gone one step further to challenge the pre-
existing view that the absence of a mitotic checkpoint correlates with the absence of a 
DDR in mitosis. Indeed, it is difficult to conceive a scenario where cells would totally 
ignore potentially deadly lesions such as DSBs in any cell cycle stage. My data show that 
mitotic cells do respond to the presence of DSBs but only activate a primary DDR, 
comprising of activation of the apical PIKK kinases ATM and DNA-PK, phosphorylation 
of γH2AX and recruitment of MDC1 and MRN to sites of DNA damage. This, however, is 
where the mitotic DDR stops, lacking recruitment of the E3 ubiquitin ligases RNF8, 
RNF168 and BRCA1, and the DDR mediator 53BP1. The restriction in the recruitment of 
these secondary factors during mitosis is likely to be multifactorial, reflecting a 
combination of mitosis-specific post-translational modifications, compacted mitotic 
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chromatin status and sequestration of certain DDR proteins within mitotic structures. These 
differences emphasize the uniqueness of the mitotic phase in human cells and highlight the 
need to adapt responses to DNA lesions to the physiological requirements of this important 
cell cycle phase. In this regard, activation of the secondary DDR is understandably 
unsuited to the characteristics of mitosis because the brevity of this phase and the timely 
execution of karyokinesis and cytokinesis could be perturbed by full DDR and checkpoint 
activation. In addition, remodelling of chromatin induced by RNF8-mediated 
ubiquitylation events would likely be deleterious in the context of highly compacted 
mitotic chromosomes. Thus, it is tempting to speculate that mitotic cells prevent secondary 
DDR to ensure timely cell division and avoid disruption in the higher-order chromatin of 
mitotic chromosomes. Nonetheless, activation of the primary DDR in mitotic cells appears 
to be biologically important, as our data indicate that it promotes cell viability and confers 
radio-resistance. Collectively, these findings indicate that human cells have evolved a 
mechanism to mark DSB during mitosis, while guaranteeing completion of cell division. 
Once the daughter cells re-enter the following interphase, a full DDR activation ensues and 
DSBs are dealt with in the more favourable chromatin environment of the G1 cell.    
 
In budding yeast, responses to DNA damage in mitosis differ in some regards to those in 
mammalian cells. In S. cerevisiae, not only do Mec1/Tel1, Rad9 and Rad53/Chk1 
contribute to activate the mitotic checkpoint that blocks the metaphase-to-anaphase 
transition in the presence of DNA damage, but also the SAC protein Mad2 acts to enforce 
this regulation after DNA damage (Clerici et al., 2004). Thus, in S. cerevisiae, DDR factors 
and mitotic factors act in concert to activate a DNA damage-induced delay in mitosis. By 
contrast, in human cells, the SAC does not seem to be activated by DNA damage per se, 
unless spindle attachment to the kinetochore is affected. However, my novel observations 
showing the localization of DDR factors within specific mitotic structures corroborate 
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existing findings indicating that DDR factors may play roles in unperturbed mitosis. This 
suggests that in human cells, even if DDR responses are minimal in mitosis and do not 
seem to affect mitotic processes, DDR factors may possess both DDR and mitotic roles. In 
mitosis, RNF8, RNF168 and 53BP1 recruitment to kinetochores, as well as RNF8 and 
BRCA1 recruitment to centrosomes, is especially significant, inferring that these factors 
may work to control mitotic progression in similar molecular ways as they do in the DDR 
cascade. To this end, RNF8 was shown to be recruited to the midbody and to be required 
for mitotic exit (Tuttle et al., 2007; Plans et al., 2008). My observations that RNF8 
depletion by siRNA causes failure to synchronize cells in mitosis suggest that RNF8 plays 
additional roles, including those controlling entry/progression through mitosis. It would be 
interesting to see how these roles correlate to RNF8’s association with the various mitotic 
structures.  
 
Human Chk1 is an important example of how a DNA damage-responsive factor also plays 
an essential role in unperturbed progression through mitosis. In S. cerevisiae, Chk1 does 
not display the essential functions present in mammalian cells, including driving cells 
through the cell cycle and monitoring unperturbed progression through S, G2 and M-
phases, yet has retained responsiveness to DNA damaging agents in late-S-phase and in 
G2/M checkpoints, including regulation of the metaphase-to-anaphase transition. In this 
study, I show that effective Chk1 phosphorylation and activation of the Chk1-branch of the 
late-S-phase and G2/M delays depends on consensus CDK phosphorylation sites on the 
mediator protein Rad9. Thus, regulation of Chk1 activation in specific phases of the cell 
cycle underlines the impact of the cell cycle on DNA damage mechanisms in budding 
yeast, like in mammalian cells. In this case, Rad9 may be directly regulated by CDK-
dependent phosphorylation events that impact on the capabilities of Rad9 to bind Chk1 and 
promote Mec1/Tel1 phosphorylation and activation of this checkpoint kinase.  
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In budding yeast, Rad9 has retained multiple roles in the DDR and checkpoint activation 
pathways. During evolution, Rad9 appears to have diverged into several mediator proteins 
in higher eukaryotes, possibly to improve fine-tuning and include additional regulations in 
increasingly complex biological systems. Here, I show that MCPH1 might be a novel 
homologue of Rad9, as it not only contains twin BRCT domains at the C-terminus, like 
BRCA1, 53BP1 and MDC1, but it also contains a CAD-like region with conserved 
consensus CDK phospho-sites, similar to those in the Rad9 CAD. Moreover, similarly to 
Rad9, MCPH1 binds Chk1 through its N-terminal region. This suggests that certain cell 
cycle regulations of mediators’ functions are retained during evolution, yet the spatio-
temporal settings of these processes have changed. Whereas in yeast DNA damage 
checkpoints can be activated in the middle of mitosis, human cells have suppressed these 
responses. Thus, the differences highlighted in this study between human and yeast cells 
help reveal how DNA damage responses and cell cycle regulations influence one another, 
and how these effects could be influence by the organism’s biological complexity. 
 
The interlink between cell cycle and DNA damage can also be analyzed from a dynamic 
point of view, monitoring cycling cells dealing with DNA damage from one phase to the 
other. Pivotal cellular process like duplication of the genetic information contained in the 
nucleus ought to be carried out synchronously with surveillance mechanisms embedded in 
the replication process itself. In addition, aberrations in the replication process or the 
presence of DNA damage during replication not only slow down and affect S-phase 
progression, but also impact on subsequent activation of G2/M checkpoint, which monitors 
unreplicated as well as damaged DNA, and on mitotic division, that activates the 
decatenation checkpoint to enable separation of genomic regions left unreplicated in 
mitosis. Thus, the process of replication and its termination continues through and affects 
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G2 and sometimes M-phase, as well as progression through S-phase. Replication requires 
the marvellously coordinated efforts of thousands of replication forks to duplicate the 
entire human genome. This complex task of proficiently and precisely replicating DNA is 
made more difficult by replication fork stalling and possibly collapsing upon encountering 
damaged DNA. Responses to DNA damage in the context of S-phase must be prompt and 
timely to facilitate the job of the replication machinery. Thus, some components of the 
active replisome that travel with the fork selectively work as surveillance factors to quickly 
respond to challenged situations. Roles for structural components of the replication fork, 
such as PCNA, but also TopBP1, Claspin, Timeless and others in stabilizing the fork under 
unperturbed conditions and following DNA damage are just starting to emerge. For 
example, it has been shown that upon induction of DNA damage in S-phase, ATR, 
recruited to the fork by RPA-coated ssDNA, phosphorylates and activates Chk1 through 
interactions with mediator proteins including TopBP1 and Claspin. 
 
GINS is a novel replication complex that has been shown to work at the interface between 
replicative polymerases and the unwinding helicase complex. In this thesis, I present the 
identification of evolutionarily conserved ATM/ATR consensus sites at the C-termini of 
two GINS subunits, Psf1 and Psf2. In budding yeast Psf1, mutation of the serine within the 
phospho-motif to a glutamic acid, possibly mimicking constitutive phosphorylation of the 
site, leads to loss of viability. This suggests that this site may not only be important for 
DNA damage-dependent phosphorylation, but also to enable replication. Further analysis 
of this mutant shows that it behaves like a dominant negative protein. Increased sensitivity 
to DNA damaging agents in the psf1-S187E strain suggests a potential dual role for this 
site in promoting and enabling replication, while responding to DNA damage during DNA 
synthesis. To this end, in human cells, Psf1 is phosphorylated after DNA damage and the 
Psf1 conserved C-terminal motif binds the UV-responsive molecular machine DDB1-
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DDB2, which links DNA repair with ubiquitylation events (Sugasawa, 2009) and regulates 
Cdt1 degradation after UV in S-phase (Hu et al., 2004). Binding of DDB1 to GINS suggest 
a mechanism analogous to PCNA, where GINS serves to bridge DDB1 to replication 
licensing factor Cdt1 and possibly others, mediating lysine 48-linked poly-ubiquitin chains 
to mark targets for proteosomal degradation. GINS is important for progression through S-
phase in human and yeast cells; the data presented in this thesis also suggest that it may 
play additional roles in regulating replication in response to DNA damage. This hypothesis 
awaits further investigation. 
 
Collectively, the work described in this thesis maps cross-talks between DDR and cell 
cycle mechanisms. The evidence presented serves to highlight evolutionarily diverging or 
converging DDR pathways that interact with the cell cycle machinery to promote cell cycle 
progression while ensuring genomic fidelity in both human and yeast cells. These data 
show that, while differences exist in how simple and more complex eukaryotes deal with 
DNA damage during diverse cell cycle phases, the molecular mechanisms underlying 
activation and unfolding of the DDR and checkpoint induction are often conserved 
throughout evolution. The observations shown in this thesis serve as a starting point for 
further investigations to minutely dissect molecular interactions and the functional 
relevance of the DDR mechanisms during individual steps of the cell cycle.  
 
Advances in this novel field at the boundary between cell cycle and DNA damage research 
might be translated into medical applications to pioneer new translational therapies based 
on emerging molecular data. For instance, the understanding of how cells respond to DNA 
damage in the radio-sensitive phase of mitosis is especially important to understand the 
differential impact of chemotherapeutic treatments on human cells at different stages of the 
cell cycle and between proliferating versus quiescent cells. Especially, the design of novel 
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anti-mitotic therapeutics requires an increasingly deep knowledge of the web of molecular 
mechanisms during physiological and challenged mitosis, with an aim of reducing side-
effects and selectively targeting cancer cells. In addition, understanding the essential role 
of Chk1 in higher eukaryotes and how this connects to other factors like microcephalin 
may not only serve to define how Chk1 inhibition negatively affects certain types of 
tumours, but may also shed light on Chk1’s role in physiological cell proliferation.  
 
The emerging links between replication factors and malignant transformations have been 
clinically implemented in various aspects of cancer pathology. Replication licensing 
proteins, such the MCM complex, are currently being used as biomarkers for hyper-
proliferation and have several translational applications, including diagnosis, prognosis and 
treatment assessment for a variety of cancers. The GINS complex could perhaps also be 
exploited as a cancer biomarker and could also provide an attractive target for novel anti-
tumour drugs to inhibit proliferation of cancer cells.  
 
The scientific knowledge gathered by research on cell and molecular biology is being 
gradually but surely translated into medical applications. It has been an enormously 
exciting and rewarding experience for me to have provided a small contribution to 
understanding biological phenomena and producing knowledge that can be used to better 
understand, detect and treat human diseases, particularly cancer.  
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